var title_f21_34_22048="Chromophore absorption spectrum";
var content_f21_34_22048=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F74419&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F74419&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 507px\">",
"   <div class=\"ttl\">",
"    Chromophore absorption spectrum",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 487px; height: 298px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAEqAecDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6pooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiivLLXXriD483ulzeIRd2T6MZIbJpERIrjzwBEAOr7QTz82G9KAPU6K+bvC3i7XhZafqNnrl7qeuX2matcajp8svmJaywgmHbF/yy+YBcd81XtfGGvWPh/WJND1691fd4Wt9SuJppvPNpePKFkCn+DCFzt7bfagD6Zor50/4SXUbaPXtN0/xNf3nh6PUtJgbWHufMkt4px/pBE3bBx/u5r0j4M6ndX9h4igl1CfU7Gx1ee1sbyaTzGkhAUgb/wCPBJ+bvQB6HRXL+INQ1r/hJ7DSNEn06386znupJby2ef7jxKFAWRMf6wnPPSl+y+NP+gx4d/8ABVN/8k0AdPRXMfZfGn/QY8O/+Cqb/wCSaPsvjT/oMeHf/BVN/wDJNAHT0V5Z8RfE/jLwZpcF4134evBLJ5ewafNHj3z55riZfjH4vj/5Y6Af+3Sb/wCPVvTw1SqrwVxSairs+iaK+eIPjB4wlx+60Af9uk3/AMerZ8M/EXxhrklwgbw/B5Mxi5sZmzwDn/Xj1rGvF4fWroYLF0nLkUtfme3UV57LqnjKOASf2h4eOe39mzf/ACRXML4/8YtNfR+Z4f8A9Fn8nP2Gb5vkVs/6/j736VyLG0XqpfmejSwdat8Eb/ce00V4LffFHxhaxu2PD7bRnH2OYf8Atau+8K3vjPX/AA1pmrjUfD0AvbdLgRHTJm2blBxn7QM9fSuiE1OPNHYrE4CvhUnWja+2q/Q7yiuFlu/GcfiW10j+0vDxM9pLd+b/AGZN8vlvGu3H2jv5mc57e9Hia78Z6H4f1DVDqXh6cWkLTeWNMmXdgdM/aDiqOQ7qiuY+y+NP+gx4d/8ABVN/8k1maHd+M9VF+RqXh6L7JdyWn/IMmO7Zj5v+PjjOelAHdUVzH2Xxp/0GPDv/AIKpv/kmj7L40/6DHh3/AMFU3/yTQB09Fcx9l8af9Bjw7/4Kpv8A5Jqhrs3jPStJub46n4elEK7tn9lzLnnHX7RQB21Fcx9l8af9Bjw7/wCCqb/5Jo+y+NP+gx4d/wDBVN/8k0AdPRXMfZfGn/QY8O/+Cqb/AOSazNGu/Gep3GqxDUvD0f2C7NqT/Zkx34jR93/Hxx9/GPagDuqK5j7L40/6DHh3/wAFU3/yTR9l8af9Bjw7/wCCqb/5JoA6eiuY+y+NP+gx4d/8FU3/AMk1heK9a8T+HLKOe61zwuZJJoo1ifT5UYq8iozjNxyFDFj7L260XsKUlFXbseiUVyluni65hSa31zw1LC43I6aZMysPUEXPNSfZfGn/AEGPDv8A4Kpv/kmge509Fcx9l8af9Bjw7/4Kpv8A5JrO0C58Z6vpi3g1Pw9FmWWPZ/ZkzfckZM5+0d9ufxoA7iiuY+y+NP8AoMeHf/BVN/8AJNZmt3fjPS301TqXh6X7Zdpaf8gyYbNwY7v+Pjn7vSgDuqK5j7L40/6DHh3/AMFU3/yTWZrF34z0260iE6l4ek/tC7+yA/2ZMNn7qSTd/wAfHP8Aq8Y96AO6ormPsvjT/oMeHf8AwVTf/JNZlzd+M4PEen6T/aXh5jd21xceb/Zkw2eU0Qxj7RznzeueNvvQB3VFcL4lu/GeiaJc6idS8PTCAKfLGmTLnLAdftB9a0/svjT/AKDHh3/wVTf/ACTQB09FcLot34z1SXU0GpeHovsV21oT/Zkx34VW3f8AHxx97p7VreFtR1afVdZ07WpbGaWxaLZLaQPCrB03cqzvyPrQB0lFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABVL+ydO+2fa/sFp9r3bvO8ld+fXdjOau0UAVbfTrK2uprq3s7aK5m/wBbLHEqvJ/vEDJ/GktNNsbNJktLK2gWY5lEUSqJD6tgc/jVuigCnDpWnwWMllDYWkdnJnfAkKiNs9crjBqa0tYLO3SCzgiggThY4kCqv0A4FTUUAcxd/wDJTdL/AOwPd/8Ao62rp65i7/5Kbpf/AGB7v/0dbV09ABRRRQB5d8fI1k0HTlkG5TcHj/gNeDXfU17d+0BqESWWk2ETLJfSSNIIs8hcY3H0Gf614hI/lTbL5cg8BoT0PpzX0GXQfskzixeLpwXs1rJK9kTWHUV6D4EhjilcxqFLvvbHc8c/pXCQRLGyGNt0bcqTXfeCf9YPrXi5/seFRqKpiYSjsz0q6/48V+lcFqdvFDJcNEgVpX8xyP4mwBn8gPyrvbr/AI8V+lcNrP3mr46nsz9SyjZHD60AYpQe4NfQnw3RY/APh9EGEWyiAHoNor581n/VyfSvob4d/wDIi6D/ANecf/oIr6PBf7uvU7eJUvqlN/3v0NlrO3bUI75olN1HE0KydwjFSy/iUU/hRqFnb6jZT2d7Es1tOhSSNujKeoqxRXQfFBVezs7ez877LEsfnStNJj+J26n8asUUAFFFFABUN5aw3ltJb3UYkhkGGQ9CKmooAKKKKACq9rZ29pJcvbxLG1zL50xH8b7QuT+CqPwqxRQAUUUUAZfibWINA0K81O55SBMhc4LseFX8SQK5nw74Og1G2bVvF9tHf6velZnWYZW3UEMsSjsBgZ9eQcjOZfGCLrfi3QNBPzQRMdSu1/2E4QH1BY/pXa1FuZ69DkUVWqty1UdF69X+n3nAaTD/AMId42j0iEkaHrCvLaxk8W868si/7JHP1xXf1yPxOtnPhwanbKDd6TMl9F77D8w+m3P5V1FlcxXtnBdQNuhnjWRD6qwyP50R0bQ6C9nOVLpuvR/8G5NUFlaQWNuILWMRRBmfaPVmLMfxJJ/Gp6Ks6gqvd2VveGA3MSyGCUTRZ/hcAgN+pqxRQAVXurO3u5LaS4iWR7aXzoSf4H2su4fgzD8asVyWseMWi1WXS/D+lT61qEP+vWKQRxw+zSHjPtSbS3M6lWNNXkzraryWVvJfwXrxKbqCN4o5O6q5UsPxKL+VYPhvxUNUv5tM1Kwm0rV4l8w2szBg6f3kYcMK6ahNPYdOpGouaLK9/Z2+oWklreRLLbyY3I3Q4Of5irFFFMsr2lnb2bXDW0Sxm4lM0pH8TkAFvyA/KsDw/wD8jr4r+tr/AOiq6euY8P8A/I6+K/ra/wDoqgDp6KKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigDyi01m1tvj7e2g1qe4E+leUttNKTHFc+bny0AAA+QZ7nk815z4Jv8AWmvrI6Rc6lP4qfTtVbXoZXkbZOu77NuVvlU7toGO1fTtFAHy5Z398uja4fBd7qc8X/CKxSam3nSuY9QMq+acscrJ5fmZAx0r0z4Mz20nibxbH4cubi58JIbX7E8kskiCUxnzQjPyecZ9DXq9FAHE+JF1RviJpA0WSySf+yrvcbtGddvnW/QKQc5xXR6Iusr539uS6dJ08r7HG6Y653bmPtjHvWXd/wDJTdL/AOwPd/8Ao62p/i7xfYeHVSKWSOS/mIWK3MgTJPQsx4Ue5qoQlUfLFXZnWrQox56jsjopHWNC8jBUHJZjgCud1Hxv4fsCyyajHK6gkrADL0914/WuO1u/0+PUkXxze3V1OUWaPT7KGQ28YPTlfvH3z+dZfjDxposnhy40Pwtp1zb3l8oiO2zMZER++2OrcAj8a6YUqfMlJ39NF9//AABRw2ZV4e0pUuWL2um2/krJfe/NHKeKLfUNSjm8X3/yRapOY7ONvvLAoO3jtwB9ev14e/XejLXqPxH8Sadd+GtI07T7LU4YrPCK1xamMFVTaMH14ryy4mVjwGH1FethsQpK707ehu8mr06b5abblq+7Zd0xt9hGT1DkH8q9A8E/6wfWvM9OuFikaNmxGxD5PY9DXpHgqaL5pPMTYvLNuGAPU14vEDU4px1PmI4DE4TFL29NxV3umt/U9Ouv+PFfpXDaz95q1dF8Y6Z4gkuLKxE6yQrvVpU2iVc4LLznGfXFZWs/eavkpUKlCThVjZ+Z+lZLUjUjeLujiNZ/1cn0r6G+Hf8AyIug/wDXnH/6CK+edZ/1cn0r6G+Hf/Ii6D/15x/+givfwX+7r1PR4k/3Sn/i/Qi+InitPBfhmTV5LKW9CSxxCCJtrMXbAxx71z+nfFvQtQ8TnTLcMLFNO/tCXUXcCKMBFcofUhXUnngnFbXxJ0q31zRrLTbmeWFp9QtzF5SB2ZlffjBI4CqzE9gp6nisjUPhRodxfSPabrCzksLqyktoF6mdtzSBiTg56DGOg6DFbnxI/VvijpFvprXGmRT3dwk9tE9tcRSWjiOdwqygSJkr3BA59RW6PGmi/wDCQrokk1zDfyNIkQms5o45mQZcJIyhWwAehNcbZ/B+CDTzaNqNqvz27iS20yKB28qQP85U5YnAHYd8Vas/hTDb+NE8QvqzzTJeT3aiS2UyESoV8tpc7iq5+UdB6UAXj8VfDVzp1/PpN39pntrB9RSOaGaBZYl6kMYzkA9cAn24NTXHxO8M2LQQ6pfG3unit5ZEWCWRIhMAUJkCYAOcZOPfFZL/AAnt30uxsv7Vmxa6LPowfyR8yydZMZ6j0p+q/Cq31DT9atW1SVBqdpYWrMIQfLFqwII553Y/CgD0qiiigAooooAKKKKACiisHx3qZ0jwjql3GxWZYSkRHXe3yrj8SKTdlcipNQi5vZGJ4A/4m+veIvEbfNHcT/Y7U/8ATKLjI9mPP4V3NY/hDSRofhnTtNAAaCEB8d3PLH/vomtilBWWpnhoOFNKW+79XqyK6gjurWa3nXdFKhjdfVSMEVyHwqnkj0G50a6bN1o9zJaNnqVByjfTBwPpXaVxUCf2T8VbgA7YNashIB2M0Jwf/HDmlLRpk1vdqQqfJ/P/AINjtaKK5Pxhrt3FfWmgaDtbWb4E+YRlbWLvKw7+w9fyNN2NatRU48zOsorzbVfDF54Usf7e0XUdQvtRtf3t4lzMWF3H/GMdiByPTHc13em6na6hpEGpwSr9kliEodjgKuMnPpjv6YpKV9GRTrOUnCas9/l/W5S8Y60ug6BcXijdckeVbR4yZJm4RQO/P6A1F4F0JvD/AIcgtZzvvZCZ7qTqXlblsnvjpn2rA0ZZPGviWPXJ1ZNC012XTozx9ol6GY+w7f8A667+lH3nzEUv30/bdNl+r+fTy9TmPG/h+41WK0v9IkWDW9OfzbWRujf3o2/2WH+etUrX4h6VCUtvEIn0bUgMSQ3MTbcjqVcAgr6Gu0qOeCG4TZcRRyp/ddQw/I03F3uipUZKTnSdm976p/lqYSeNvDLjjXdPH1mA/nUo8X+HD/zHtL/8Ck/xqd/DuiSHMmj6a31tUP8ASoz4V8PHroOkn/tzj/wpe8L/AGj+7+JmS/EXwnFK8ba1AWU4JRHYfgQMH6ioPBOpWmreKfFV1YSmWAvbKGKMvIi54IBrY/4RLw7kEaDpQPtaR/4VT8P/API6+K/ra/8AoqqV+prT9pr7S3yOnooopmgUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFNl3iJ/JCmTadoY4Ge2favJJ/iFr2nfDTxfrd/DYvq2larJp8SRBvJXDxoCc4JALk5OM47UAeu0V4xL478TWV1qfhy4ubGfWIdZsdLi1NbYrGFuUL7zFu5ZQpGMgEkfj2nwv8Q6hrun6zDrDQy3uk6rPpjzwpsSfy8Yfbk7SQ3Iz2oAo+OLu9svGVhNpz20TjSLvfPcPtSBPOt8ufXHp/PpXLLpmgeIfG/h+y0+VNcSNbi41a6YF1clAEyen3ugHTiux8U6hbaf8QNKa8tbu6hk0m7jMdtaPcn/AF1ueVRSccdSMdK6Hw5qNlfRTJp9heWUcRGVuLCS1Bzn7odVz05x049a6aWI9lFpLXX+vkctTCxqVFUlrbv09PXq/kcx/wAIl4g0N3h8G65FBpr5xZ36GVbfPeNuuP8AZPH1rZ8LeFE0i5l1HULuTVNcnXbLfTDBC/3EUcKvsK6aiolXnJWf/BfqzZUop3PMfjx/yBNN/wCu7f8AoNeB3fU1758eP+QJpv8A13b/ANBrwO76mvYy7+GgxH8McYTLpisigyJJkcdeOlaMNtaX1tZw2care3syxKysRsX+LI/Sq+mfNbMvcMGrr/BGm241gXnlKJFGAfc9TWOZzjTXtZfZ1Xm+ifz/AFPmcLj69DEujTnJNyez6NX18v1Ga/4VvPDupaM+kXhuHlLxwrIioykLuwWHXPOM/wBamHiOC+/dXaNZ3fQxycAnvg11vj9vKbwxJ/1EkTP+8pFc14jtIRfSLPEr21z94EdH9fbNfM8/1yjBVtZWbT66N3X3benmfoGAxkMLU9pKCUW0pNK1rrRtLTfRu19b3sjndY/1UlfQ3w7/AORF0H/rzj/9BFfNOo289irpG5mtv7rH5k+h7ivevB+v28fwy02TTZIrq9jgjtI4Q3/LwcKqMOoGSCT2XJ6V04WKjQSTurn0PEq/2SFv5v0Ogs1GpeJrm8LB7fT1+yQAdPNIDSt6HjYg9CHHc1ukgDJ4A71S0TT00rSrazR2kMS/PI33pHJy7n3ZiWPuao+OIpJ/BXiCGCN5JZNPuEREBLMxjYAADqa1PiDZ3pgfOvIyOetCOsiB0YMp5BByDXgPh7QvE0D/AA9bVGa5tYtHvUjhjsGiazzbKAkrZOWPAGQvKnisrwxD42k8HXGi6E+tmNfDxSWG8tDbi3ut4xHCxRSSY93c9c56YAPpKOWOXd5ciPtODtOcH0p9eC+Gba2sPFOm6l4Q02fQdOsdGmTWbi/tJLaAyBP3fmBtu9lfJYjnHevUfhv4hn8T+HWv7mWxmP2iSOOW0yqyRg/KxQsxjYgg7GORkZ60AdTRRRQAUUUUAFFFFABXE+OHOo+J/DGhJhke4N9cDt5cQyAfYn9RXbVw/hX/AIm3xA8S6wfmhtNmlwH02/NIP++sfnUT1sjmxPvctP8Amf4LV/lb5ncUUUVZ0hXMeONJv71NO1HRBG2q6ZP50UchwJVIw8ee2R/KunopNXViKlNVIuLOGfxD4uv08jTfCxspzw1xfXC+XH7gDlvw/Ktfwp4bXRjcXl7cPfazd4NzduMZ9FUfwqPT/wCsB0VFJR6syhQtLmnJya2vbT5KwhAIIIyD1BriR8PLT57T+09QXQmlMv8AZauFjyTkruHzbM/w5rt6KbinuXUowq251cjtoIrW3igt41jhiUIiKMBQOABUlFFM1SsFFFFABRRRQAVzHh//AJHXxX9bX/0VUt34y0W0upreeW8EsTlHC2FwwyDg4IQg/UGs7wTqVtqvinxVdWTSNCXtlBkieI5EX91wD+lAHZ0UUUAFFFFABRRRQAUUUUAFFFFABRRRQAUV43rWp2us+NZ9N1Dx1r1tP9v+w22naJC1skDYyPNlZDvYjB+9jkYB616P4S03V9Jtbi01nWDrCLJ/otzLEqT+XgfLLtAVmBz8wAyOozQBu0UUUANmjWWJ43zsdSpwSDg+45FcrYfDzwxY2Gp2UGms1pqQIu4prqaVZTnOTvc4bPO4YPA54rrKKAOTg+HnheDQ7nSY9M/0O5lWeUtPI0rSLja/mlt4IwMEHitnw5oOm+HNNFho1sLa2DtIV3M7M7HJZmYksT6kmtOigDmLv/kpul/9ge7/APR1tXT1zF3/AMlN0v8A7A93/wCjraunoAKKKKAPMfjx/wAgTTf+u7f+g14Hd9TXvnx4/wCQJpv/AF3b/wBBrwO76mvey7+GjPEfwybTiVIIOK9D8E/6z8a87sOor0TwT/rB9a8fP2+Wx83GK+uRfU6D4oDZ4asLn/n1voZvpg4/rWZ4iiE0ciHr1B963/iJbfa/AmoxgZIi8wf8AIb+lcy9x9s0y2uc582FX/MA189TnKOGp1I7xk/0a/U/QctowryqUKqvGcVf8U/0OQ1Jt9sxPXHNeo6F4MZvDvh3xF4ZMNrrkNrHIY5BmG6Owqdw7NhmG4ep+teW6qNqTjtya+ivh3/yIug/9ecf/oIr3YRUIPk2buvRq5318dVeVUZSd5KThK/VxvF3Xm1cZ4R8VQ68Jra4gew1i2O25sZT86f7Q/vKfUf4V0lc34r8KW2uPHeQSvYazbj/AEa/h4dPZv7y+x9T61zb+Mb+30+90LX4xYeJmhaGzmHEN27fKjoemckfL/8AqBa+qPEnQhWi6mH6bx6rzXdfiuvc7DwncS3ujrfTSM4u5ZJ4snpCznygP+AbT9Sa2KhsraKys4LW3UJBBGsUajsqjAH5CuG+PcVxN8JfEEdmksk5SLasQJY/vk6Ac9Kk4jvZNnlt5u3Zj5t3THvSRxpGuIkVF64UYFfPHi3TvES6j42TWJhqM0nhdFjktbR4kP73hAu5st17/hXoXwr1TVb/AF3xFDLf3+p6FALcWd3e2whbzSp81FwiZAOO3FAHpFc5J438OR6ydKfVoBeh/LK4baG/ul8bc9sZqXx5qr6J4Q1S/hbbNHCRG3o7EKp/AkVV0nwnpw8FQaLeWqMksIM5IyzSkfM+f72e/aobd7I5qtSo58lK10ru/wCC+euv4HUUVyHw01C5m0i50vUpTJqOkXDWcrN1dR9x/wARxnviuuJABJOAO9UndXNaVRVYKa6nI+JNY1K58QweHPDzpBdtF9our10Di2jzgYU8Fj6H/wCuG+GdS1Oy8R3Xh3X7lbyYRC6s7zyxGZo84ZSo43KfTtUPw5RtRvNe8RycjUbox27esEXyqR9efyrV8X+H5dYjtLnTboWWr2LmS1uCuQMjDIw/ukdf8ioV37xxx9pOPt4tt30XTl/LVa+vWxs6leR6fp91eTnEVvE0r/RRk/yrnvhlZvbeD7SacYub5nvZfdpDuH/ju2sm90jxd4ljTTfEDaZY6VuBumsmZnuFBztGfug4/wA9K72GJIIY4oVCRxqFVR0AAwBTWrubU26tTnaaSVlfz3/IfRRRVnUFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFcx4f/wCR18V/W1/9FV09cx4f/wCR18V/W1/9FUAdPRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHjXxn8QanpPivR9P0rV7rS4rm3mvJv7N0VNRuXkRo0V2VgQFwcbhzlQOmMeneEJ5rrwvpU91c3N1PJbozz3NsLeWQkcs0Q4Qn+72rz34qW2mah430m11HVtQ0OeHS7u4hvrbWP7PVgHizFnad2SFJ5+UKDg9u2+G94NQ8AeHbwC8AuLCGUfbZjNN8yA/PIQC55+9gZ64oA6OiiigAqC+uRZ2c1w0U0wjXd5cKF3b2VR1NT1BfR3EtpKlnOlvcMuElePzAp9SuRn6ZFAHHR/EWym8GaPr8FhdyNq9yLOzs8qJHlLsoUknao+RiSTwBWz4M8TW/inTbm5gt5rWe0upLK6t5sFoZozhlyCQeo5HrXL2fw1ntvB+k6INc3TaRfpf2F19jA8t1Zjh03/ODvbuOo9K6PwJ4XHhXTb2Brxr27vr2bULq4MYjDyyEFiFBOBwOMmgCtqt3b2nxJ0p7ueKBDpN2A0rhQT51txzXS2l7a3m77JcwT7MbvKkDYz0zj6Vy+tWFnqHxI0mK/tLe6jXSbtgk0YcA+dbc4I68mul0/TLDTt/9n2VraeZjf5ESpux0zgc9T+dAFuiiigDzH48f8gTTf8Aru3/AKDXgd31Ne+fHj/kCab/ANd2/wDQa8Du+pr3su/hozxH8MlsOor0TwT/AKwfWvO7DqK9E8E/6wfWvGz/AGPnI/73E9H1CNZtLaKQZR1KsPUEYryjw8zroP2WX/W2cslu31Vv8CK9auv+PFfpXlE2LTxTqtp0W4VbtB7/AHW/UV83hPfoVafpL7tPyf4H6Jl3uVac+94/fr+a/ExNYHyyH2r6I+Hf/Ii6D/15x/8AoIr571UBlcEgAgjJr1vwT4ZuNX8M6bLq+pXP2RbdEtbe1kMahAOGbHVj19v0H0eFUamEhKTtbT7r/pY5s5rTw3tMLGDbdTnXRcrgr+9a3xc2m/luelVyvjrS7TxA+k6HexCWC4naeYdGWONCdynsd5iH0asaPxZB4Oa80jXJru8uYpB9hVEMk1zG4+VR6kEEEmmQyeOdW1hdVttI0rS41tzBDHqMzyOqswZjtQDBO1OD021o8PKOvTvseJh8XzJTjdSXTqmtCWFvEXgg7JxP4h8Or92Rebu2X3H/AC0Ufn9AMVpweJLHxPeaRDoN95sTSNdXXlkoyxxgfIw4IJkePg9QG6iq8tx8QLFDK9p4f1RAM+TbvJBIfoXytc1oOl6Z461TV9bsWvfD2v2sy2kiwMEkjKjLF1HDAsXGT12D6VMqTS5tH6HorEUcS7Vlyy7paP1X6r7met0VHbo8cESSyGWRVCtIQAXOOTgcDNSVicrOJ+Lvz+FoID0uL63iI9cvn+ldtXD+PD/aPiXwnoqclrz7fKPRIQSM+xJI/Cu4qF8TOalrWqS9F+v6nGeJtM1DS9fTxL4ftvtUrRiG/s1IBnjHRl/21x+I4+tDWdb1Dxdaf2P4dsL+0W4Gy8vbuAxC3jP3lAP3nI4wP/rj0Kihw8xSw121GVk91/l2v1K2m2UOm6fbWVqu2C3jWNB7AYqzRRVnSkkrIKKKKBhRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVzHh/wD5HXxX9bX/ANFVLd+B/Cl5dTXN34a0We4mcySSyWUbM7E5JJIySfWs7wTpdho/inxVaaTZW1laq9swht4ljQExcnAAFAHZ0UUUAFFFFABRRRQAUUUUAFFFFABRRRQB5j4yj1S41Ga28RfD+28XaSsxlsJoHgdogR9145iuDxyykgjGcV1/g6bXbixml8Q6baaVucC1sYJhK0MQUACRwApbOeF4AwMnrXM/FzxRqfhe48Pz21w9npL3IN9OlmbgsokiHlcA7NyNK27Gf3YA5NdN4CvNR1Dwfpd3rSuL+aLfJ5kYjYgk7Syj7pK7SR2JoA36KKKACiiigAoqO4mitoHmuJEihjBZ5HYKqgdyT0FVtF1Wx1vTIdR0m5jurKbd5c0f3WwxU4/EEUAYt3/yU3S/+wPd/wDo62rp65i7/wCSm6X/ANge7/8AR1tXT0AFFFFAHmPx4/5Amm/9d2/9BrwO76mvfPjx/wAgTTf+u7f+g14Hd9TXvZd/DRniP4ZLYdRXongn/WD6153YdRXongn/AFg+teNn+x85H/e4npV1/wAeK/SvKvHK/ZdQsNSXgRP5Up/2G7n6H+deq3X/AB4r9K4DxNbpd208Eo+SRSp9vevl8DVVKopS22fo9H+B+jYOi61Fxj8W69VqvxOO1j/VyV7t4Z1W10P4W6ZqV++y3t7CN29T8owB7k4A+tfOs155NsbS9/d3EY25I4cDoQa9Y8Gq3jez8N2Ihk/4R/RYo5bqR1IW5uVGFjGeqryT+Xoa+nweFdOlafwp7915evQ6s/x1Kvgqaptc99uq06rdWNrw34Vu9cjHijWbm4svEF03m27RH/j1gwdkW08dCSe/PPfPQDwpcXWF1rXdQvoR/wAskIgRv97byfzrqaK0liZt6afp6HxcsDRm7yV++rs/VXs/uOC1k3fgKGa/06O4vtE2MXs9xd4HxwUJ52k8Ee9ZuoaPd+GrbS/FPh0/b5YbdV1SKLkX0Z+Z5R/t7izfj7YPprqroyOoZWGCpGQR6VxcLN4K1QW7hj4cvJP3T9fskp/hP+wf0/POlOo5u/2vzX+f9bnPOP1R2/5dv/yV/wDyP5em3X2F1He2VvdQhxFPGsqB1KnDDIyOx5qZmCqWYhVAySTgAUtcD4m1GTxdev4Z8Pzn7ODjVL2P7sUfeNT3Zun5++OKUktjtrVVSj3b2Xdk3gkjX/EOreKWBMDf6BYEj/lihyzj/eb+RruKgsLSCwsoLS0jEVvAgjRB2A6VPRFWQ6FN04We+79WFFFFM1CiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACuY8P/API6+K/ra/8AoqunrmPD/wDyOviv62v/AKKoA6eiiigAooooAKKKKACiiigAooooAKKKKAPPvinf3uh32h63Z3GllLbz4Hs9R1FbNJjIEw4ZvlJUKeD2c4re+HMMlv4I0iObUINRkEOWuYJvOjckk4V8ncBnaD7VxPx0hsUvPDd/e6jodo9ubiOOPVbJ7tZt4jB2xqD0wOcdSPXnufAEsc/g7SpYJbKWJ4cq9jbmCFhk8pGeVHtQB0FFFFABRRRQBT1lS+lXSixXUSYyPsjFQJv9k7vl59+K474I6RrHh7wBY6Jr2nGzubIuobzkkEoaRnyNpOMbsc13tFAHE+JNMTVfiJpEL3V7bBdKu33Wk7Qsf31uMEjqOeldHoujppPnbL3UbrzcZ+2XLTbcZ+7u6defwrLu/wDkpul/9ge7/wDR1tXT0AFFFFAHmPx4/wCQJpv/AF3b/wBBrwO76mvfPjx/yBNN/wCu7f8AoNeB3fU172Xfw0Z4j+GS2HUV6J4J/wBYPrXndh1FeieCf9YPrXjZ/sfOR/3uJ6Vdf8eK/SuG1n7zV3N1/wAeK/SuG1n7zV8fT2Z+n5RscNraK8T7lBx0yM19D/DoAeBdBAGB9jj/APQa+etZ/wBXJ9K+hvh3/wAiLoP/AF5x/wDoIr6TBN/VkvM7OJIpYWEra836HQ0UUVufFhXKeIvGFrY3/wDZWnWU2savw32W3GRH3Bdjwv8ATik8davewmy0XQWUazqTFUc8/Z4h9+U/Tt/9atXwx4fsvDuni2slJdjvmnfmSZ+7Me5qW23ZHNOc6knTp6W3f6Lz/I56XRPE3iSPbr2ox6VYP96x07mRl/uvKfy+Xg11WjaTY6LYJZaZbJb26dFXufUnqT7mr1FCilqXToRg+bd93v8A16BRRRVGwUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAc7d+HtQnuppY/Fuu2yO5ZYYo7MpGCfurugLYHuSfes7wTZzWPinxVDcahdahIHtj590Iw5zF0/doq8fSuzrmPD/wDyOviv62v/AKKoA6eiiigAooooAKKKKACiiigAooooAKKKKAPM/i9FHLqOjR2tprF1rckNwLMaf5Y8sK8MhkYyYGVeOIgZ55FdL8Mvsn/CB6N/Z013PbGHIku1Cyltx3bgOAQ2RgcccZrgfiz4e0e28V6Xql5ouvanHfNL9rfTXuZHh2RqEKqjBVycA8c8nsa9J8Dw2MHhPTItKtLyzsVixFBeKyzIMnhw3IP1oA3KKKKACiivBfjZerB4u1NNXv7+0hj0Ay6KIZ5Ile+8w/d2Ebn+6MHt2oA96orgpfEVrc+DNRsdS1a5sNX07TLeTUpkBikt5JYwwIYrtySD0zj2qP4D6rHqvww0c/bDdXUCGK5LOWdZNxOGJ5zgj86ANq7/AOSm6X/2B7v/ANHW1dPXE+JH1SP4iaQdFt7Kef8Asq73LdztEoXzrfkFUY5zjjH410eiyazIJv7ctdOt8Y8r7HcvNu653bo0x2xjPfpQBp0UUUAeY/Hj/kCab/13b/0GvA7vqa98+PH/ACBNN/67t/6DXgd31Ne9l38NGeI/hkth1FeieCf9YPrXndh1FeieCf8AWD6142f7Hzkf97ielXX/AB4r9K4bWfvNXc3X/Hiv0rhtZ+81fH09mfp+UbHEaz/q5PpX0N8O/wDkRdB/684//QRXzzrP+rk+lfQ3w7/5EXQf+vOP/wBBFfSYL/d16ndxJ/ulP/F+h0NMnljghkmmYJHGpZ2PQADJJp9cR8TtQnksYPDmlr5up6uTFtBxshHMjH04yPz9K2k7K58LWqezg5f1foJ8PIpNXvtT8WXasG1BvJs1b+C2Q4HHbcRk/TPeu4rnLGbVrGygtbbQIkggRY0X7avCgYH8NYXxMXXNR+H2u+TbSaZeWsH2u3mgutzFoiHK/KB1CkfjSirKwqFP2cFF79fXqegUV8w2eveItU1S0FxdXsVl49uo3tgsrA2cUN1hlTnjMWCSMZzzXaW/xC1m9+Jv9jWV/ALGXULjTTDPCgmgZI3ZZAgO4ruXgtjcM8DtRrY9qor5u8PePvEWlfD7w2i6xFcS3N3cwX15eY3WDISUikdyQGfqC/QDA7Gu48KeLPEuveK9C003+lxQyaMNSu3gg85Zyt0Y2Ebbht3KOvzAZOAeDQB6zRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVzHh//AJHXxX9bX/0VUt3deLFupls9H0KS2DkRvLqsqOy54LKLYgHHYE/U1neCZNQk8U+Km1e3tbe6322Y7Wdpkx5XHzMiH/x2gDs6KKKACiiigAooooAKKKKACiiigAooooA8z+M0V2zaPM1re3+jRCdruzstQ+ySM2E8uQtuUsq4fIzxuBPSur+HsWow+CtHTWpjNfiAGRzKJTgklQXHDELgFu5Ga4f45W1nc33hxLia/eaQzRvY2Vg1291bb4XlGB93mOMZ9GPBrr/hbHbReANGWwukurYxFklSMxrgsx2hTyoGduD0xQB1VFFFABQQDjI6UUUAFFFFAHMXf/JTdL/7A93/AOjraunrmLv/AJKbpf8A2B7v/wBHW1dPQAUUUUAeY/Hj/kCab/13b/0GvA7vqa98+PH/ACBNN/67t/6DXgd31Ne9l38NGeI/hkth1FeieCf9YPrXndh1FeieCf8AWD6142f7Hzkf97ielXX/AB4r9K4bWfvNXc3X/Hiv0rhtZ+81fH09mfp+UbHEaz/q5PpX0N8O/wDkRdB/684//QRXzzrP+rk+lfQnw+YL4D0NmIVRZRkk8ADbX0mC/wB3Xqd3Ev8AulP/ABfobGrajbaTp1xfX0gjtoELux/kPUnoB61y/gPTbi6nufFGsoRqOoj9xG3/AC7W3VEHueCf/wBdUI1/4WBr0dwcnwrp0mY1I4vZx3x3Rf1/E49CrRe879D8+h+/n7T7K2833/y+/sFFFFWdYUgABJAAJ6n1paKAEKKQQVBB6jHWlAwMDpRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFcx4f/wCR18V/W1/9FV09cx4f/wCR18V/W1/9FUAdPRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHhfxbutA0/xPe3c3iPxvJrNrD5xsNGlAS0jKLlsmMiNSFBPzH1x0r1L4eafLpXgvSrK4tri1liiw0NxOs0iEsThnUBWPPUAVU8XfDvwx4rlln1fTVN7JH5Ru4HMUu3GOWUjdxxhsiuh0eyfTtMt7OS8ub1oV2/aLlg0snuxAAJ98UAXKKKKAOI8d63q9v4j8P6DodxbWU2pJdTPdTw+aEWFFIULkDksMnPAFUNM8f3dz8Ej40ks4vty2UkxgGfLMiMyZ9dpK5xnp3711viPwzpHiRLddZtPPNuWaJ1leN03DDYZCDgjgjODVeHwX4dhCiLSrdVGnnSwvO37KTuMeM4IJ5z196AOQ8I+LPEd1qOsaReyade3sGmW+pW04iaFAZVyY3AJyAehHJFdL8KtevPE/w/0fWNT8v7ZdRs0nlrtXIdl4H0AqfSvA/h7SbS+ttPsDDHeosdwwnlLuijCrvLbgAOAARir3hvw7pfhqw+xaJbG2tN24Rea7hT7bicfQUAcp441lNE8Z2FwJ7aG4bSLtIDc7vLZ/OtyAdoz0Bra8C+LrXxXYO8aeRewYFxbk52k9CD3U9jRd/wDJTdL/AOwPd/8Ao62rP8dWMul3tv4t0pD9qshtvYk4+0W38QPuvUfT2FTK61OevKVO1RbLdeXdea/I7eiq+n3kGoWMF3ZyCW3nQOjjuDViqN001dHmPx4/5Amm/wDXdv8A0GvA7vqa98+PH/IE03/ru3/oNeB3fU172Xfw0RiP4ZLYdRXongn/AFg+ted2HUV6J4J/1g+teNn+x85H/e4npV1/x4r9K4bWfvNXc3X/AB4r9K4bWfvNXx9PZn6flGxxGs/6uT6V6fa3E+s+FfDHhLTZmjku7GOa/mTrDbADI+rHj/6xry3XZFjifPU8Aete4fCHQbfTPCtpfgtLe38KSSSv1C4+VB6AD/PTH0GEd6CiLiquq1KGEhve8n2TWi9Zfld9jstPsrfTrGCzs4lit4UCIi9ABViiius+XSSVkFFFFAwooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigCjLq+mxSNHLqFmkinDK06gg+hGawfC1xDdeMPFcttNHNGWtRvjYMP9V6itifw9os8zyz6Rp0krsWd3tkZmJ6kkjk1i+ErO2sfF3iuGyt4beENakRwoEUExegoA66iiigAooooAKKKKACiiigAooooAKKKKACiiigAoornvGviaPwzY2Ti0lvby+u47K0to3VDJK+SAWbhRgHk0AdDRXN+D/Flr4j0C41MwS2TWk0tvdwTEFoJIj84JHBx1yK5XSfi/p91HLcajpV9p1k+nzanZzSMjm5gjYhsKD8rccKfzoA9Oorg/DPxETVzqEN3omoWd9a2ceoJaoVneeCQZVk2n73YqehNbvgTxLF4v8J2Gu29vJbRXYcrFIQWXa7LyR/u5oAr3f/JTdL/7A93/AOjraumYBlIYAg8EHvXM3f8AyU3S/wDsD3f/AKOtq6egDgNFU+CvE7aPK23QdUkL6ex6QTH70OewPUf45rv6yPFOhW3iLRptPu8ru+aOVfvROPuuPcf4iszwNrV1dxXOka1hdb00iOfn/XJ/DKPZh+vpmoXuuxyU/wBxP2T+F7fqv8vL0Ob+PH/IE03/AK7t/wCg14Hd9TXvnx4/5Amm/wDXdv8A0GvA7vqa+hy7+GjfEfwyWw6ivRPBP+sH1rzuw6ivRPBP+sH1rxs/2PnI/wC9xPSrr/jxX6VwmvyJCkskjBUUEkmu7uv+PFfpXlWvudY1SW2jP+g2rfvmH/LR/wC79B3r5Gir3ufomExMqFNKmrzlpFd35+S3fkcrdh7gSXcoIBH7pT2X1+pr6V+Hf/Ii6D/15x/+givnjWBiKQAYGK+h/h3/AMiLoP8A15x/+givosG74f5ndnGEjhcBTje8nK7fVtrV/wCXZWXQ6Giiitz5QKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACuY8P/API6+K/ra/8AoqunrmPD/wDyOviv62v/AKKoA6eiiigAooooAKKKKACiiigAooooAKKKKACiiigArm/HHhj/AISazsBDeGxvtPvI760uPKEoSRMj5kJG4EE8ZFdJRQBxHhrwLLodjDarrMs8U1zdXeqBoFUX7zKQe/7sA4IxnpWDpfwet4YXtdW1q41Cyi02bS7KLyFia3ikYksWBO9xwAcAcdK9VooA4Dwv4AvdEl1C9k183erz2MWn29y1mqJbwxj5R5e47jnkkkZ9q1Phr4UuPBfhmHRZdTGoW9uT5DfZxEUUsWIPzHPJPNdXRQBxmvWCaj8RtJilmuoQuk3bbredomP763HJUgkc9K6TS9Mj03zfKuL2bzMZ+03LzYxnpuJx17Vj3f8AyU3S/wDsD3f/AKOtq6egArj/ABzot2ZIPEOgDGt2A+4OlzD1aIjv3I9/wI7Cik1dWM6tJVY8r/4bzPH/AIr6vba74M0XULNsxTSkle6Nt5U+4PFeK3fU16t8ZdBOiXS31lIV07UJi81v2SfHLj6g8+/4Y8puq9vK53hyvdGDquVPkn8S3/zXk/8AgEth1FeieCf9YPrXndh1Fdx4f1CHTLWS5uMlVOFUdXbso9zXl58rqx4PMo4qMpbI7jxpqc1tpttYadg6let5cQ/uL/E59gK5h9Pi0yyS1hyQo+Zj1Zu5P1roNA0q6VJ9a1j/AJCd2Nqx54t4h0Qf1/8A11l6z95q+SVkuVH6JkNJ1J/WKi12S7L/ADe7+S6HEaz/AKuT6V9DfDv/AJEXQf8Arzj/APQRXzzrP+rk+lfQ3w7/AORF0H/rzj/9BFfQYL/d16nt8Sf7pT/xfodDRRRW58SFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAGLc+Hop7iSU6hqyF2LFY76RVGewAOAPasnwdZrY+LPFUKTXEwDWp3TymRv8AVep5rsK5jw//AMjr4r+tr/6KoA6eiiigAooooAKKKKACiiigAooooAKKKKACiiigCtqV/a6ZYT3uo3EVtaQLvkllYKqD1Jqp4e1/SvEdibzQ7+C9t1cxs8TZ2sOoI6g8jg+tYXxd8PX3ijwBqWl6UEe8cxSxxyNtWQpIr7Ce2QuOe+KxPBeneJdM1fX9buNCSGTXNTt91ibyMm1t1TY8xZcqx77QcmgDr7Txd4fvPEEuiWurWkuqxFg1sr5YFfvD0JHcDkU3SvGXhzVru8tdN1qxuJ7RWknVJR8ig4LZ6FQepHArzDQ/AviOLVrDTLmxSCwsNYvNS/tdbhCZklRlVQgO8MS3OQB8vU1laL8NfFNzp9rpd9YwaYmmaJfaYl0LlHW8kmLbSAvzBOcncAeTxQM9m0Lxf4f16G7m0jV7O6itMGdlkwIweQxz0BweenFaGjarY63psWoaTdR3dlNu8uaM5VtrFTg/UEfhXlvgnwzrsGqX2q634eSOKLQbfSE057iGU3rR8sxwSgBxgbj0PNdB8ENJ1jw94Bs9E17TGsbiyaQBvOjkWUPK75GwnGNwHNAjYu/+Sm6X/wBge7/9HW1dPWDrvhz+1NUtdRg1XUdNu7eGS3D2flfMjsjEESRuOqL0xVb/AIRjUP8AocvEX/fNn/8AI9AHT0VzH/CMah/0OXiL/vmz/wDkeoL7Qrmxsri7vPG3iCG2gjaWWRls8IqjJJ/0fsBQBzP7QMqw+HdPeQEr9oIIHuMf1rwadSh29V7V7VZ6donxLD6dceKPFcr2yJdLBdwQW7NG/wByVf3A3Kcdf8azde+HfgvRtZ0rStR8Sa+uoanKIreFXhYknjJxD8oz3Pv6GuyjiI04rdSXX/PXY58TQ9qk4u0l1/T0PK7WQRgZyT2ArsfAECajqTXVyGLWsvlpGfuq2Ac+55FehR/BDQ4zlda18H/rpB/8Zq5pvwj0/TGkax8QeIIjI/mNh7c5bgZ5h9hXHj5Txa3sebDLajqqpUa09TTuv+PFfpXnt9eR3U14kasDbS+S+7udqtx7YYVrxTaJdeIjoK+MfFJmFy1kJjb24t2uFGWhEv2fG8DtTPE/hHw/4akjF94j8US3mpSs0draxwTTTsqgMQiwdAoGTwBXiwy2pFO7X9fI+ywOYQw9uZM881o4hlJ6AGvoP4aSib4feHZVBCvYxMM9cFQa4+P4Q6TqFnFNJrXiRVmjD+XKYEdQRnDDycg+o7Va1XTbbwH4fsIX8XeJ4rRWjsbO1t4raaSRsYSNF+zkscD9K9XDwdKkqbN83zanjqUKdNNWd3e3+Z3kmqQx67b6SUk+0TW0l0rADaFRkUg85zmQduxo17VIdF0a91O6SR4LWJpXWMAsQPTJAz+NcN4d0y18Swx+ItP8ZeJC8CS2heWO1jeH5lMkbobfggoucjt6GsjS7zSvG7voi+LvFrxX1s8sQuLW3hS7hB2s0bfZxkZ+hrU8A9fqhpOqQ6oLwwJIv2W5e1feAMsmMkYPTmsf/hGNQ/6HLxF/3zZ//I9c14SsrHUdR1yx8P8AjXxE8tpcB70hLXb5smScE2/P3TnHFAHplFcx/wAIxqH/AEOXiL/vmz/+R6P+EY1D/ocvEX/fNn/8j0AdPVTVr+LS9OnvZ1dooV3MEAJPPbNYf/CMah/0OXiL/vmz/wDkeoL7wbdX1pJbXXi7xDJBIMMpFoMj8IKAOuormP8AhGNQ/wChy8Rf982f/wAj0f8ACMah/wBDl4i/75s//kegDp6oaXqkOpT6jFCkitY3JtZC4GGbYj5GD0w4/WsY+GNQAJPjLxF/3zZ//I9cd4Pex1PW77T9N8UeMrLULlf7RdL2yggNwvyx+am+35HCDjH060Aes0VzH/CMah/0OXiL/vmz/wDkej/hGNQ/6HLxF/3zZ/8AyPQB09UNb1SHR7Fbq5SR4zPDb4jAJ3SyrEp5I4BcE+2ax/8AhGNQ/wChy8Rf982f/wAj1W1HwTcajbCC98W+IZYhJHKFxaD5o3V0PEHZlU/hQB2FFcx/wjGof9Dl4i/75s//AJHo/wCEY1D/AKHLxF/3zZ//ACPQB09UtH1GLVrAXdurrGZJI8OADlHZD0J7qaxf+EY1D/ocvEX/AHzZ/wDyPXMeCoLDVzqdh4b8beI3j024KT/u7XbvdmYlSbf5gTuORx6cYoA9Oqhq2qQ6Y1is6SMbu5W1TYBwzAkE5PT5TWP/AMIxqH/Q5eIv++bP/wCR6q3vgme+Nsbrxb4hkNvMJ4uLQbXAIB4g9zQB2NUNT1SHTrjTYZkkZr+5+yxlAMK3lvJluemIz0zyRWP/AMIxqH/Q5eIv++bP/wCR65fxnaW2k3OlJqnivxZd3/nNPZW1nb20025UKs4VbfoFkIyePm9aAPT6oXGqQwa5ZaWySGe7gmuEYAbQsRjDA85z+9XHHY1h23h2/nt4pl8X+JUEiBwskdorDIzgg2/B9qil8E3Euo29/J4t8Qm7t45Io5MWnyo5QsMeRjkxp+VAHQ67qkOjaTPqFykjwwgFljALHLAcZI9av15t480y20rQGbxH4w8TSWdxKlusMUVq7zSMcqihbfJJI/SrXheJvEtjNdaf4x8Up5E7200VxBaxSRSrjcjKbfqMj86AOw0rVIdSkv0gSRTZ3LWsm8AZYKrZGD0wwrH8P/8AI6+K/ra/+iq5/W9KtfBWkX+rX/jTxFa2skpnmYJauZJCoHA+znkhRwOOKkGs6N4KjS/vNR1rV7vXEFwoNussxjjjBLbIkUBVUjJI70Aeh0VU0jUrTWNLtdR02ZZ7O6jWWKRcjcpGRweR9DVugAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKy/FOkjXvDWq6Q0hiF9ayW3mAZ2b1K5x3xmtSigDynw14M8XaXeXWsST6ENZg0eDR7CMNK8BWNgTJKdoYE46DOPWneKvhdeaj4qtNa03X7qNzqkV9cpN5Z8tUUqBEfLJyAcBWO3lu5r1SigAooooA8jsfhrrEHiWBZLrTz4ft9fk1+N1Z/tJdgcRFcbcAn727kdqd4y8A+IPE8uk6nqkPh2/1O2gubW4tJTKlqySH926HazB1wpPHJzgjivWqKAMfwdpM2heFNJ0q6uTdT2dtHA8xz85UY4z29Pasf4jeHNQ12LRLrRZbVdR0nUI76OO6LLFKFBBQsoJXIbrg12FFAHnvg3wz4n0CzEP2vSd2o315f6oyq7GJ5RmMQZABw2M7gMjpWH8Mfhpq3hbxRb6lctptrFFZvbXP2KaWQ6g5bIkdHULH64XPPtXr1FABXDeE9C8Raf478R6vqa6QLHVvJIFvPI0kflJsXhkA5HJ54PrW54516Twv4T1LWorI3xsoxK0Ak8ssuRuO7BxgEnp2ridV+Mmm2V14jihsZLhdKtIbmFxLgXZkMY2L8pwQZUB69elAHqdFcvJ430m11W20zUftdrfzusChrOYwtMV3eWs2zYzdeh5xSQeP/DM9jaXiaon2a6t57qORonUCKE7ZGbI+XBOPmxk8DNAHU0VwOr/EvTotNS40mKW5mF7a2ssFzFJbOiTthZNrqCQRkg4wcda1B8QPDn9pvY/bZBIryxiQ20ohd4gTIiSbdjMoByAT0oA6qiuM074neEr+K6lg1QrFbWn2+R5raWIGDIG9dyjdyQOM8nHWs3Wvi3oFloVzqNlHfXjW0tvFJbm0mhdfOJ2MdydCFYg9DwOrDIB6I+7Y2zBfHGema868D+HPFln4yv8AXfFr6NdT3URgE1rPKWt4gcrFGjIAFzySSSTTk+KmkQ+KNT0zVFls7aAWRt7h4JcyfaE3fvF2fusHaPmx17YrovG/iJ/DthZG0tReajf3kVjaQM+xWkcnlmwcKFDEnB6UAdFRXO6r4y0TSItWbU73yv7JEH20iF28vzjiPGAc5PpnHfFZ178TfCllqcthcahMLmK5a0cLZzMBMozs3BCCxHQDOe1AHZ0VxN78QLEaNo2u6WovdDu71bK5n+aN7YsxQMUYZwHwCDg85Ga7agAooooAzfEmlDXdBvtLe6uLRLuIxNNbsFkUHrgkHqOPxrkPhx4Fv/CXiLxDd3GqteWV95K26FUVsRoFy4VFAIxtAXjHXmvQaKACiiigArzL4qfD678U6tFqFjBpV250+bT3h1FnVYt7BlmQqrHepB4447ivTaKAMzwvpsuj+G9L024uWu5rS2jgedushVQC344rToooA434q+GL3xZ4cgsLBrRvLvIria3u9wiuY0JJiZlBZcnHIGePek+FXha88JaBd2V60Cia9luYba3leVLaN8YjDuAzYIJyR3rs6KAOa+I2k6nr3g3UtJ0b7GLi+ia3ZruRkREYEEjarEnpxiuT1Lwh4qeDw9f2LaKNZ0+wn0yeKSaXyGjdVCurbN24bQSCvOSM16jRQBgeAtAPhbwdpOiNMJ3s4BG8gGAzdWI9sk4rfoooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAKuq2MOp6Zd2F0u63uoXgkX1VlIP6GvM7L4J6Lb2nh+Fr68lbSrprl3bGboF0bZJ/sjy0H4V6tRQB5zcfCuzuPGY8Qy6ncyTLqKaiiSQxsylRjyxIRvEfooIA96dF8JtEE/iUzT3clvrUTwiEMFW0V3MjiP0y+G59B2r0SigDzHTfhFY2entatqGc3NrcB4bGCA/uGLKG2KNxOeSfTjHOVt/hDpttrl1fW95iKeaafy3soHkRpA2QJiu/aCxIGc9s16bRQB5lqnwssm8PfZEkuL1rfQm0eKEyLD5o8xJFbfg7W3IvYj2NZmhfDfWNW0vxMni6+nhuNVazEMgkjmlj+zElWYqiock9MdByc817BRQBwV/wDDiHUE8Qm91S5luNbSxFxKI0XDWpBDADgbiOR27Vo/EPQ77VbbSLzRljk1LSdQivoopG2rMoBV0LdsqxwfUCusooA8r8RfDi/8UeI/FD3up3GnaLqiWX7mFYnM5hGfmJBK7WA6EZzW5/wruz+1PP8Abbjc2vrr+No/1gTb5f8Au+/Wu4ooA811L4fzxeHLPw1pspl0661f+0L+4mIVkiEvnFFA6ksFAPYZzXpVFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAH/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The absorption spectra vary among chromophores. Absorption of light by melanin progressively decreases with increasing wavelengths of light. In contrast, the absorption of light by water molecules generally increases as wavelengths increase. Oxyhemoglobin has two peaks of light absorption within the visible light range.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_34_22048=[""].join("\n");
var outline_f21_34_22048=null;
var title_f21_34_22049="Diphtheria, tetanus toxoids, acellular pertussis, recombinant hepatitis B, and inactivated poliovirus vaccine: Patient drug information";
var content_f21_34_22049=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Diphtheria, tetanus toxoids, acellular pertussis, recombinant hepatitis B, and inactivated poliovirus vaccine: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/57/18326?source=see_link\">",
"     see \"Diphtheria, tetanus toxoids, acellular pertussis, recombinant hepatitis B, and inactivated poliovirus vaccine: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?3/25/3478?source=see_link\">",
"     see \"Diphtheria, tetanus toxoids, acellular pertussis, recombinant hepatitis B, and inactivated poliovirus vaccine: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F161308\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Pediarix&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F2934399\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Pediarix&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt adi-os drugH1Div\" id=\"F10028705\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     CDC Information",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705779",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Vaccine Information Statements (VIS) are made by the staff of the Centers for Disease Control and Prevention (CDC). Each VIS gives information to properly inform the adult receiving the vaccine or, in the case of a minor, the child's parent or legal representative about the risks and benefits of each vaccine. Before a doctor vaccinates a child or an adult, the provider is required by the National Childhood Vaccine Injury Act to give a copy of the VIS. You can also get foreign language versions.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705999",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <a href=\"file://www.immunize.org/vis/vis_multi_vaccine_infants.asp\" target=\"_blank\">",
"        Vaccine Information Statements (VIS)",
"       </a>",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11720 Version 29.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-61.234.146.186-C88E1676B6-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_34_22049=[""].join("\n");
var outline_f21_34_22049=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F161308\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2934399\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028705\">",
"      CDC Information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?17/57/18326?source=related_link\">",
"      Diphtheria, tetanus toxoids, acellular pertussis, recombinant hepatitis B, and inactivated poliovirus vaccine: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?3/25/3478?source=related_link\">",
"      Diphtheria, tetanus toxoids, acellular pertussis, recombinant hepatitis B, and inactivated poliovirus vaccine: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_34_22050="Patient information: Hemorrhagic stroke (The Basics)";
var content_f21_34_22050=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/16221\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"UTD.htm?21/2/21542\">",
"         Signs of stroke",
"        </a>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?5/17/5394\">",
"         Patient information: Brain aneurysm (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?33/58/34722\">",
"         Patient information: High blood pressure in adults (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?3/45/3795\">",
"         Patient information: Recovery after stroke (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?23/55/24435\">",
"         Patient information: Stroke (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?2/44/2755\">",
"         Patient information: Warfarin (Coumadin) (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?36/16/37121\">",
"         Patient information: What are clinical trials? (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?7/63/8180\">",
"         Patient information: Hemorrhagic stroke treatment (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?37/37/38484\">",
"         Patient information: Stroke symptoms and diagnosis (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Hemorrhagic stroke (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/hemorrhagic-stroke-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H28217852\">",
"      <span class=\"h1\">",
"       What is a hemorrhagic stroke?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Stroke is the term doctors use when a part of the brain is damaged because it goes without blood for too long. The word &ldquo;hemorrhage&rdquo; means bleeding. In a hemorrhagic stroke, the blood supply to a part of the brain is cut off because a blood vessel in or on the brain starts bleeding.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H28217859\">",
"      <span class=\"h1\">",
"       How can you tell if someone is having a stroke?",
"      </span>",
"      &nbsp;&mdash;&nbsp;To tell if someone is having a stroke, just think of the word &ldquo;FAST&rdquo; (",
"      <a class=\"graphic graphic_figure graphicRef73487 \" href=\"UTD.htm?21/2/21542\">",
"       figure 1",
"      </a>",
"      ). Each letter in the word stands for 1 of the things to watch for:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        <strong>",
"         F",
"        </strong>",
"        ace &mdash; Does the person&rsquo;s face look uneven or droop to 1 side?",
"       </li>",
"       <li>",
"        <strong>",
"         A",
"        </strong>",
"        rm &mdash; Does the person have weakness or numbness in 1 or both arms? Does 1 arm drift down if the person tries to hold both arms out?",
"       </li>",
"       <li>",
"        <strong>",
"         S",
"        </strong>",
"        peech &mdash; Is the person having trouble speaking? Does his or her speech sound strange?",
"       </li>",
"       <li>",
"        <strong>",
"         T",
"        </strong>",
"        ime &mdash;",
"        <strong>",
"         If you see any of these signs, call 9-1-1.",
"        </strong>",
"        You need to act FAST and get to a hospital. The sooner treatment begins, the better the chances of recovery.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Sometimes, people get a severe headache that starts all of a sudden when they have a hemorrhagic stroke.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H28217866\">",
"      <span class=\"h1\">",
"       How are hemorrhagic strokes treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;In the hospital, your doctor might:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Give you medicines and other treatments to reduce the brain damage caused by the bleeding",
"       </li>",
"       <li>",
"        Give you medicines to lower your blood pressure, if your blood pressure is too high",
"       </li>",
"       <li>",
"        Stop any medicines you take that thin the blood. If you take blood-thinning medicines, he or she might give you treatments to help your blood get thicker and stop bleeding.",
"       </li>",
"       <li>",
"        Do tests to figure out the cause of the bleeding",
"       </li>",
"       <li>",
"        Watch the pressure in your brain to make sure that it doesn&rsquo;t get too high",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Some people are also treated with surgery, depending on their symptoms and other factors. Doctors can do surgery to:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Remove a collection of blood, if it is pressing down on the brain or causing the brain to swell",
"       </li>",
"       <li>",
"        Stop the bleeding in the brain and fix the blood vessel that was bleeding",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H28217873\">",
"      <span class=\"h1\">",
"       Can hemorrhagic strokes be prevented?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Sometimes. You can lower your chance of having a hemorrhagic stroke by:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Getting treated for high blood pressure &ndash; This is very important, because untreated high blood pressure is a common cause of hemorrhagic strokes. Treatment can involve lifestyle changes, diet changes, and medicines.",
"       </li>",
"       <li>",
"        Not smoking",
"       </li>",
"       <li>",
"        Not using illegal drugs",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Having surgery to fix the abnormal blood vessel that caused the stroke can also prevent it from bleeding again.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H28217880\">",
"      <span class=\"h1\">",
"       What happens after a stroke?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Some people recover from a stroke without any long-term problems or with only minor problems. But many people have serious problems after a stroke. For example, they might be unable to speak or feed themselves, or they might be unable to move one side of their body.",
"     </p>",
"     <p>",
"      After a stroke, people are also more likely to get other medical problems. These can include blood clots in the legs, heart problems, bed sores, or lung infections. Your doctor or nurse will try to prevent these problems from happening and will treat them if they do happen.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H28217887\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?23/55/24435?source=see_link\">",
"       Patient information: Stroke (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?33/58/34722?source=see_link\">",
"       Patient information: High blood pressure in adults (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?5/17/5394?source=see_link\">",
"       Patient information: Brain aneurysm (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?2/44/2755?source=see_link\">",
"       Patient information: Warfarin (Coumadin) (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?3/45/3795?source=see_link\">",
"       Patient information: Recovery after stroke (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?36/16/37121?source=see_link\">",
"       Patient information: What are clinical trials? (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?37/37/38484?source=see_link\">",
"       Patient information: Stroke symptoms and diagnosis (Beyond the Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?7/63/8180?source=see_link\">",
"       Patient information: Hemorrhagic stroke treatment (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?21/34/22050?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 16221 Version 1.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-61.234.146.186-C2E244C14E-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_34_22050=[""].join("\n");
var outline_f21_34_22050=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28217852\">",
"      What is a hemorrhagic stroke?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28217859\">",
"      How can you tell if someone is having a stroke?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28217866\">",
"      How are hemorrhagic strokes treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28217873\">",
"      Can hemorrhagic strokes be prevented?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28217880\">",
"      What happens after a stroke?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28217887\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/16221\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?21/2/21542\">",
"      Signs of stroke",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?5/17/5394?source=related_link\">",
"      Patient information: Brain aneurysm (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?7/63/8180?source=related_link\">",
"      Patient information: Hemorrhagic stroke treatment (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?33/58/34722?source=related_link\">",
"      Patient information: High blood pressure in adults (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?3/45/3795?source=related_link\">",
"      Patient information: Recovery after stroke (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?23/55/24435?source=related_link\">",
"      Patient information: Stroke (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?37/37/38484?source=related_link\">",
"      Patient information: Stroke symptoms and diagnosis (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?2/44/2755?source=related_link\">",
"      Patient information: Warfarin (Coumadin) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?36/16/37121?source=related_link\">",
"      Patient information: What are clinical trials? (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_34_22051="Volume responsiveness to guide fluid therapy";
var content_f21_34_22051=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F86275&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F86275&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 646px\">",
"   <div class=\"ttl\">",
"    Volume responsiveness to guide fluid therapy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 626px; height: 475px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Frank-Starling relationship with corresponding respiratory variations in the arterial pressure waveform. High respiratory variation in the arterial pressure or in the plethysmographic waveforms indicates that the patient is on the steep portion of the Frank-Starling relationship. Low variation indicates that the patient is on the plateau. Cardiac output maximization concepts aim at increasing cardiac output until it reaches the plateau of the Frank-Starling relationship. This goal, as demonstrated on this figure, could be achieved by minimizing respiratory variation in arterial pressure or plethysmographic waveform.",
"    <div class=\"footnotes\">",
"     * Arterial waveform obtained from invasive arterial monitoring.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Rinehart J, Liu N, Alexander B, Cannesson M. Closed-Loop Systems in Anesthesia: Is There a Potential for Closed-Loop Fluid Management and Hemodynamic Optimization? Anesth Analg 2012; 114:130. Copyright &copy; 2012 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_34_22051=[""].join("\n");
var outline_f21_34_22051=null;
var title_f21_34_22052="Angiolupoid sarcoidosis";
var content_f21_34_22052=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F71687&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F71687&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Angiolupoid sarcoidosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Angiolupoid sarcoidosis. Well demarcated, erythematous plaques on the cheek with numerous telangiectasias are characteristic of this clinical variant.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_34_22052=[""].join("\n");
var outline_f21_34_22052=null;
var title_f21_34_22053="Plantar warts close view";
var content_f21_34_22053=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F53424&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F53424&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Plantar warts",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 323px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Multiple hyperkeratotic papules are present on the sole of the foot. Note the presence of thrombosed capillaries and the interruption of dermatoglyphics (skin lines).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_34_22053=[""].join("\n");
var outline_f21_34_22053=null;
var title_f21_34_22054="Discoid lupus PI";
var content_f21_34_22054=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F56910&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F56910&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 604px\">",
"   <div class=\"ttl\">",
"    Discoid lupus erythematosus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 584px; height: 334px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Figure A shows skin changes from discoid lupus on the left ear of this patient.",
"    <br>",
"     Figure B shows skin changes from discoid lupus on the right cheek of this patient.",
"     <div class=\"footnotes\">",
"     </div>",
"     <div class=\"reference\">",
"      Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"     </div>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_34_22054=[""].join("\n");
var outline_f21_34_22054=null;
var title_f21_34_22055="Hydrocodone and acetaminophen: Pediatric drug information";
var content_f21_34_22055=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Hydrocodone and acetaminophen: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"UTD.htm?42/51/43832?source=see_link\">",
"    see \"Hydrocodone and acetaminophen: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?22/53/23381?source=see_link\">",
"    see \"Hydrocodone and acetaminophen: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block black-box-warn drugH1Div\" id=\"F13135478\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     ALERT: U.S. Boxed Warning",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The FDA-approved labeling includes a boxed warning. See Warnings/Precautions section for a concise summary of this information.  For verbatim wording of the boxed warning, consult the product labeling or",
"     <a href=\"file://www.fda.gov\" target=\"_blank\">",
"      www.fda.gov",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F179839\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      hycet&reg;;",
"     </li>",
"     <li>",
"      Lorcet&reg; 10/650;",
"     </li>",
"     <li>",
"      Lorcet&reg; Plus;",
"     </li>",
"     <li>",
"      Lortab&reg;;",
"     </li>",
"     <li>",
"      Margesic&reg; H;",
"     </li>",
"     <li>",
"      Maxidone&reg;;",
"     </li>",
"     <li>",
"      Norco&reg;;",
"     </li>",
"     <li>",
"      Stagesic&trade;;",
"     </li>",
"     <li>",
"      Vicodin ES&reg;;",
"     </li>",
"     <li>",
"      Vicodin HP&reg;;",
"     </li>",
"     <li>",
"      Vicodin&reg;;",
"     </li>",
"     <li>",
"      Xodol&reg; 10/300;",
"     </li>",
"     <li>",
"      Xodol&reg; 5/300;",
"     </li>",
"     <li>",
"      Xodol&reg; 7.5/300;",
"     </li>",
"     <li>",
"      Zamicet&trade;;",
"     </li>",
"     <li>",
"      Zolvit&reg;;",
"     </li>",
"     <li>",
"      Zydone&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1053218\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Analgesic, Narcotic",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antitussive",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Cough Preparation",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1053212\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"UTD.htm?42/51/43832?source=see_link\">",
"      see \"Hydrocodone and acetaminophen: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Oral:",
"     <b>",
"      Note:",
"     </b>",
"     Doses based on hydrocodone:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Children and Adolescents:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Analgesic; opioid-naive patients",
"     </b>",
"     (American Pain Society, 2008; Carr, 1992; Jacox, 1994):",
"     <b>",
"      Note:",
"     </b>",
"     Doses should be titrated to appropriate analgesic effect; maximum daily dose of acetaminophen should be limited to &le;90 mg/kg/",
"     <b>",
"      day",
"     </b>",
"     not to exceed 4000 mg/day (and possibly less in patients with hepatic impairment or ethanol use):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Children and Adolescents &lt;50 kg: Usual initial dose: 0.1-0.2 mg/kg every 3-4 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Children and Adolescents &ge;50 kg: Usual initial dose: 5-10 mg every 3-4 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Antitussive:",
"     </b>",
"     Children: 0.6 mg/kg/day or 20 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     /day divided in 3-4 doses/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     &lt;2 years: Do not exceed 1.25 mg/single dose",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     2-12 years: Do not exceed 5 mg/single dose",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     &gt;12 years: Do not exceed 10 mg/single dose",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Analgesic: Note:",
"     </b>",
"     Doses should be titrated to appropriate analgesic effect: Average starting dose in opioid-naive patients: Hydrocodone 5-10 mg 4 times/day; maximum daily dose of acetaminophen should be limited to &le;4000 mg/day (and possibly less in patients with hepatic impairment or ethanol use).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Dosage ranges (based on specific product labeling): Hydrocodone 2.5-10 mg every 4-6 hours (maximum dose of hydrocodone may be limited by the acetaminophen content of specific product)",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F179820\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Capsule, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Margesic&reg; H, Stagesic&trade;: Hydrocodone bitartrate 5 mg and acetaminophen 500 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Elixir, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Lortab&reg;: Hydrocodone bitartrate 7.5 mg and acetaminophen 500 mg per 15 mL (480 mL) [contains ethanol 7%, propylene glycol; tropical fruit punch flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Solution, oral: Hydrocodone bitartrate 7.5 mg and acetaminophen 325 mg per 15 mL;  hydrocodone bitartrate 7.5 mg and acetaminophen 500 mg per 15 mL (5 mL, 10 mL, 15 mL, 118 mL, 473 mL); hydrocodone bitartrate 10 mg and acetaminophen 325 mg per 15 mL (7.5 mL, 15 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     hycet&reg;: Hydrocodone bitartrate 7.5 mg and acetaminophen 325 mg per 15 mL (473 mL) [contains ethanol 7%, propylene glycol; tropical fruit punch flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Zamicet&trade;: Hydrocodone bitartrate 10 mg and acetaminophen 325 mg per 15 mL (473 mL) [contains ethanol 6.7%, propylene glycol; fruit flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Zolvit&reg;: Hydrocodone bitartrate 10 mg and acetaminophen 300 mg per 15 mL (480 mL) [contains ethanol 7%, propylene glycol; tropical fruit punch flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hydrocodone bitartrate 2.5 mg and acetaminophen 500 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hydrocodone bitartrate 5 mg and acetaminophen 300 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hydrocodone bitartrate 5 mg and acetaminophen 325 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hydrocodone bitartrate 5 mg and acetaminophen 500 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hydrocodone bitartrate 7.5 mg and acetaminophen 300 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hydrocodone bitartrate 7.5 mg and acetaminophen 325 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hydrocodone bitartrate 7.5 mg and acetaminophen 500 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hydrocodone bitartrate 7.5 mg and acetaminophen 650 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hydrocodone bitartrate 7.5 mg and acetaminophen 750 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hydrocodone bitartrate 10 mg and acetaminophen 300 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hydrocodone bitartrate 10 mg and acetaminophen 325 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hydrocodone bitartrate 10 mg and acetaminophen 500 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hydrocodone bitartrate 10 mg and acetaminophen 650 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hydrocodone bitartrate 10 mg and acetaminophen 660 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hydrocodone bitartrate 10 mg and acetaminophen 750 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Lorcet&reg; 10/650: Hydrocodone bitartrate 10 mg and acetaminophen 650 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Lorcet&reg; Plus: Hydrocodone bitartrate 7.5 mg and acetaminophen 650 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Lortab&reg;:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     5/500: Hydrocodone bitartrate 5 mg and acetaminophen 500 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     7.5/500: Hydrocodone bitartrate 7.5 mg and acetaminophen 500 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     10/500: Hydrocodone bitartrate 10 mg and acetaminophen 500 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Maxidone&reg;: Hydrocodone bitartrate 10 mg and acetaminophen 750 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Norco&reg;:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Hydrocodone bitartrate 5 mg and acetaminophen 325 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Hydrocodone bitartrate 7.5 mg and acetaminophen 325 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Hydrocodone bitartrate 10 mg and acetaminophen 325 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Vicodin&reg;: Hydrocodone bitartrate 5 mg and acetaminophen 300 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Vicodin ES&reg;: Hydrocodone bitartrate 7.5 mg and acetaminophen 300 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Vicodin HP&reg;: Hydrocodone bitartrate 10 mg and acetaminophen 300 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Xodol&reg;:",
"    </p>",
"    <p style=\"text-indent:0em;margin-left:4em;text-align:justify;\">",
"     5/300: Hydrocodone bitartrate 5 mg and acetaminophen 300 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     7.5/300: Hydrocodone bitartrate 7.5 mg and acetaminophen 300 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     10/300: Hydrocodone bitartrate 10 mg and acetaminophen 300 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Zydone&reg;:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Hydrocodone bitartrate 5 mg and acetaminophen 400 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Hydrocodone bitartrate 7.5 mg and acetaminophen 400 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Hydrocodone bitartrate 10 mg and acetaminophen 400 mg",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F179805\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes: Oral solution, tablet",
"    </p>",
"   </div>",
"   <div class=\"block csi drugH1Div\" id=\"F179858\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Controlled Substance",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C-III",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1053223\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Oral: May administer with food or milk to decrease GI distress",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1053222\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Relief of moderate to severe pain (FDA approved in adults); has also been used as an antitussive (hydrocodone)",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F179867\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Lorcet&reg; may be confused with Fioricet&reg;",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Lortab&reg; may be confused with Cortef&reg;",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Vicodin&reg; may be confused with Hycodan, Indocin&reg;",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Zydone&reg; may be confused with Vytone",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      High alert medication:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       The Institute for Safe Medication Practices (ISMP) includes this medication among its list of drug classes which have a heightened risk of causing significant patient harm when used in error.",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Other safety concerns:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Duplicate therapy issues: This product contains acetaminophen, which may be a component of other combination products. Do not exceed the maximum recommended daily dose of acetaminophen.",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F179864\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Bradycardia, cardiac arrest, circulatory collapse, coma, hypotension",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Anxiety, dizziness, drowsiness, dysphoria, euphoria, fear, lethargy, lightheadedness, malaise, mental clouding, mental impairment, mood changes, physiological dependence, sedation, somnolence, stupor",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Pruritus, rash",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Hypoglycemic coma",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Abdominal pain, constipation, gastric distress, heartburn, nausea, peptic ulcer, vomiting, xerostomia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Genitourinary: Ureteral spasm, urinary retention, vesical sphincter spasm",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hematologic: Agranulocytosis, bleeding time prolonged, hemolytic anemia, iron deficiency anemia, occult blood loss, thrombocytopenia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hepatic: Hepatic necrosis, hepatitis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Skeletal muscle rigidity",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Otic: Hearing impairment or loss (chronic overdose)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Renal: Renal toxicity, renal tubular necrosis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Acute airway obstruction, apnea, dyspnea, respiratory depression (dose related)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Allergic reactions, clamminess, diaphoresis",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1053226\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to hydrocodone, acetaminophen, or any component; CNS depression; severe respiratory depression",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F1053211\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution in patients with adrenal insufficiency (Addison&rsquo;s disease), biliary tract disease, pancreatitis, CNS depression/coma, acute alcoholism, delirium tremens, hypothyroidism (myxedema), severe liver, pulmonary or renal impairment, urinary stricture, prostatic hypertrophy, or seizures.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Use caution when combining with other CNS depressants (eg, centrally acting antiemetics, general anesthetics, phenothiazines, sedative-hypnotics) as there may be additive CNS effects. If combined therapy is needed, consider reducing the dose of one or both agents.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Although several case reports of acetaminophen-associated hemolytic anemia have been reported in patients with G-6-PD deficiency, a direct cause and effect relationship has not been well established (concurrent illnesses such as fever or infection may precipitate hemolytic anemia in patients with G-6-PD deficiency); therefore, acetaminophen is generally thought to be safe when given in therapeutic doses to patients with G-6-PD deficiency.",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1053210\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Acetaminophen may cause severe hepatotoxicity",
"     <b>",
"      [U.S. Boxed Warning]",
"     </b>",
"     , potentially requiring liver transplant or resulting in death; hepatotoxicity is usually associated with excessive acetaminophen intake (&gt;4 g/day in adults). Risk is increased with alcohol use, pre-existing liver disease, and intake of more than one source of acetaminophen-containing medications. Chronic daily dosing in adults has also resulted in liver damage in some patients. Do not exceed maximum daily doses; consider acetaminophen content of all products (prescription and OTC), including combination products when evaluating the total daily dose of acetaminophen; adults ingesting &gt;4 g/day of acetaminophen should seek medical attention immediately.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Hypersensitivity and anaphylactic reactions have been reported with acetaminophen and hydrocodone; use with caution in patients with hypersensitivity reactions to other phenanthrene derivative opioid agonists (morphine, codeine, hydromorphone, oxycodone, oxymorphone, levorphanol); discontinue immediately if symptoms of allergic or hypersensitivity reactions occur.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Hydrocodone may cause CNS depression which may impair physical or mental abilities; patients must be cautioned about performing tasks which require mental alertness (eg, operating machinery or driving). Respiratory depression may occur even at therapeutic dosages; use with extreme caution in patients with respiratory diseases including asthma, emphysema, COPD, cor pulmonale, hypoxia, hypercapnia, pre-existing respiratory depression, significantly decreased respiratory reserve, other obstructive pulmonary disease, kyphoscoliosis, or other skeletal disorder which may alter respiratory function.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Use with extreme caution in patients with head injury, intracranial lesions, or elevated intracranial pressure; exaggerated elevation of ICP may occur. May cause hypotension; use with caution in patients with circulatory shock, hypovolemia, impaired myocardial function, or those receiving drugs which may exaggerate hypotensive effects (including phenothiazines or general anesthetics). Hydrocodone may obscure diagnosis or clinical course of patients with acute abdominal conditions.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Physical and psychological dependence may occur; abrupt discontinuation after prolonged use may result in withdrawal symptoms; warn patients of possible impairment of alertness or physical coordination; concurrent use of agonist/antagonist analgesics (ie, pentazocine, nalbuphine, and butorphanol) may precipitate withdrawal symptoms and/or reduce analgesic efficacy in patients following prolonged therapy with mu opioid agonists such as hydrocodone. Infants born to women physically dependent on opioids will also be physically dependent and may experience respiratory difficulties or opioid withdrawal symptoms (neonatal abstinence syndrome). Symptoms of opiate withdrawal may include excessive crying, diarrhea, fever, hyper-reflexia, irritability, tremors, or vomiting. High potential for abuse; healthcare providers should be alert to problems of abuse, misuse, and diversion.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Some tablets contain tartrazine which may cause allergic reactions in susceptible individuals. Some liquid formulations contain propylene glycol and alcohol (~7%); in neonates large amounts of propylene glycol delivered orally, intravenously (eg, &gt;3000 mg/day), or topically have been associated with potentially fatal toxicities which can include metabolic acidosis, seizures, renal failure, and CNS depression; use liquid formulations containing propylene glycol with caution in neonates.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F179851\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to individual components.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F179814\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alcohol (Ethyl): CNS Depressants may enhance the CNS depressant effect of Alcohol (Ethyl).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alvimopan: Analgesics (Opioid) may enhance the adverse/toxic effect of Alvimopan. This is most notable for patients receiving long-term (i.e., more than 7 days) opiates prior to alvimopan initiation.  Management: Alvimopan is contraindicated in patients receiving therapeutic doses of opioids for more than 7 consecutive days immediately prior to alvimopan initiation.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ammonium Chloride: May increase the excretion of Analgesics (Opioid).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Amphetamines: May enhance the analgesic effect of Analgesics (Opioid).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Anticonvulsants (Hydantoin): May increase the metabolism of Acetaminophen. This may 1) diminish the effect of acetaminophen; and 2) increase the risk of liver damage.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antipsychotic Agents (Phenothiazines): May enhance the hypotensive effect of Analgesics (Opioid).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ARIPiprazole: CYP3A4 Inhibitors (Weak) may increase the serum concentration of ARIPiprazole.  Management: Monitor for increased aripiprazole pharmacologic effects. Aripiprazole dose adjustments may or may not be required based on concomitant therapy and/or indication. Consult full interaction monograph for specific recommendations.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Azelastine (Nasal): CNS Depressants may enhance the CNS depressant effect of Azelastine (Nasal).",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Barbiturates: May increase the metabolism of Acetaminophen. This may 1) diminish the effect of acetaminophen; and 2) increase the risk of liver damage.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Busulfan: Acetaminophen may increase the serum concentration of Busulfan.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CarBAMazepine: May increase the metabolism of Acetaminophen. This may 1) diminish the effect of acetaminophen; and 2) increase the risk of liver damage.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cholestyramine Resin: May decrease the absorption of Acetaminophen. Effect is minimal if cholestyramine is administered 1 hour after acetaminophen.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CNS Depressants: May enhance the adverse/toxic effect of other CNS Depressants.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levocabastine (Nasal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dasatinib: Acetaminophen may enhance the hepatotoxic effect of Dasatinib. Dasatinib may increase the serum concentration of Acetaminophen.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Desmopressin: Analgesics (Opioid) may enhance the adverse/toxic effect of Desmopressin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Droperidol: May enhance the CNS depressant effect of CNS Depressants. Management: Consider dose reductions of droperidol or of other CNS agents (e.g., opioids, barbiturates) with concomitant use.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     HydrOXYzine: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Imatinib: Acetaminophen may enhance the hepatotoxic effect of Imatinib. Imatinib may increase the serum concentration of Acetaminophen.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Isoniazid: May enhance the adverse/toxic effect of Acetaminophen.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lomitapide: CYP3A4 Inhibitors (Weak) may increase the serum concentration of Lomitapide.  Management: Limit the maximum adult dose of lomitapide to 30 mg daily when used in combination with any weak CYP3A4 inhibitor.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Magnesium Sulfate: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     MAO Inhibitors: May enhance the orthostatic hypotensive effect of Orthostatic Hypotension Producing Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metyrapone: May increase the serum concentration of Acetaminophen. More importantly, by inhibiting the conjugative metabolism of acetaminophen, metyrapone may shift the metabolism towards the oxidative route that produces a hepatotoxic metabolite.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metyrosine: CNS Depressants may enhance the sedative effect of Metyrosine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mipomersen: Acetaminophen may enhance the hepatotoxic effect of Mipomersen.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mirtazapine: CNS Depressants may enhance the CNS depressant effect of Mirtazapine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mixed Agonist / Antagonist Opioids: May diminish the analgesic effect of Analgesics (Opioid). Management: Seek alternatives to mixed agonist/antagonist opioids in patients receiving pure opioid agonists, and monitor for symptoms of therapeutic failure/high dose requirements (or withdrawal in opioid-dependent patients) if patients receive these combinations.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Paraldehyde: CNS Depressants may enhance the CNS depressant effect of Paraldehyde.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Peginterferon Alfa-2b: May decrease the serum concentration of CYP2D6 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pegvisomant: Analgesics (Opioid) may diminish the therapeutic effect of Pegvisomant.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Perampanel: May enhance the CNS depressant effect of CNS Depressants. Management: Patients taking perampanel with any other drug that has CNS depressant activities should avoid complex and high-risk activities, particularly those such as driving that require alertness and coordination, until they have experience using the combination.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pimozide: CYP3A4 Inhibitors (Weak) may increase the serum concentration of Pimozide.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pramipexole: CNS Depressants may enhance the sedative effect of Pramipexole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Prilocaine: Methemoglobinemia Associated Agents may enhance the adverse/toxic effect of Prilocaine. Combinations of these agents may increase the likelihood of significant methemoglobinemia.  Management: Monitor patients for signs of methemoglobinemia (e.g., hypoxia, cyanosis) when prilocaine is used in combination with other agents associated with development of methemoglobinemia.  Avoid lidocaine/prilocaine in infants receiving such agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Probenecid: May increase the serum concentration of Acetaminophen. Probenecid may also limit the formation of at least one major non-toxic metabolite, possibly increasing the potential for formation of the toxic NAPQI metabolite.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     QuiNIDine: May decrease serum concentrations of the active metabolite(s) of Hydrocodone.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ROPINIRole: CNS Depressants may enhance the sedative effect of ROPINIRole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rotigotine: CNS Depressants may enhance the sedative effect of Rotigotine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Selective Serotonin Reuptake Inhibitors: Analgesics (Opioid) may enhance the serotonergic effect of Selective Serotonin Reuptake Inhibitors. This may cause serotonin syndrome.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Oxybate: May enhance the CNS depressant effect of CNS Depressants. Management: Consider alternatives to combined use. When combined use is needed, consider minimizing doses of one or more drugs. Use of sodium oxybate with alcohol or sedative hypnotics is contraindicated.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     SORAfenib: Acetaminophen may enhance the hepatotoxic effect of SORAfenib. SORAfenib may increase the serum concentration of Acetaminophen.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Succinylcholine: May enhance the bradycardic effect of Analgesics (Opioid).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Thiazide Diuretics: Analgesics (Opioid) may enhance the orthostatic hypotensive effect of Thiazide Diuretics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vitamin K Antagonists (eg, warfarin): Acetaminophen may enhance the anticoagulant effect of Vitamin K Antagonists. Most likely with daily acetaminophen doses &gt;1.3 g for &gt;1 week.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Zolpidem: CNS Depressants may enhance the CNS depressant effect of Zolpidem.  Management: Reduce the Intermezzo brand sublingual zolpidem dose to 1.75 mg for men who are also receiving other CNS depressants.  No such dose change is recommended for women.  Avoid use with other CNS depressants at bedtime; avoid use with alcohol.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F1053228\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Food Interactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Rate of absorption of acetaminophen may be decreased when given with food high in carbohydrates",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F179815\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F179829\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hydrocodone is teratogenic in animal reproduction studies. In humans, birth defects, including some heart defects, have been associated with maternal use of opioid analgesics, including hydrocodone, during the first trimester of pregnancy (Broussard, 2011). Use of opioids during pregnancy may produce physical dependence in the neonate. Symptoms of opioid withdrawal may include excessive crying, diarrhea, fever, hyper-reflexia, irritability, respiratory rate increased, sneezing, tremors, vomiting, or yawning; respiratory depression may occur in the newborn if opioids are used prior to delivery. Also refer to acetaminophen monograph.",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F1053217\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Pain relief; respiratory rate; mental status; blood pressure; signs of misuse, abuse, and addiction",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1053209\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Acetaminophen: Inhibits the synthesis of prostaglandins in the CNS and peripherally blocks pain impulse generation; produces antipyresis from inhibition of hypothalamic heat-regulating center",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Hydrocodone: Binds to opiate receptors in the CNS, causing inhibition of ascending pain pathways, altering the perception of and response to pain; produces generalized CNS depression; suppresses cough in medullary center",
"    </p>",
"   </div>",
"   <div class=\"block phd drugH1Div\" id=\"F1053225\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Narcotic analgesia:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Onset of action: Within 10-20 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Duration: 4-6 hours",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F13372013\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hydrocodone:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metabolism: Hepatic; O-demethylation; N-demethylation and 6-ketosteroid reduction",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Half-life elimination: ~4 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Time to peak serum concentration: 1-1.6 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Elimination: Urine",
"    </p>",
"   </div>",
"   <div class=\"block pai drugH1Div\" id=\"F1053216\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Patient Information",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?22/53/23381?source=see_link\">",
"      see \"Hydrocodone and acetaminophen: Patient drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Avoid use if allergy to acetaminophen and/or opioid exists or if liver disease is present; avoid alcohol; may cause drowsiness and impair ability to perform activities requiring mental alertness or physical coordination; may be habit-forming; avoid abrupt discontinuation after prolonged use",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      American Academy of Pediatrics Committee on Drugs, \"'Inactive' Ingredients in Pharmaceutical Products: Update (Subject Review),\"",
"      <i>",
"       Pediatr",
"      </i>",
"      , 1997, 99(2):268-78.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?21/34/22055/abstract-text/9024461/pubmed\" id=\"9024461\" target=\"_blank\">",
"        9024461",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Bean-Lijewski JD, Kruitbosch SH, Hutchinson L, et al, \"Post-Tonsillectomy Pain Management in Children: Can We Do Better?\"",
"      <i>",
"       Otolaryngol Head Neck Surg",
"      </i>",
"      , 2007, 137(4):545-51.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?21/34/22055/abstract-text/17903568/pubmed\" id=\"17903568\" target=\"_blank\">",
"        17903568",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Carr D, Jacox A, Chapman CR, et al, &ldquo;Clinical Practice Guideline Number 1: Acute Pain Management: Operative or Medical Procedures and Trauma,&rdquo; Rockville, Maryland: U.S. Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research, AHCPR Publication No 92-0032, 1992.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Jacox A, Carr D, Payne R, et al, &ldquo;Clinical Practice Guideline Number 9: Management of Cancer Pain,&rdquo; Rockville, Maryland: U.S. Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research, AHCPR Publication No. 94-0592, 1994.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      \"Principles of Analgesic Use in the Treatment of Acute Pain and Cancer Pain,\" 6th ed, Glenview, IL: American Pain Society, 2008.",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 13359 Version 38.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-125.39.66.147-6A12EA632A-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_34_22055=[""].join("\n");
var outline_f21_34_22055=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13135478\">",
"      ALERT: U.S. Boxed Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F179839\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1053218\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1053212\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F179820\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F179805\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F179858\">",
"      Controlled Substance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1053223\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1053222\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F179867\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F179864\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1053226\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1053211\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1053210\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F179851\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F179814\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1053228\">",
"      Food Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F179815\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F179829\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1053217\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1053209\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1053225\">",
"      Pharmacodynamics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13372013\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1053216\">",
"      Patient Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13359\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13359|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?42/51/43832?source=related_link\">",
"      Hydrocodone and acetaminophen: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?22/53/23381?source=related_link\">",
"      Hydrocodone and acetaminophen: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_34_22056="Approach to the child with palpitations";
var content_f21_34_22056=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Approach to the child with palpitations",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/34/22056/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/34/22056/contributors\">",
"     Robert Mazor, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/34/22056/contributors\">",
"     Suzan Mazor, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/34/22056/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/34/22056/contributors\">",
"     George A Woodward, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/34/22056/contributors\">",
"     Jan E Drutz, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/34/22056/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/34/22056/contributors\">",
"     James F Wiley, II, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?21/34/22056/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 5, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Palpitations describe perception of the heartbeat that is usually concerning to the patient. In adults, palpitations occasionally herald serious underlying cardiac events [",
"    <a class=\"abstract\" href=\"UTD.htm?21/34/22056/abstract/1\">",
"     1",
"    </a>",
"    ]. However, palpitations in children typically arise from physiologic stimuli, such as fever, exercise, anxiety, or anemia, rather than life-threatening causes (eg, cardiac arrhythmia). In addition, children with serious arrhythmias may report no palpitations. This topic will review the differential diagnosis and approach to the child with palpitations.",
"   </p>",
"   <p>",
"    The differential diagnosis of tachycardia in children who do not have palpitations is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/38/9832?source=see_link\">",
"     \"Approach to the child with tachycardia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis of palpitations encompasses rare etiologies that are life-threatening and common causes (",
"    <a class=\"graphic graphic_algorithm graphicRef78536 \" href=\"UTD.htm?4/22/4448\">",
"     algorithm 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef52851 \" href=\"UTD.htm?32/61/33756\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Life-threatening causes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children with a serious underlying cause for their palpitations often have a history of syncope, congenital heart disease, or cardiac surgery (",
"    <a class=\"graphic graphic_table graphicRef52851 \" href=\"UTD.htm?32/61/33756\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?21/34/22056/abstract/2-6\">",
"     2-6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3839549\">",
"    <span class=\"h3\">",
"     Arrhythmias",
"    </span>",
"    &nbsp;&mdash;&nbsp;Arrhythmias are a very uncommon cause of palpitations in children with structurally normal hearts but are frequently seen in children with surgically corrected structural heart disease [",
"    <a class=\"abstract\" href=\"UTD.htm?21/34/22056/abstract/6\">",
"     6",
"    </a>",
"    ]. Arrhythmias may be broadly classified as fast or slow. The child with tachyarrhythmia and shock should be triaged and managed per the American Heart Association (AHA) guidelines for assessment of cardiopulmonary instability espoused in the Pediatric Advanced Life Support (PALS) course [",
"    <a class=\"abstract\" href=\"UTD.htm?21/34/22056/abstract/7\">",
"     7",
"    </a>",
"    ]. (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/38/9832?source=see_link\">",
"     \"Approach to the child with tachycardia\"",
"    </a>",
"    )",
"    <br/>",
"    <br/>",
"    A key component of this assessment requires categorization of the QRS complex from the cardiorespiratory (CR) monitor or 12-lead ECG as narrow or wide (",
"    <a class=\"graphic graphic_algorithm graphicRef67438 \" href=\"UTD.htm?11/37/11860\">",
"     algorithm 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/34/22056/abstract/2\">",
"     2",
"    </a>",
"    ]. A 12-lead ECG before and after intervention is preferable if patient status allows. Supraventricular tachycardia (SVT) is the most common non-sinus tachyarrhythmia of childhood and often presents with palpitations in verbal children [",
"    <a class=\"abstract\" href=\"UTD.htm?21/34/22056/abstract/2,8\">",
"     2,8",
"    </a>",
"    ]. Most infants with SVT are asymptomatic although feeding problems, pallor, or dyspnea, especially with feeding, may occur [",
"    <a class=\"abstract\" href=\"UTD.htm?21/34/22056/abstract/8\">",
"     8",
"    </a>",
"    ]. Ventricular tachycardia is rare in children with structurally normal hearts. (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/9/15514?source=see_link\">",
"     \"Management of supraventricular tachycardia in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/40/22152?source=see_link\">",
"     \"Management and evaluation of wide QRS complex tachycardia in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/8/43144?source=see_link\">",
"     \"Sustained monomorphic ventricular tachycardia: Diagnosis and evaluation\"",
"    </a>",
"    )",
"    <br/>",
"    <br/>",
"    Symptomatic sinus bradycardia in children often arises from respiratory failure with hypoxemia. Sick sinus syndrome, Mobitz type II atrioventricular blockage, and complete atrioventricular dissociation are usually seen in children with structural heart disease, including children with pacemaker malfunction. (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/24/33161?source=see_link\">",
"     \"Bradycardia in children\"",
"    </a>",
"    )",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3839556\">",
"    <span class=\"h3\">",
"     Myocarditis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Myocarditis is most commonly viral in origin, with Coxsackie virus B and other enteroviruses accounting for most cases. Clinical findings of myocarditis include tachycardia out of proportion to fever, poor perfusion, and signs of heart failure. Patients with myocarditis may develop a variety of tachy- and bradyarrhythmias. Children with fulminant myocarditis may rapidly develop cardiogenic shock. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/53/34647?source=see_link&amp;anchor=H3#H3\">",
"     \"Clinical manifestations and diagnosis of myocarditis in children\", section on 'Clinical manifestations'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3839563\">",
"    <span class=\"h3\">",
"     Hypertrophic cardiomyopathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypertrophic cardiomyopathy (HCM) manifests as a hypertrophied, nondilated left ventricle and septum. Patients with HCM may present with palpitations or syncope during strenuous exercise caused by atrial fibrillation or ventricular arrhythmia. The subset of HCM patients who present with syncope are at significant risk for sudden death [",
"    <a class=\"abstract\" href=\"UTD.htm?21/34/22056/abstract/9\">",
"     9",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/10/36007?source=see_link\">",
"     \"Causes of syncope in children and adolescents\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/42/36522?source=see_link\">",
"     \"Clinical manifestations, diagnosis, and evaluation of hypertrophic cardiomyopathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5376790\">",
"    <span class=\"h3\">",
"     Hypoglycemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;The early manifestations of hypoglycemia in children and adolescents are caused by the autonomic response to hypoglycemia and may include tachycardia with palpitations, sweating, weakness, tremor, and feelings of nervousness",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    hunger. These symptoms and signs usually occur at higher blood glucose concentrations (between 40 and 70",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    [2.2 and 3.9 mM]) than the neuroglycopenic signs and symptoms (lethargy, irritability, behavioral abnormalities, seizures, or coma), and may function as a \"warning system.\" (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/0/8201?source=see_link&amp;anchor=H5#H5\">",
"     \"Approach to hypoglycemia in infants and children\", section on 'Clinical features'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3839570\">",
"    <span class=\"h3\">",
"     Poisoning",
"    </span>",
"    &nbsp;&mdash;&nbsp;Toxin exposures have the potential to cause life-threatening tachy- and bradyarrhythmias. The specific arrhythmia depends on the characteristics of the toxic agent (",
"    <a class=\"graphic graphic_table graphicRef66773 \" href=\"UTD.htm?23/11/23742\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3839577\">",
"    <span class=\"h3\">",
"     Pheochromocytoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pheochromocytoma and paragangliomas are rare neoplasms in children. Tumors that arise from the adrenal medulla are termed pheochromocytomas, and those with extraadrenal origins are called paragangliomas. The classic triad of symptoms in these disorders consists of episodic headache, sweating, and tachycardia, usually accompanied by hypertension. Malignant hypertension can occur, with its associated complications (eg, increased intracranial pressure, encephalopathy). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/14/38121?source=see_link\">",
"     \"Pheochromocytoma in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/27/41398?source=see_link\">",
"     \"Malignant hypertension and hypertensive encephalopathy in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Common causes",
"    </span>",
"    &nbsp;&mdash;&nbsp;See table 1 for a differential diagnosis of palpitations (",
"    <a class=\"graphic graphic_table graphicRef52851 \" href=\"UTD.htm?32/61/33756\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3839658\">",
"    <span class=\"h3\">",
"     Increased metabolic rate",
"    </span>",
"    &nbsp;&mdash;&nbsp;Increased metabolic rate accompanies fever and anemia. The resulting sinus tachycardia and hyperdynamic cardiac activity may cause palpitations.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3839665\">",
"    <span class=\"h3\">",
"     Catecholamine release",
"    </span>",
"    &nbsp;&mdash;&nbsp;Palpitations may also follow the catecholamine release associated with exercise, emotional arousal, and psychiatric distress (eg, anxiety, panic attack) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/34/22056/abstract/10\">",
"     10",
"    </a>",
"    ]. Hypoglycemia is a life-threatening cause of catecholamine release that warrants rapid recognition and treatment. (See",
"    <a class=\"local\" href=\"#H5376790\">",
"     'Hypoglycemia'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3839672\">",
"    <span class=\"h3\">",
"     Hyperventilation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hyperventilation, breathing in excess of physiologic requirement to maintain oxygenation and ventilation, may occur without obvious underlying etiology in adolescents [",
"    <a class=\"abstract\" href=\"UTD.htm?21/34/22056/abstract/11-14\">",
"     11-14",
"    </a>",
"    ]. Patients with hyperventilation often have associated symptoms of dyspnea, chest tightness, chest pain, paresthesias, and palpitations (often described as a \"racing\" heart) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/34/22056/abstract/13\">",
"     13",
"    </a>",
"    ]. Frequently they attribute their symptoms to a life-threatening problem and appear very anxious. In addition, children with hyperventilation may have a past medical history of asthma [",
"    <a class=\"abstract\" href=\"UTD.htm?21/34/22056/abstract/12\">",
"     12",
"    </a>",
"    ].",
"    <br/>",
"    <br/>",
"    While clinical findings reveal no serious cardiac or pulmonary abnormalities, patients with severe hyperventilation may display a positive Chvostek or Trousseau sign, laryngospasm, or spontaneous carpopedal spasm [",
"    <a class=\"abstract\" href=\"UTD.htm?21/34/22056/abstract/11,14\">",
"     11,14",
"    </a>",
"    ]. Ancillary studies (eg, venous or arterial blood gas and electrolytes) typically show respiratory alkalosis. Rarely, T wave changes, including ST segment depression, T wave flattening, and T wave inversion may appear on ECG during the hyperventilation episode [",
"    <a class=\"abstract\" href=\"UTD.htm?21/34/22056/abstract/14\">",
"     14",
"    </a>",
"    ].",
"    <br/>",
"    <br/>",
"    Once serious etiologies, such as status asthmaticus, metabolic acidosis pain, central nervous system disorders, and drug intoxication are excluded, treatment consists of reassurance [",
"    <a class=\"abstract\" href=\"UTD.htm?21/34/22056/abstract/13,14\">",
"     13,14",
"    </a>",
"    ]. Additional measures may be necessary to end the acute episode such as placement of a partial rebreather oxygen mask with oxygen flow set below 5 liters per minute allows the patient to rebreathe carbon dioxide without causing hypoxia or benzodiazepine administration (eg,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?31/34/32296?source=see_link\">",
"     diazepam",
"    </a>",
"    0.2",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    up to adult dose of 5 mg) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/34/22056/abstract/14\">",
"     14",
"    </a>",
"    ].",
"    <br/>",
"    <br/>",
"    Patients with hyperventilation need close follow-up and counseling. Up to 40 percent of patients with hyperventilation will have repeated episodes into adulthood [",
"    <a class=\"abstract\" href=\"UTD.htm?21/34/22056/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3839679\">",
"    <span class=\"h3\">",
"     Drug-induced",
"    </span>",
"    &nbsp;&mdash;&nbsp;Drug induced palpitations, as opposed to toxic exposures (",
"    <a class=\"graphic graphic_table graphicRef66773 \" href=\"UTD.htm?23/11/23742\">",
"     table 2",
"    </a>",
"    ), involve medications and substances with sympathomimetic or anticholinergic properties that increase heart rate and cardiac contractility with routine dosing [",
"    <a class=\"abstract\" href=\"UTD.htm?21/34/22056/abstract/15-18\">",
"     15-18",
"    </a>",
"    ]. Implicated agents include",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?38/54/39782?source=see_link\">",
"     albuterol",
"    </a>",
"    , caffeine, tobacco, cough and cold preparations, dietary supplements that contain ephedra, herbal medications, energy drinks, recreational drugs, and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?19/33/19991?source=see_link\">",
"     isotretinoin",
"    </a>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3839686\">",
"    <span class=\"h3\">",
"     Postural orthostatic tachycardia syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Postural orthostatic tachycardia syndrome (POTS) is defined as a form of orthostatic intolerance characterized by an excessive increase in heart rate (&gt;30 bpm over baseline or to &gt;120 bpm in adults) that occurs on standing without arterial hypotension. POTS is a common disorder among teenage girls that manifests as palpitations, anxiety, dizziness, and tremulousness. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/30/29159?source=see_link\">",
"     \"Postural tachycardia syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3839693\">",
"    <span class=\"h3\">",
"     Premature atrial contractions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Premature atrial contractions (PACs), the most common sinus arrhythmia of childhood, result from premature depolarization of an atrial focus. Patients often describe that they feel like their heart \"stops\" or \"flip-flops.\" PACs are benign [",
"    <a class=\"abstract\" href=\"UTD.htm?21/34/22056/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3839700\">",
"    <span class=\"h3\">",
"     Premature ventricular contractions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Premature ventricular contractions (PVCs) result from premature depolarization of a ventricular focus or reentry. Once structural heart disease and ventricular dysfunction are excluded by ancillary testing, PVCs can be considered benign [",
"    <a class=\"abstract\" href=\"UTD.htm?21/34/22056/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Other causes",
"    </span>",
"    &nbsp;&mdash;&nbsp;See table 1 for a differential diagnosis of palpitations (",
"    <a class=\"graphic graphic_table graphicRef52851 \" href=\"UTD.htm?32/61/33756\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hyperthyroidism frequently presents with palpitations in children. Goiter, diaphoresis, weight loss, heat intolerance, tachycardia, and widened pulse pressure comprise common additional findings. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?7/29/7641?source=see_link&amp;anchor=H4#H4\">",
"       \"Clinical manifestations and diagnosis of hyperthyroidism in children and adolescents\", section on 'Clinical manifestations'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Acute rheumatic fever (ARF) is a delayed, nonsuppurative sequela of a pharyngeal infection with the group A streptococcus. Fever and pancarditis are clinical manifestations of this disease that can cause tachycardia. Other findings include arthralgia, arthritis, erythema marginatum, subcutaneous nodules, and chorea. Testing for recent streptococcal infection is essential to establish the diagnosis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/20/23879?source=see_link\">",
"       \"Clinical manifestations and diagnosis of acute rheumatic fever\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Mitral valve prolapse is associated with a wide variety of clinical features. Palpitations are a common presenting complaint in MVP. The evaluation of patients with symptomatic palpitations is similar to that in patients without MVP. Palpitations are often associated with ventricular premature beats, but supraventricular arrhythmias can also occur. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/19/17719?source=see_link\">",
"       \"Arrhythmic complications of mitral valve prolapse\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?3/25/3476?source=see_link\">",
"       \"Mitral valve prolapse syndrome\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     HISTORY",
"    </span>",
"    &nbsp;&mdash;&nbsp;A careful history helps to identify patients at higher risk for a life-threatening cause for their palpitations.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Palpitation description - Palpitations caused by life threatening tachyarrhythmias often start and stop abruptly (like turning a light switch on and off). Children may feel like there is a butterfly in their chest or like their heart is beating so fast that it will come out of the chest. These palpitations generally are of short duration (seconds to minutes).",
"      <br/>",
"      <br/>",
"      Palpitations due to cardiac hyperdynamic states with sinus tachycardia are often described as a rushing or pounding in the ears, particularly when the patient is supine. Exercise, fever, anemia, pharmaceuticals, nutraceuticals, caffeine drinks, and emotional arousal may produce this sensation of increased ventricular stroke volume that often lasts minutes to hours.",
"      <br/>",
"      <br/>",
"      Children with premature atrial or ventricular contractions may note the increased stroke volume of the compensatory heart beat as a \"flip-flop\" or say that their heart \"stops\". A similar sensation may be produced in patients with bradycardia and high grade (Type II or Type III) atrioventricular block due to escape beats. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?42/38/43623?source=see_link\">",
"       \"Irregular heart rate (arrhythmias) in children\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Palpitations associated with diaphoresis, headache, flushing and hypertensions suggest pheochromocytoma. Palpitations associated with heat intolerance and diaphoresis suggest hyperthyroidism.",
"     </li>",
"     <li>",
"      Congenital heart disease, repaired or unrepaired - Palpitations in this setting have a high likelihood of cardiac arrhythmia as an underlying cause [",
"      <a class=\"abstract\" href=\"UTD.htm?21/34/22056/abstract/6,19\">",
"       6,19",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Syncope - A history of palpitations with syncope, especially in association with exercise, raises concern for a primary cardiac etiology such as cardiac arrhythmia, hypertrophic cardiomyopathy, or myocardial ischemia (usually related to congenital anomaly of a coronary artery). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/7/12409?source=see_link&amp;anchor=H2#H2\">",
"       \"Suspected heart disease in infants and children: Criteria for referral\", section on 'Timing of referral'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/0/18442?source=see_link\">",
"       \"Reflex syncope\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      In children with intermittent tachyarrhythmias (eg, prolonged QT syndrome or Wolff-Parkinson-White syndrome), palpitations with abrupt syncope may be described. Triggers for these events involve intrinsic catecholamine stimulation such as exercise, sudden exposure to cold water (diving), or sudden surprise. Unlike vasovagal syncope, patients usually fall without protecting themselves from injury. Unlike seizures, patients usually recover full mental status without a postictal phase as long as the arrhythmia is of short duration. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/10/11432?source=see_link\">",
"       \"Emergent evaluation of syncope in children and adolescents\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       Illness/fever",
"      </span>",
"      - A history of viral illness or fever in conjunction with respiratory distress or myocardial dysfunction suggests myocarditis, especially if tachycardia is out of proportion to the degree of fever or is present after defervescence. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/53/34647?source=see_link\">",
"       \"Clinical manifestations and diagnosis of myocarditis in children\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      A history of a recent streptococcal infection in the febrile patient with tachycardia raises clinical suspicion for acute rheumatic fever. If signs of carditis, such as a new murmur of mitral valve regurgitation or pericardial rub are present, then the patient meets Jones criteria for the diagnosis of acute rheumatic fever. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/20/23879?source=see_link\">",
"       \"Clinical manifestations and diagnosis of acute rheumatic fever\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Family history - Family history of sudden cardiac death or deafness raises clinical suspicion for genetic disorders such as long QT syndrome and hypertrophic cardiomyopathy that may cause sudden onset of ventricular tachycardia with palpitations and syncope.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     PHYSICAL EXAMINATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ill-appearing patients with palpitations need rapid assessment for hypoxemia, hypoglycemia, and hemodynamic instability. Clinicians should emergently treat the patient with cardiovascular collapse per American Heart Association guidelines for cardiopulmonary resuscitation (",
"    <a class=\"graphic graphic_algorithm graphicRef78536 \" href=\"UTD.htm?4/22/4448\">",
"     algorithm 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_algorithm graphicRef67438 \" href=\"UTD.htm?11/37/11860\">",
"     algorithm 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_algorithm graphicRef81356 \" href=\"UTD.htm?1/61/2000\">",
"     algorithm 3",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?21/34/22056/abstract/7\">",
"     7",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/24/33161?source=see_link\">",
"     \"Bradycardia in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/38/9832?source=see_link\">",
"     \"Approach to the child with tachycardia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Vital signs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several vital sign changes provide important findings in children with palpitations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Tachycardia is defined as the presence of a heart rate value greater than expected for age. In addition to the values published for specific age groups [",
"      <a class=\"abstract\" href=\"UTD.htm?21/34/22056/abstract/20\">",
"       20",
"      </a>",
"      ], clinicians may use the basic guideline of &gt;160 BPM for infants (&lt; 2 years), &gt;140 BPM for children (2 to 10 years), and &gt;100 BPM for children over 10 years of age, adolescents, and young adults to define tachycardia (",
"      <a class=\"graphic graphic_table graphicRef78097 \" href=\"UTD.htm?27/37/28252\">",
"       table 3",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Conversely, bradycardia means a heart rate measurement that is less than expected for age or &lt;90 BPM for infants, &lt;70 BPM for children, and &lt;60 BPM for adolescents and adults [",
"      <a class=\"abstract\" href=\"UTD.htm?21/34/22056/abstract/20\">",
"       20",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      An orthostatic increase in heart rate &gt;30 BPM over baseline without hypotension defines postural orthostatic tachycardia.",
"     </li>",
"     <li>",
"      An elevated blood pressure for age may be seen in patients with anxiety, panic attacks, hyperventilation, or pheochromocytoma.",
"     </li>",
"     <li>",
"      Hypertension with a widened pulse pressure suggests hyperthyroidism.",
"     </li>",
"     <li>",
"      Fever should prompt evaluation for other findings consistent with myocarditis or acute rheumatic fever.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Cardiovascular findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most stable patients with palpitations have a normal cardiac examination.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with fever or anemia may demonstrate short systolic flow murmurs of medium to high pitch.",
"     </li>",
"     <li>",
"      Patients with mitral valve prolapse may display a midsystolic click or multiple clicks followed by a midsystolic to late systolic murmur at the apex of the left ventricle over the mitral area (",
"      <a class=\"graphic graphic_movie graphicRef57858 \" href=\"UTD.htm?7/55/8051\">",
"       movie 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_movie graphicRef80360 \" href=\"UTD.htm?15/40/16004\">",
"       movie 2",
"      </a>",
"      ). These findings may be transient depending in part upon loading conditions, such as squatting, that increase blood flow to the heart (",
"      <a class=\"graphic graphic_table graphicRef75155 \" href=\"UTD.htm?11/1/11292\">",
"       table 4",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/37/26202?source=see_link\">",
"       \"Auscultation of cardiac murmurs\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/57/41876?source=see_link\">",
"       \"Physiologic and pharmacologic maneuvers in the differential diagnosis of heart murmurs and sounds\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The pancarditis of acute rheumatic fever may manifest as a pericardial rub or the murmur of mitral regurgitation. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/37/26202?source=see_link\">",
"       \"Auscultation of cardiac murmurs\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Myocarditis may be evident based on the presence of a gallop or murmur of mitral or tricuspid insufficiency in association with other signs of heart failure. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/53/34647?source=see_link\">",
"       \"Clinical manifestations and diagnosis of myocarditis in children\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Patients with congenital heart disease may have a variety of cardiac findings, depending on the physiologic status of their cardiac lesion, including cyanosis, pathologic murmurs, and evidence of cardiac failure.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Noncardiovascular findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other important findings in patients with palpitations include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Conjunctival pallor that suggests anemia.",
"     </li>",
"     <li>",
"      Exophthalmos with or without goiter that indicates hyperthyroidism.",
"     </li>",
"     <li>",
"      Hyperventilation that consists of markedly rapid breathing or deep breathing, often accompanied by sighing, without an obvious etiology.",
"     </li>",
"     <li>",
"      Tachypnea with rales that implies pulmonary congestion from left sided heart failure seen in patients with myocarditis or congenital heart disease.",
"     </li>",
"     <li>",
"      Hepatomegaly and jugular venous distension that suggests right-sided heart failure seen in patients with myocarditis or congenital heart disease.",
"     </li>",
"     <li>",
"      Diaphoresis with flushing that is found in patients with pheochromocytoma.",
"     </li>",
"     <li>",
"      High levels of emotional distress without life-threatening findings seen in patients with anxiety, panic attack, or hyperventilation.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     ANCILLARY STUDIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the acutely symptomatic patient with palpitations, monitoring and assessment of the cardiac rhythm is vital.",
"   </p>",
"   <p>",
"    Standard bedside cardiac monitors often do not provide satisfactory rhythm tracings to allow detailed decision making. Thus, a standard 12-lead ECG and rhythm strip should be obtained upon presentation and concurrent with any attempts at cardioversion or defibrillation to guide therapy and to provide valuable data should the patient require pediatric cardiology consultation [",
"    <a class=\"abstract\" href=\"UTD.htm?21/34/22056/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Even in the patient who is asymptomatic on presentation, continuous monitoring during initial evaluation and a standard ECG is often helpful since an ECG is essential in the diagnosis of Wolff-Parkinson-White and long QT syndromes and may be helpful in the diagnosis of premature atrial and ventricular beats.",
"   </p>",
"   <p>",
"    Readily available hemoglobin or hematocrit measurement can confirm clinical suspicion of anemia.",
"   </p>",
"   <p>",
"    Clinical findings suggestive of hyperthyroidism can be confirmed by serum thyroid testing. Serum levels of thyroxine (T4) and triiodothyronine (T3) are elevated, and TSH secretion is suppressed in hyperthyroidism. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/29/7641?source=see_link\">",
"     \"Clinical manifestations and diagnosis of hyperthyroidism in children and adolescents\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If the patient presents with an acute tachyarrhythmia, the clinician should obtain an echocardiogram to evaluate myocardial function, as well as to evaluate for underlying structural heart disease soon after normal sinus rhythm is established, preferably within a few days. In the hemodynamically unstable patient, this study should be performed on an emergent basis as the information will impact therapeutic decision making.",
"   </p>",
"   <p>",
"    Cardiac troponin levels (troponin-I and -T) may be elevated in myocarditis. However, myocardial enzymes (creatine kinase [CK], MB isoenzyme of CK [CK-MB]) levels are generally not helpful as they are rarely abnormal. Serum PCR identification of a viral infection, or viral isolation from other body sites, such as the oropharynx or gastrointestinal tract, can support the diagnosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/53/34647?source=see_link&amp;anchor=H8#H8\">",
"     \"Clinical manifestations and diagnosis of myocarditis in children\", section on 'Cardiac enzymes'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/38/39530?source=see_link\">",
"     \"Troponins and creatine kinase as biomarkers of cardiac injury\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Pharyngeal Group A Streptococcus culture, Antistreptolysin O (ASO), anti-deoxyribonuclease B (anti-DNase B),",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    antihyaluronidase titers are essential for documenting antecedent streptococcal infection as part of the diagnosis of rheumatic fever. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/20/23879?source=see_link&amp;anchor=H11#H11\">",
"     \"Clinical manifestations and diagnosis of acute rheumatic fever\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Twenty-four hour ambulatory ECG (Holter) monitors, longer term event and implantable loop recorders are helpful for sporadic events [",
"    <a class=\"abstract\" href=\"UTD.htm?21/34/22056/abstract/22\">",
"     22",
"    </a>",
"    ], but prescription of these should be limited to a pediatric cardiologist. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/38/43623?source=see_link&amp;anchor=H14#H14\">",
"     \"Irregular heart rate (arrhythmias) in children\", section on 'Holter monitor'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/38/43623?source=see_link&amp;anchor=H15#H15\">",
"     \"Irregular heart rate (arrhythmias) in children\", section on 'Event monitor'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     ALGORITHMIC APPROACH",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ill-appearing patients require rapid assessment of airway, breathing, and circulation (",
"    <a class=\"graphic graphic_algorithm graphicRef78536 \" href=\"UTD.htm?4/22/4448\">",
"     algorithm 1",
"    </a>",
"    ). The evaluation should focus on identifying and treating hypoxia, hypoglycemia, shock, and arrhythmia (",
"    <a class=\"graphic graphic_algorithm graphicRef67438 \" href=\"UTD.htm?11/37/11860\">",
"     algorithm 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_algorithm graphicRef81356 \" href=\"UTD.htm?1/61/2000\">",
"     algorithm 3",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/38/9832?source=see_link\">",
"     \"Approach to the child with tachycardia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Children with a history of palpitations, but who are not acutely symptomatic, should be placed on continuous cardiac monitoring and undergo a 12-lead ECG.",
"   </p>",
"   <p>",
"    Patients with a history of syncope, congenital heart disease, or cardiac surgery are at higher risk of having a cardiac arrhythmia as the cause of their palpitations [",
"    <a class=\"abstract\" href=\"UTD.htm?21/34/22056/abstract/19\">",
"     19",
"    </a>",
"    ]. These children warrant involvement of a pediatric cardiologist early in their evaluation so that an echocardiogram looking for cardiac structural abnormality and advanced testing for cardiac rhythm disturbance occur. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/7/12409?source=see_link&amp;anchor=H2#H2\">",
"     \"Suspected heart disease in infants and children: Criteria for referral\", section on 'Timing of referral'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Poisoned patients with palpitations are also at high risk for cardiac arrhythmia. Drugs associated with rhythm disturbance following overdose are listed in the table (",
"    <a class=\"graphic graphic_table graphicRef66773 \" href=\"UTD.htm?23/11/23742\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Additional findings help distinguish among the life-threatening causes of palpitations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The diagnosis of Wolff-Parkinson-White syndrome is made if ventricular preexcitation (delta wave) and a short PR interval are present on 12-lead ECG [",
"      <a class=\"abstract\" href=\"UTD.htm?21/34/22056/abstract/2\">",
"       2",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?16/61/17370?source=see_link&amp;anchor=H13260510#H13260510\">",
"       \"Epidemiology, clinical manifestations, and diagnosis of the Wolff-Parkinson-White syndrome\", section on 'Electrocardiographic (ECG) findings'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      A prolonged corrected QT interval (QTc) identifies the presence of long QT syndrome [",
"      <a class=\"abstract\" href=\"UTD.htm?21/34/22056/abstract/20,23,24\">",
"       20,23,24",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/6/33897?source=see_link\">",
"       \"Diagnosis of congenital long QT syndrome\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/55/23418?source=see_link\">",
"       \"Acquired long QT syndrome\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Sinus bradycardia with SA block or SA arrest identifies sick sinus syndrome. Children with pacemaker malfunction often have bradyarrhythmia. Causes include poor capture, battery failure, and lead misplacement. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/24/33161?source=see_link\">",
"       \"Bradycardia in children\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/14/21737?source=see_link\">",
"       \"Pacing system malfunction: Evaluation and management\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Fever with heart failure is found in children with myocarditis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/53/34647?source=see_link\">",
"       \"Clinical manifestations and diagnosis of myocarditis in children\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The ECG may also document premature extrasystoles. If the history is convincing for periodic episodes of palpitations, but the initial workup is unrevealing, clinicians should refer the patient to a pediatric cardiologist for further evaluation and testing. Potential methods that a cardiologist will use to identify the cardiac rhythm during the palpitation episode include 24 hour ambulatory ECG (Holter) monitors, longer term event recorders, and implantable loop recorders [",
"      <a class=\"abstract\" href=\"UTD.htm?21/34/22056/abstract/22,25\">",
"       22,25",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Children with palpitations, headache, diaphoresis, and hypertension should undergo evaluation for pheochromocytoma. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/14/38121?source=see_link\">",
"       \"Pheochromocytoma in children\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Well-appearing patients with a single episode of palpitations typically have a benign cause, such as fever, anemia, ingestion of medications and substances with sympathomimetic or anticholinergic effects, postural tachycardia syndrome, or hyperventilation (",
"    <a class=\"graphic graphic_algorithm graphicRef78536 \" href=\"UTD.htm?4/22/4448\">",
"     algorithm 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Some patients with significant psychiatric distress due to anxiety, panic attack, or other mental illness may also present with palpitations. These patients warrant appropriate workup for potential organic causes, such as hyperthyroidism, and further mental health assessment and support.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The approach to the evaluation of palpitations is summarized in the algorithm (",
"    <a class=\"graphic graphic_algorithm graphicRef78536 \" href=\"UTD.htm?4/22/4448\">",
"     algorithm 1",
"    </a>",
"    ). Assessment for ill appearance and the determination of rhythm are early decision points in the evaluation of children with palpitations. Ill-appearing patients with tachycardia or shock require immediate resuscitation (",
"    <a class=\"graphic graphic_algorithm graphicRef67438 \" href=\"UTD.htm?11/37/11860\">",
"     algorithm 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_algorithm graphicRef81356 \" href=\"UTD.htm?1/61/2000\">",
"     algorithm 3",
"    </a>",
"    ). Children with syncope or congenital heart disease are more likely to have a life-threatening dysrhythmia. The table lists the causes of palpitations, highlighting the most common and the most life-threatening etiologies (",
"    <a class=\"graphic graphic_table graphicRef52851 \" href=\"UTD.htm?32/61/33756\">",
"     table 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/38/9832?source=see_link\">",
"     \"Approach to the child with tachycardia\"",
"    </a>",
"    .)",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/34/22056/abstract/1\">",
"      Weber BE, Kapoor WN. Evaluation and outcomes of patients with palpitations. Am J Med 1996; 100:138.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/34/22056/abstract/2\">",
"      Doniger SJ, Sharieff GQ. Pediatric dysrhythmias. Pediatr Clin North Am 2006; 53:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/34/22056/abstract/3\">",
"      Kaltman J, Shah M. Evaluation of the child with an arrhythmia. Pediatr Clin North Am 2004; 51:1537.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/34/22056/abstract/4\">",
"      Wisten A, Messner T. Symptoms preceding sudden cardiac death in the young are common but often misinterpreted. Scand Cardiovasc J 2005; 39:143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/34/22056/abstract/5\">",
"      Amital H, Glikson M, Burstein M, et al. Clinical characteristics of unexpected death among young enlisted military personnel: results of a three-decade retrospective surveillance. Chest 2004; 126:528.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/34/22056/abstract/6\">",
"      Woods WA, McCulloch MA. Cardiovascular emergencies in the pediatric patient. Emerg Med Clin North Am 2005; 23:1233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/34/22056/abstract/7\">",
"      Kleinman ME, de Caen AR, Chameides L, et al. Part 10: Pediatric basic and advanced life support: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations. Circulation 2010; 122:S466.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/34/22056/abstract/8\">",
"      Vos P, Pulles-Heintzberger CF, Delhaas T. Supraventricular tachycardia: an incidental diagnosis in infants and difficult to prove in children. Acta Paediatr 2003; 92:1058.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/34/22056/abstract/9\">",
"      Maron BJ. Hypertrophic cardiomyopathy in childhood. Pediatr Clin North Am 2004; 51:1305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/34/22056/abstract/10\">",
"      Ginsburg GS, Riddle MA, Davies M. Somatic symptoms in children and adolescents with anxiety disorders. J Am Acad Child Adolesc Psychiatry 2006; 45:1179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/34/22056/abstract/11\">",
"      Gardner WN. The pathophysiology of hyperventilation disorders. Chest 1996; 109:516.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/34/22056/abstract/12\">",
"      Weinberger M, Abu-Hasan M. Pseudo-asthma: when cough, wheezing, and dyspnea are not asthma. Pediatrics 2007; 120:855.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/34/22056/abstract/13\">",
"      Saisch SG, Wessely S, Gardner WN. Patients with acute hyperventilation presenting to an inner-city emergency department. Chest 1996; 110:952.",
"     </a>",
"    </li>",
"    <li>",
"     Firah MM, Zorc JJ. Behavioral emergencies. In: Textbook of Pediatric Emergency Medicine, 5th, Fleisher GR, Ludwig S, Henretig FM.  (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2006. p.1853.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/34/22056/abstract/15\">",
"      Haller CA, Benowitz NL. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. N Engl J Med 2000; 343:1833.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/34/22056/abstract/16\">",
"      Laforest L, Van Ganse E, Devouassoux G, et al. Patient-reported adverse events under asthma therapy: a community pharmacy-based survey. Clin Pharmacol Ther 2007; 82:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/34/22056/abstract/17\">",
"      Gee P, Richardson S, Woltersdorf W, Moore G. Toxic effects of BZP-based herbal party pills in humans: a prospective study in Christchurch, New Zealand. N Z Med J 2005; 118:U1784.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/34/22056/abstract/18\">",
"      Hasdemir C, Sagcan A, Sekuri C, et al. Isotretinoin (13-cis-retinoic acid) associated atrial tachycardia. Pacing Clin Electrophysiol 2005; 28:348.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/34/22056/abstract/19\">",
"      Chandar, JS, Wolff, GS, Garson, A Jr, et al. Ventricular arrhythmias in postoperative tetralogy of Fallot. Am J Cardiol 1990; 65:655.",
"     </a>",
"    </li>",
"    <li>",
"     Park, MK, Guntheroth, WG. How to Read Pediatric ECG's, 3rd Edition, Mosby Yearbook, St Louis 1992.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/34/22056/abstract/21\">",
"      Wathen JE, Rewers AB, Yetman AT, Schaffer MS. Accuracy of ECG interpretation in the pediatric emergency department. Ann Emerg Med 2005; 46:507.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/34/22056/abstract/22\">",
"      Rossano J, Bloemers B, Sreeram N, et al. Efficacy of implantable loop recorders in establishing symptom-rhythm correlation in young patients with syncope and palpitations. Pediatrics 2003; 112:e228.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/34/22056/abstract/23\">",
"      Moss AJ. Long QT Syndrome. JAMA 2003; 289:2041.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/34/22056/abstract/24\">",
"      Ackerman MJ. The long QT syndrome: ion channel diseases of the heart. Mayo Clin Proc 1998; 73:250.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/34/22056/abstract/25\">",
"      Zimetbaum P, Kim KY, Ho KK, et al. Utility of patient-activated cardiac event recorders in general clinical practice. Am J Cardiol 1997; 79:371.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6436 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-189.41.172.26-18D72DAC39-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_34_22056=[""].join("\n");
var outline_f21_34_22056=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H13\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Life-threatening causes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3839549\">",
"      - Arrhythmias",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3839556\">",
"      - Myocarditis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3839563\">",
"      - Hypertrophic cardiomyopathy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5376790\">",
"      - Hypoglycemia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3839570\">",
"      - Poisoning",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3839577\">",
"      - Pheochromocytoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Common causes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3839658\">",
"      - Increased metabolic rate",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3839665\">",
"      - Catecholamine release",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3839672\">",
"      - Hyperventilation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3839679\">",
"      - Drug-induced",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3839686\">",
"      - Postural orthostatic tachycardia syndrome",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3839693\">",
"      - Premature atrial contractions",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3839700\">",
"      - Premature ventricular contractions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Other causes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      HISTORY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      PHYSICAL EXAMINATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Vital signs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Cardiovascular findings",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Noncardiovascular findings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      ANCILLARY STUDIES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      ALGORITHMIC APPROACH",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"EM/6436\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6436|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?4/22/4448\" title=\"algorithm 1\">",
"      Pediatric palpitations algorithm",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?11/37/11860\" title=\"algorithm 2\">",
"      Pediatric tachycardia algorithm",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?1/61/2000\" title=\"algorithm 3\">",
"      Undifferentiated pediatric shock algorithm",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6436|MOV\">",
"      <a href=\"#\" title=\"MOVIES\">",
"       MOVIES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?7/55/8051\" title=\"movie 1\">",
"      Mitral valve prolapse with patient standing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?15/40/16004\" title=\"movie 2\">",
"      Mitral valve prolapse with patient squatting",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6436|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?32/61/33756\" title=\"table 1\">",
"      Causes palpitations child",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/11/23742\" title=\"table 2\">",
"      Drug and toxin induced ECG abnormalities",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?27/37/28252\" title=\"table 3\">",
"      Normal respiratory rate and heart rate in children",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?11/1/11292\" title=\"table 4\">",
"      Maneuvers mitral valve prolapse",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/55/23418?source=related_link\">",
"      Acquired long QT syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/0/8201?source=related_link\">",
"      Approach to hypoglycemia in infants and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/38/9832?source=related_link\">",
"      Approach to the child with tachycardia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/19/17719?source=related_link\">",
"      Arrhythmic complications of mitral valve prolapse",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/37/26202?source=related_link\">",
"      Auscultation of cardiac murmurs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/24/33161?source=related_link\">",
"      Bradycardia in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/10/36007?source=related_link\">",
"      Causes of syncope in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/20/23879?source=related_link\">",
"      Clinical manifestations and diagnosis of acute rheumatic fever",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/29/7641?source=related_link\">",
"      Clinical manifestations and diagnosis of hyperthyroidism in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/53/34647?source=related_link\">",
"      Clinical manifestations and diagnosis of myocarditis in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/42/36522?source=related_link\">",
"      Clinical manifestations, diagnosis, and evaluation of hypertrophic cardiomyopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/6/33897?source=related_link\">",
"      Diagnosis of congenital long QT syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/10/11432?source=related_link\">",
"      Emergent evaluation of syncope in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/61/17370?source=related_link\">",
"      Epidemiology, clinical manifestations, and diagnosis of the Wolff-Parkinson-White syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/38/43623?source=related_link\">",
"      Irregular heart rate (arrhythmias) in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/27/41398?source=related_link\">",
"      Malignant hypertension and hypertensive encephalopathy in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/40/22152?source=related_link\">",
"      Management and evaluation of wide QRS complex tachycardia in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/9/15514?source=related_link\">",
"      Management of supraventricular tachycardia in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/25/3476?source=related_link\">",
"      Mitral valve prolapse syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/14/21737?source=related_link\">",
"      Pacing system malfunction: Evaluation and management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/14/38121?source=related_link\">",
"      Pheochromocytoma in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/57/41876?source=related_link\">",
"      Physiologic and pharmacologic maneuvers in the differential diagnosis of heart murmurs and sounds",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/30/29159?source=related_link\">",
"      Postural tachycardia syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/0/18442?source=related_link\">",
"      Reflex syncope",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/7/12409?source=related_link\">",
"      Suspected heart disease in infants and children: Criteria for referral",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/8/43144?source=related_link\">",
"      Sustained monomorphic ventricular tachycardia: Diagnosis and evaluation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/38/39530?source=related_link\">",
"      Troponins and creatine kinase as biomarkers of cardiac injury",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_34_22057="Acne hyperpigmentation";
var content_f21_34_22057=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F78119%7EDERM%2F58817&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F78119%7EDERM%2F58817&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Postinflammatory hyperpigmentation",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 324px; height: 279px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    In this patient, healing acne was the cause of the postinflammatory hyperpigmented patch.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Goodheart HP. Goodheart's Photoguide of Common Skin Disorders, 2nd ed. Lippincott Williams &amp; Wilkins, Philadelphia 2003. Copyright &copy; 2003 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Postinflammatory hyperpigmentation and scarring in acne vulgaris",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Multiple hyperpigmented macules and scars are present in this woman with acne vulgaris.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_34_22057=[""].join("\n");
var outline_f21_34_22057=null;
var title_f21_34_22058="Urinalysis in the diagnosis of kidney disease";
var content_f21_34_22058=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Urinalysis in the diagnosis of kidney disease",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/34/22058/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/34/22058/contributors\">",
"     Ron Wald, MDCM, MPH, FRCPC",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/34/22058/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/34/22058/contributors\">",
"     Gary C Curhan, MD, ScD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/34/22058/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/34/22058/contributors\">",
"     John P Forman, MD, MSc",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?21/34/22058/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 10, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The urinalysis is an informative and noninvasive diagnostic tool that is readily accessible to the clinician. Performance and interpretation of the urinalysis are practical skills for clinicians in both the ambulatory and hospital settings. In conjunction with the history, physical examination, and serum chemistries, the urinalysis plays a central role in evaluating acute and chronic kidney disease. In addition, abnormal findings on a routine urinalysis, often in an otherwise asymptomatic patient, may be the first evidence of underlying kidney disease. The urinalysis can also be used in some patients to monitor the course of kidney diseases.",
"   </p>",
"   <p>",
"    Interpretation of the urinalysis in patients with established or suspected kidney disease will be presented in this topic. Assessment of kidney function, a general approach to the patient with kidney disease, an overview of the indications for kidney biopsy, and the differential diagnosis and evaluation of glomerular disease are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/45/36570?source=see_link\">",
"     \"Assessment of kidney function\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/60/35785?source=see_link\">",
"     \"Diagnostic approach to the patient with acute kidney injury (acute renal failure) or chronic kidney disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/11/21690?source=see_link\">",
"     \"Indications for and complications of renal biopsy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/31/27130?source=see_link\">",
"     \"Differential diagnosis and evaluation of glomerular disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     WHEN TO PERFORM A COMPLETE URINALYSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A complete urinalysis consists of three components: gross evaluation, dipstick analysis, and microscopic examination of the urine sediment. These components are discussed in detail below. (See",
"    <a class=\"local\" href=\"#H3\">",
"     'Gross assessment'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H4221132\">",
"     'Urine dipstick'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H13\">",
"     'Urine sediment'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    A complete urinalysis should be performed in the following settings:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a patient with evidence of kidney disease, such as someone with albuminuria or an acute or chronic reduction in the glomerular filtration rate.",
"     </li>",
"     <li>",
"      In a patient with suspected kidney disease. Kidney disease may be suspected on the basis of clinical findings (eg, edema) or because of a concurrent illness that is commonly associated with kidney disease (eg, active systemic lupus erythematosus, secondary hypertension).",
"     </li>",
"     <li>",
"      In a patient with known or suspected kidney stones. A complete urinalysis may identify crystals that suggest the etiology of the stone.",
"     </li>",
"     <li>",
"      A complete urinalysis is also needed to clarify the significance of findings noted on urine dipstick analyses (eg, microscopic hematuria) from otherwise asymptomatic individuals who may have had the urine dipstick as part of a workup for another condition (eg, hypertension, diabetes mellitus).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4220647\">",
"    <span class=\"h1\">",
"     OBTAINING THE SPECIMEN FOR ANALYSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The urine specimen must be properly collected in order to reliably interpret the findings and thus maximize diagnostic utility. The following technique should be followed whenever feasible [",
"    <a class=\"abstract\" href=\"UTD.htm?21/34/22058/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The specimen should be collected into a clean dry container.",
"     </li>",
"     <li>",
"      Patients should be asked to clean the external genitalia and provide a midstream specimen for analysis.",
"     </li>",
"     <li>",
"      In patients with indwelling urinary catheters, a recently produced urine sample should be obtained (ie, directly from the catheter tubing), if feasible, rather than a sample from the urometer or drainage bag. This will ensure that the sample represents recently produced urine and to avoid contamination of the sample by debris in the collection bag.",
"     </li>",
"     <li>",
"      The specimen should be examined at room temperature within two hours of retrieval. If this is not feasible, the sample should be refrigerated at 2 to 8 degrees Celsius and then re-warmed to room temperature prior to assessment.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     GROSS ASSESSMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Normal urine is clear and light yellow in color. Urine turbidity and color may be altered in a number of settings.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24158999\">",
"    <span class=\"h2\">",
"     Turbidity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Turbid urine may be seen in patients whose urine contains precipitated crystals, an abundance of cells (red blood cells, white blood cells, and epithelial cells), chyle, and infection [",
"    <a class=\"abstract\" href=\"UTD.htm?21/34/22058/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24158992\">",
"    <span class=\"h2\">",
"     Urine color",
"    </span>",
"    &nbsp;&mdash;&nbsp;The yellow color of urine is lighter when urine is dilute and darker when concentrated, such as after an overnight water restriction. The urine may also have a variety of other colors.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     Red to brown urine",
"    </span>",
"    &nbsp;&mdash;&nbsp;The excretion of red to brown urine is observed in a variety of clinical settings [",
"    <a class=\"abstract\" href=\"UTD.htm?21/34/22058/abstract/3\">",
"     3",
"    </a>",
"    ]. The initial step in the evaluation of this abnormality is centrifugation of the urine to see if the red color is in the urine sediment or the supernatant (",
"    <a class=\"graphic graphic_algorithm graphicRef55923 \" href=\"UTD.htm?22/63/23550\">",
"     algorithm 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      If the red color is seen only in the sediment (and the supernatant is not red), the patient has hematuria. (See",
"      <a class=\"local\" href=\"#H88671922\">",
"       'Detection of heme'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      If, on the other hand, the supernatant is red, then the supernatant should be tested for heme with a urine dipstick:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      If a urine dipstick of the red supernatant is positive for heme, the patient has either hemoglobinuria or myoglobinuria. (See",
"      <a class=\"local\" href=\"#H2011323053\">",
"       'Hemoglobinuria and myoglobinuria'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      If a urine dipstick of the red supernatant is negative for heme, the patient may have one of a variety of unusual conditions. (See",
"      <a class=\"local\" href=\"#H4221030\">",
"       'Other causes of red urine'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2011323053\">",
"    <span class=\"h4\">",
"     Hemoglobinuria and myoglobinuria",
"    </span>",
"    &nbsp;&mdash;&nbsp;Both hemoglobinuria and myoglobinuria can produce a red or red to brown urine. Rarely, hemoglobinuria is associated with black urine.",
"   </p>",
"   <p>",
"    Hemoglobin and myoglobin can be distinguished on a centrifuged blood sample by their effects on the color of the plasma and on the plasma haptoglobin concentration:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hemoglobin is relatively poorly filtered, due both to its large size (molecular weight 69,000 of the tetramer and 34,000 of the dimer) and protein binding to haptoglobin. Only the unbound dimer is filtered. Hemoglobinuria will not occur until haptoglobin is fully saturated and the filtered load of free hemoglobin exceeds proximal reabsorptive capacity. Although this does not require a high plasma concentration of the free dimer, the total hemoglobin concentration (protein-bound + tetramer + dimer) at this time generally exceeds 100 to 150",
"      <span class=\"nowrap\">",
"       mg/dL,",
"      </span>",
"      resulting in a red to brown color of the plasma [",
"      <a class=\"abstract\" href=\"UTD.htm?21/34/22058/abstract/4\">",
"       4",
"      </a>",
"      ]. Haptoglobin levels typically fall due to hepatic removal of the haptoglobin-hemoglobin complex.",
"      <br/>",
"      <br/>",
"      Hemoglobinuria is often associated with red urine. However, the combination of prolonged transit time through the nephron with glomerular bleeding and an acid urine pH may result in the formation of methemoglobin, which has a smoky brown or \"Coca cola\" color [",
"      <a class=\"abstract\" href=\"UTD.htm?21/34/22058/abstract/4\">",
"       4",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/59/34746?source=see_link&amp;anchor=H10#H10\">",
"       \"Etiology and evaluation of hematuria in adults\", section on 'Glomerular versus nonglomerular bleeding'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Myoglobin, in comparison, is a monomer (molecular weight 17,000) and is not protein bound. As a result, it is rapidly filtered and excreted, thereby allowing the plasma to retain its normal color unless renal failure limits myoglobin excretion. In addition, although myoglobin can bind to haptoglobin, the binding affinity is low, and thus excess plasma myoglobin does not lower the plasma haptoglobin concentration [",
"      <a class=\"abstract\" href=\"UTD.htm?21/34/22058/abstract/5,6\">",
"       5,6",
"      </a>",
"      ]. The source of the excess myoglobin is skeletal muscle breakdown (rhabdomyolysis), which is also associated with a marked elevation in the serum creatine phosphokinase concentration. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?31/55/32632?source=see_link&amp;anchor=H25326281#H25326281\">",
"       \"Clinical manifestations and diagnosis of rhabdomyolysis\", section on 'Urine findings and myoglobinuria'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/6/22632?source=see_link&amp;anchor=H11512183#H11512183\">",
"       \"Clinical features and diagnosis of heme pigment-induced acute kidney injury (acute renal failure)\", section on 'Urinalysis'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4221030\">",
"    <span class=\"h4\">",
"     Other causes of red urine",
"    </span>",
"    &nbsp;&mdash;&nbsp;A red urine supernatant that is negative for heme can be seen in several conditions. These include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Use of certain medications such as",
"      <a class=\"drug drug_general\" href=\"UTD.htm?10/31/10746?source=see_link\">",
"       rifampin",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/48/35594?source=see_link\">",
"       phenytoin",
"      </a>",
"     </li>",
"     <li>",
"      Consumption of food dyes",
"     </li>",
"     <li>",
"      Ingestion of beets (beeturia), rhubarb, or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?39/21/40276?source=see_link\">",
"       senna",
"      </a>",
"     </li>",
"     <li>",
"      Acute intermittent porphyria (",
"      <a class=\"graphic graphic_picture graphicRef57844 \" href=\"UTD.htm?14/47/15088\">",
"       picture 1",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Beeturia refers to the presence of red urine after the ingestion of beets. Approximately 14 percent of individuals who consume beets develop beeturia due to the excretion of betalaine (betanin) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/34/22058/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. Increased intestinal absorption appears to be the primary abnormality in beeturia [",
"    <a class=\"abstract\" href=\"UTD.htm?21/34/22058/abstract/7,9\">",
"     7,9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Other urine colors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rarely, the urine has other colors. These include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      White urine, which may be due to pyuria, phosphate crystals, chyluria [",
"      <a class=\"abstract\" href=\"UTD.htm?21/34/22058/abstract/10\">",
"       10",
"      </a>",
"      ], or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?17/25/17816?source=see_link\">",
"       propofol",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?21/34/22058/abstract/11\">",
"       11",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Green urine, which may be due to the administration of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?1/7/1143?source=see_link\">",
"       methylene blue",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?21/34/22058/abstract/12\">",
"       12",
"      </a>",
"      ],",
"      <a class=\"drug drug_general\" href=\"UTD.htm?17/25/17816?source=see_link\">",
"       propofol",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?21/34/22058/abstract/13-17\">",
"       13-17",
"      </a>",
"      ], or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?26/30/27112?source=see_link\">",
"       amitriptyline",
"      </a>",
"      .",
"     </li>",
"     <li>",
"      Black urine, may be due to hemoglobinuria [",
"      <a class=\"abstract\" href=\"UTD.htm?21/34/22058/abstract/18,19\">",
"       18,19",
"      </a>",
"      ], myoglobulinuria, or ochronosis. The black urine in ochronosis, which usually results from alkaptonuria (also called black urine disease), is caused by the urinary excretion of homogentisic acid. The black color may only be apparent after the urine stands for some time, permitting oxidation of homogentisic acid. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/4/23624?source=see_link&amp;anchor=H19#H19\">",
"       \"Disorders of tyrosine metabolism\", section on 'Alkaptonuria'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Purple urine, which may be due to bacteriuria in patients with urinary catheters. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?43/24/44422?source=see_link&amp;anchor=H6#H6\">",
"       \"Urinary tract infection associated with urethral catheters\", section on 'Purple urine bag syndrome'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      These and other colors can occur in children with inborn errors of metabolism (",
"      <a class=\"graphic graphic_table graphicRef74441 \" href=\"UTD.htm?20/58/21420\">",
"       table 1",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4221132\">",
"    <span class=\"h1\">",
"     URINE DIPSTICK",
"    </span>",
"    &nbsp;&mdash;&nbsp;The urine dipstick provides a rapid semiquantitative assessment of urinary characteristics on a series of test pads embedded on a reagent strip. Most dipsticks permit the analysis of the following core urine parameters: heme, leukocyte esterase, nitrite, albumin, hydrogen ions, specific gravity, and glucose. Dipsticks from different manufacturers vary as to the other urine parameters that are analyzed. Users should be familiar with the specific characteristics of the reagent strips they are using and adhere to manufacturer instructions regarding the amount of urine required and the time that needs to elapse before interpreting the color on any given test pad.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H88671922\">",
"    <span class=\"h2\">",
"     Detection of heme",
"    </span>",
"    &nbsp;&mdash;&nbsp;The urine dipstick is a highly sensitive test for the presence of heme in the urine, with the ability to detect minimal hematuria (eg, one to two red blood cells per high-powered field) [",
"    <a class=\"abstract\" href=\"UTD.htm?21/34/22058/abstract/20\">",
"     20",
"    </a>",
"    ]. Thus, the dipstick is at least as sensitive as the urine sediment examination for the detection of hematuria. False-negative results are therefore unusual, and, as a result, a dipstick that is negative for heme reliably excludes hematuria [",
"    <a class=\"abstract\" href=\"UTD.htm?21/34/22058/abstract/21,22\">",
"     21,22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, a positive dipstick for heme may result not only from hematuria, but also from free hemoglobin or free myoglobin. In addition, the dipstick may be falsely positive if there is semen present in the urine [",
"    <a class=\"abstract\" href=\"UTD.htm?21/34/22058/abstract/23\">",
"     23",
"    </a>",
"    ]. Thus, a positive dipstick does not establish the presence of red blood cells in the urine, and the diagnosis of hematuria requires confirmation with microscopy. (See",
"    <a class=\"local\" href=\"#H2011323053\">",
"     'Hemoglobinuria and myoglobinuria'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/59/34746?source=see_link\">",
"     \"Etiology and evaluation of hematuria in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4221400\">",
"    <span class=\"h2\">",
"     Detection of leukocyte esterase",
"    </span>",
"    &nbsp;&mdash;&nbsp;Leukocyte esterase released by lysed neutrophils and macrophages is a surrogate marker of the presence of white blood cells. Excessively dilute urine may favor cell lysis and lower the threshold for test positivity. In contrast, a concentrated urine may impede cell lysis and therefore produce a false-negative result. Proteinuria and glucosuria may also lead to a false-negative test for leukocyte esterase [",
"    <a class=\"abstract\" href=\"UTD.htm?21/34/22058/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Pyuria (white blood cells in the urine) is commonly associated with bacteriuria. However, if the corresponding urine culture is negative (ie, sterile pyuria), interstitial nephritis, renal tuberculosis, and nephrolithiasis should be considered. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/41/24214?source=see_link\">",
"     \"Urine sampling and culture in the diagnosis of urinary tract infection in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4221431\">",
"    <span class=\"h2\">",
"     Nitrite",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many",
"    <strong>",
"    </strong>",
"    enterobacteriaceae species, the most common microorganisms causing urinary tract infections, elaborate the enzyme nitrate reductase, which confers the ability to convert urinary nitrate to nitrite. Thus, nitrite-positive urine may indicate underlying bacteriuria. However, bacteriuria or frank infection may still be present in the absence of nitrite positivity. This would occur with organisms expressing low levels of nitrate reductase (eg, enterococcus), or when urine dwell time in the bladder is short [",
"    <a class=\"abstract\" href=\"UTD.htm?21/34/22058/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Protein",
"    </span>",
"    &nbsp;&mdash;&nbsp;The urine dipstick test for protein is most sensitive to albumin and provides a semiquantitative means of assessing albuminuria. There are several important limitations of dipstick testing for the urine concentration of albumin:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In most cases, high albuminuria in the range of 30 to 300",
"      <span class=\"nowrap\">",
"       mg/day",
"      </span>",
"      (formerly called microalbuminuria) cannot be detected with dipstick testing. This is important in some patients at high risk for kidney disease, such as those with diabetes, since therapy with an angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) would be considered in such patients. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?38/33/39449?source=see_link&amp;anchor=H24#H24\">",
"       \"Microalbuminuria in type 2 diabetes mellitus\", section on 'Summary and recommendations'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/16/20745?source=see_link&amp;anchor=H220350#H220350\">",
"       \"High albuminuria (microalbuminuria) and cardiovascular disease\", section on 'Summary and recommendations'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      A patient with very high albuminuria that is normally detectable by the dipstick (more than 300",
"      <span class=\"nowrap\">",
"       mg/day,",
"      </span>",
"      formerly called macroalbuminuria) may still have a negative dipstick if the urine is very dilute.",
"     </li>",
"     <li>",
"      Even if the urine dipstick is positive, the semiquantitative categories of albuminuria that are reported (trace, 1+, 2+, and 3+) are",
"      <strong>",
"       not",
"      </strong>",
"      necessarily reliable. A dilute urine, for example, will underestimate the degree of albuminuria. In contrast, a concentrated urine may register as 3+ but may",
"      <strong>",
"       not",
"      </strong>",
"      indicate heavy albuminuria.",
"      <strong>",
"      </strong>",
"     </li>",
"     <li>",
"      The dipstick is insensitive to non-albumin proteins, most notably nephrotoxic immunoglobulin light chains in the setting of multiple myeloma. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/1/22551?source=see_link&amp;anchor=H11#H11\">",
"       \"Pathogenesis and diagnosis of myeloma cast nephropathy (myeloma kidney)\", section on 'Diagnosis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Recent exposure to iodinated radiocontrast agents can induce transient albuminuria [",
"      <a class=\"abstract\" href=\"UTD.htm?21/34/22058/abstract/25\">",
"       25",
"      </a>",
"      ]. However, this may not be observed with newer non-ionic contrast agents [",
"      <a class=\"abstract\" href=\"UTD.htm?21/34/22058/abstract/26\">",
"       26",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Thus, patients at high risk for glomerular disease, those with persistent albuminuria by dipstick testing, and those who may have kidney disease associated with multiple myeloma should undergo a",
"    <strong>",
"     quantitative",
"    </strong>",
"    measurement of protein excretion. This can be accomplished with a 24-hour urine collection, although collecting these specimens may be cumbersome in ambulatory care settings. An alternative method is calculating the protein-to-creatinine ratio or, if the patient has albuminuria, the albumin-to-creatinine ratio on a random (spot) urine sample. (See",
"    <a class=\"medical medical_patient\" href=\"UTD.htm?20/41/21151?source=see_link\">",
"     \"Patient information: Collection of a 24-hour urine specimen (Beyond the Basics)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/37/13914?source=see_link\">",
"     \"Assessment of urinary protein excretion and evaluation of isolated non-nephrotic proteinuria in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H413867\">",
"    <span class=\"h3\">",
"     Sulfosalicylic acid test",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sulfosalicylic acid (SSA) detects all proteins in urine and may be useful in patients with acute kidney injury (AKI) of unclear etiology and a benign urinalysis. A positive SSA test in conjunction with a negative dipstick usually indicates the presence of non-albumin proteins in the urine, most often immunoglobulin light chains. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/1/22551?source=see_link\">",
"     \"Pathogenesis and diagnosis of myeloma cast nephropathy (myeloma kidney)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The SSA test is performed by mixing one-part urine supernatant (eg, 2.5 mL) with three-parts 3 percent SSA and assessing whether the urine becomes turbid, which suggests the presence of proteinuria. The SSA test is described in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/37/13914?source=see_link&amp;anchor=H8#H8\">",
"     \"Assessment of urinary protein excretion and evaluation of isolated non-nephrotic proteinuria in adults\", section on 'Sulfosalicylic acid test'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Hydrogen ion concentration",
"    </span>",
"    &nbsp;&mdash;&nbsp;The urine hydrogen ion concentration, measured as the pH, reflects the degree of acidification of the urine. The urine pH ranges from 4.5 to 8, depending upon the systemic acid-base balance. The urine pH is most often used clinically in patients with metabolic acidosis. The appropriate renal response to acidemia is to increase urinary acid excretion, with the urine pH falling below 5.3 and usually below 5. A higher value may indicate the presence of renal tubular acidosis. A discussion of the urine pH in the diagnosis of renal tubular acidosis is presented elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/32/10759?source=see_link\">",
"     \"Overview of renal tubular acidosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In some settings, the urine pH is not indicative of urinary acidification. As an example, infection with any pathogen that produces urease, such as Proteus mirabilis, can result in a urine pH above 7 to 7.5, even if urinary acidification is normal. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/1/14355?source=see_link\">",
"     \"Chapter 13B: Meaning of urine osmolality and pH\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H418670915\">",
"    <span class=\"h2\">",
"     Specific gravity",
"    </span>",
"    &nbsp;&mdash;&nbsp;The concentration or osmolality of the urine can be estimated by measuring the urine specific gravity, which is defined as the weight of the solution compared with the weight of an equal volume of distilled water. Many urine dipsticks have the capacity to provide an estimate of specific gravity. The urine specific gravity generally varies with the osmolality, rising by approximately .001 for every 35 to 40",
"    <span class=\"nowrap\">",
"     mosmol/kg",
"    </span>",
"    increase in urine osmolality. Thus, a urine osmolality of 280",
"    <span class=\"nowrap\">",
"     mosmol/kg",
"    </span>",
"    (which is isosmotic to normal plasma) is usually associated with a urine specific gravity of 1.008 or 1.009.",
"   </p>",
"   <p>",
"    However, there is an important difference between these measures of concentration: the urine osmolality is determined by the number of particles in the urine (eg, urea, sodium, potassium), while the specific gravity is determined by both the number and size of the particles in the urine. This becomes important clinically when there are large molecules in the urine, such as glucose or radiocontrast media. In these settings, the specific gravity can reach 1.03 to 1.05 (suggesting a highly concentrated urine) despite a urine osmolality that may be dilute to plasma.",
"   </p>",
"   <p>",
"    This concern about larger particles raising the urine specific gravity out of proportion to the urine osmolality does",
"    <strong>",
"     not",
"    </strong>",
"    apply if there is a very low urine specific gravity, since there are no causes of falsely low specific gravity measurements. As an example, a specific gravity &le;1.003 is indicative of a maximally dilute urine (&le;100",
"    <span class=\"nowrap\">",
"     mosmol/kg).",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H413987\">",
"    <span class=\"h3\">",
"     Urine osmolality",
"    </span>",
"    &nbsp;&mdash;&nbsp;The urine specific gravity provides an estimate of the urine osmolality, which most accurately measures the solute concentration of the urine (a function of the number of solute particles per unit volume). The plasma osmolality is maintained within a narrow range (normal 275 to 290",
"    <span class=\"nowrap\">",
"     mosmol/kg),",
"    </span>",
"    principally because the kidney is able to excrete urine with an osmolality markedly different from that of plasma. This effect is mediated by antidiuretic hormone (ADH), which promotes water reabsorption in the collecting tubules, thereby raising the urine osmolality. After a water load, for example, the plasma sodium concentration and plasma osmolality fall, leading to reductions in ADH release and urine osmolality that permits an appropriate increase in water excretion. On the other hand, unreplaced water losses due, for example, to exercise-associated perspiration on a hot day result in an increase in plasma sodium and osmolality. This leads to an increase in ADH release and an increase in urine osmolality with appropriate reduction in urinary water losses. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/10/16552?source=see_link\">",
"     \"Chapter 6B: Antidiuretic hormone and water balance\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/29/17875?source=see_link\">",
"     \"Chapter 9A: Water balance and regulation of plasma osmolality\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In most clinical settings, the urine osmolality can be measured directly, and estimation using the urine specific gravity is unnecessary. Where available, direct measurement of the urine osmolality is most useful in the evaluation of patients with the following disorders: hyponatremia, hypernatremia, polyuria, and AKI:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hyponatremia (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/20/21832?source=see_link&amp;anchor=H6#H6\">",
"       \"Evaluation of the patient with hyponatremia\", section on 'Urine osmolality'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?9/53/10074?source=see_link&amp;anchor=H7#H7\">",
"       \"Osmotic demyelination syndrome and overly rapid correction of hyponatremia\", section on 'Rapid rate of correction'",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Hypernatremia (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?35/63/36857?source=see_link\">",
"       \"Etiology and evaluation of hypernatremia\"",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Polyuria (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/47/24312?source=see_link&amp;anchor=H10#H10\">",
"       \"Diagnosis of polyuria and diabetes insipidus\", section on 'Water restriction test'",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      AKI (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/54/12138?source=see_link\">",
"       \"Etiology and diagnosis of prerenal disease and acute tubular necrosis in acute kidney injury (acute renal failure)\"",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Glucose",
"    </span>",
"    &nbsp;&mdash;&nbsp;The presence of glucose in the urine (glycosuria) is detected by the dipstick and reported semiquantitatively. Glycosuria may be due to either the inability of the kidney to reabsorb filtered glucose in the proximal tubule despite normal plasma glucose levels (renal glycosuria) or urinary spillage because of abnormally high plasma glucose concentrations. In patients with normal renal function, significant glycosuria does not generally occur until the plasma glucose concentration exceeds 180",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (10",
"    <span class=\"nowrap\">",
"     mmol/L).",
"    </span>",
"   </p>",
"   <p>",
"    When",
"    glycosuria occurs with a normal plasma glucose, a primary defect of proximal tubule reabsorption needs to be considered. In this setting, glycosuria may coexist with additional manifestations of proximal tubular dysfunction, including phosphaturia (leading to hypophosphatemia), uricosuria, renal tubular acidosis, and aminoaciduria. This constellation is called the Fanconi syndrome and may result from a variety of disorders, including multiple myeloma, heavy metal exposure, and treatment with certain medications. Glycosuria may also be an isolated defect (isolated renal glycosuria) associated with genetic mutations affecting renal glucose transport. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/48/27400?source=see_link\">",
"     \"Types of renal disease in multiple myeloma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/44/18120?source=see_link\">",
"     \"Etiology and diagnosis of distal (type 1) and proximal (type 2) renal tubular acidosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     URINE SEDIMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Microscopic examination of the urine sediment is an essential part of the urinalysis, as it enables confirmation and clarification of urine dipstick findings and also the identification of structures that are not evaluated by the urine dipstick (eg, epithelial cells, casts, crystals).",
"   </p>",
"   <p>",
"    To perform the urine sediment examination, at least 10 mL of urine is centrifuged at 3000 rpm for five minutes. Most of the supernatant is then poured out, and the pellet is resuspended with gentle shaking of the tube. A pipette can then be used to place approximately 50 microL (or a small drop) of resuspended sediment on a glass slide, followed by application of a coverslip [",
"    <a class=\"abstract\" href=\"UTD.htm?21/34/22058/abstract/24\">",
"     24",
"    </a>",
"    ]. An alternative approach is to tilt the test tube and insert the corner of the coverslip into the tube to extrude a single drop of resuspended sediment; the coverslip is then laid onto the slide, thereby allowing a thin film of sediment to become interposed between the coverslip and the slide.",
"   </p>",
"   <p>",
"    A brightfield (or if available, phase-contrast) microscope with a binocular head, built-in light source, and polarizing filters should be used [",
"    <a class=\"abstract\" href=\"UTD.htm?21/34/22058/abstract/1\">",
"     1",
"    </a>",
"    ]. The light intensity should be subdued because structures may be missed if the light is excessively bright. As the specimen is reviewed, the fine adjustment on the microscope should be manipulated to appreciate structures in different levels of depth within the sample [",
"    <a class=\"abstract\" href=\"UTD.htm?21/34/22058/abstract/2\">",
"     2",
"    </a>",
"    ]. The entire specimen is initially scanned at low-power (100x) with particular attention to the edges of the coverslip where casts tend to migrate. High-power (400x) should then be used to better characterize structures that were identified at lower power. Polarized light may be used to search for lipid-laden elements or crystals as warranted by the clinical context.",
"   </p>",
"   <p>",
"    The urine sediment examination should be performed by a clinician trained in urine microscopy because the diagnostic yield may be substantially greater compared with a urinalysis performed by laboratory staff [",
"    <a class=\"abstract\" href=\"UTD.htm?21/34/22058/abstract/27\">",
"     27",
"    </a>",
"    ]. However, in a study using photograph images, there was only fair to moderate agreement among nephrologists in identifying important structures [",
"    <a class=\"abstract\" href=\"UTD.htm?21/34/22058/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Crystalluria",
"    </span>",
"    &nbsp;&mdash;&nbsp;Whether crystals form in the urine depends upon a variety of factors, including the degree of concentration of constituent molecules, the urine pH, and the presence of inhibitors of crystallization. Many different forms may be observed in normal patients and in those with defined disorders:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Uric acid crystals &ndash; Uric acid crystals as well as amorphous urates are observed in acid urine, a milieu that favors the conversion of the relatively soluble urate salt into the insoluble uric acid (",
"      <a class=\"graphic graphic_picture graphicRef61827 graphicRef73642 \" href=\"UTD.htm?23/39/24177\">",
"       picture 2A-B",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/57/27541?source=see_link\">",
"       \"Uric acid renal diseases\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Calcium phosphate or calcium oxalate crystals &ndash; The formation of calcium oxalate crystals is not dependent upon the urine pH, while calcium phosphate crystals only form in a relatively alkaline urine (",
"      <a class=\"graphic graphic_picture graphicRef65169 graphicRef67694 \" href=\"UTD.htm?14/28/14788\">",
"       picture 3A-B",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/53/33626?source=see_link\">",
"       \"Risk factors for calcium stones in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Cystine crystals &ndash; Cystine crystals, with their characteristic hexagonal shape, are diagnostic of cystinuria (",
"      <a class=\"graphic graphic_picture graphicRef56834 \" href=\"UTD.htm?2/10/2208\">",
"       picture 4",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?24/62/25577?source=see_link\">",
"       \"Cystine stones\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Magnesium ammonium phosphate crystals &ndash; Magnesium ammonium phosphate (struvite) and calcium carbonate-apatite are the constituents of struvite stones (",
"      <a class=\"graphic graphic_picture graphicRef54594 \" href=\"UTD.htm?34/38/35439\">",
"       picture 5",
"      </a>",
"      ). Normal urine is undersaturated with ammonium phosphate. Struvite stone formation occurs only when ammonia production is increased and the urine pH is elevated, which decreases the solubility of phosphate. Both increased ammonia production and increased urine pH occur only in the setting of a urinary tract infection with a urease-producing organism, such as Proteus or Klebsiella. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/54/40802?source=see_link\">",
"       \"Pathogenesis and clinical manifestations of struvite stones\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The observation of crystals in the urine is useful in patients with known or suspected kidney stones and is a risk factor for recurrent calcium oxalate [",
"    <a class=\"abstract\" href=\"UTD.htm?21/34/22058/abstract/29\">",
"     29",
"    </a>",
"    ] or cystine [",
"    <a class=\"abstract\" href=\"UTD.htm?21/34/22058/abstract/30\">",
"     30",
"    </a>",
"    ] stone formation. In addition, crystalluria may have diagnostic utility in other settings:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The presence of magnesium phosphate crystals, which is consistent with infection. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/54/40802?source=see_link\">",
"       \"Pathogenesis and clinical manifestations of struvite stones\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The combination of acute kidney injury (AKI) and calcium oxalate crystals, which is consistent with ethylene glycol ingestion. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/3/4154?source=see_link&amp;anchor=H4#H4\">",
"       \"Methanol and ethylene glycol poisoning\", section on 'Clinical features of overdose'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The presence of a larger number of uric acid crystals occurring in association with AKI, which is consistent with tumor lysis syndrome. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/1/19481?source=see_link\">",
"       \"Tumor lysis syndrome: Definition, pathogenesis, clinical manifestations, etiology and risk factors\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/1/19481?source=see_link&amp;anchor=H491877#H491877\">",
"       \"Tumor lysis syndrome: Definition, pathogenesis, clinical manifestations, etiology and risk factors\", section on 'Clinical manifestations'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Microorganisms",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bacteria are often seen in the urine, although the clinical significance of bacteriuria is generally guided by patient symptoms (",
"    <a class=\"graphic graphic_picture graphicRef83631 \" href=\"UTD.htm?17/21/17747\">",
"     picture 6",
"    </a>",
"    ). Fungi are also frequently present (",
"    <a class=\"graphic graphic_picture graphicRef83631 \" href=\"UTD.htm?17/21/17747\">",
"     picture 6",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/19/42295?source=see_link\">",
"     \"Approach to the adult with asymptomatic bacteriuria\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Cells",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cellular elements that may be found in the urinary sediment include red blood cells, white blood cells, and epithelial cells from all levels of the urinary tract. Infrequently, tumor cells can be observed, which suggest the diagnosis of genitourinary malignancy (eg, bladder cancer)",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    infiltration of the renal parenchyma with malignant cells (eg, lymphoma). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/47/20217?source=see_link\">",
"     \"Clinical presentation, diagnosis, and staging of bladder cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/61/27610?source=see_link&amp;anchor=H18#H18\">",
"     \"Clinical presentation and diagnosis of non-Hodgkin lymphoma\", section on 'Extranodal sites'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Hematuria",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hematuria can be benign or reflect serious underlying disease (",
"    <a class=\"graphic graphic_figure graphicRef61296 \" href=\"UTD.htm?13/34/13870\">",
"     figure 1",
"    </a>",
"    ). The evaluation of patients with hematuria is discussed in detail separately, but some of the major issues will be briefly reviewed here. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/59/34746?source=see_link\">",
"     \"Etiology and evaluation of hematuria in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Hematuria may be grossly visible or microscopic. Microscopic hematuria is commonly defined as the presence of two or more red blood cells per high powered field in a spun urine sediment [",
"    <a class=\"abstract\" href=\"UTD.htm?21/34/22058/abstract/20\">",
"     20",
"    </a>",
"    ] (",
"    <a class=\"graphic graphic_picture graphicRef80282 \" href=\"UTD.htm?43/46/44768\">",
"     picture 7",
"    </a>",
"    ). The urine color change in gross hematuria does not necessarily reflect a large degree of blood loss since as little as 1 mL of blood per liter of urine can induce a visible color change. As previously mentioned, red to brown urine can be observed without red blood cells. (See",
"    <a class=\"local\" href=\"#H4\">",
"     'Red to brown urine'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Hematuria may be transient or persistent. Transient hematuria is relatively common in young patients and may occur following exercise or sexual intercourse [",
"    <a class=\"abstract\" href=\"UTD.htm?21/34/22058/abstract/20\">",
"     20",
"    </a>",
"    ]. Menstruation may confound the evaluation of hematuria, and the urinalysis should be repeated when the patient is not menstruating. However, even transient hematuria can represent underlying malignancy, especially in patients over the age of 50 years. Transient hematuria can also occur with urinary tract infection (eg, cystitis or prostatitis). This is typically accompanied by pyuria and bacteriuria, and patients may often complain of dysuria. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/59/34746?source=see_link\">",
"     \"Etiology and evaluation of hematuria in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Persistent hematuria should always be evaluated. Among the more common pathologic causes are kidney stones, malignancy, and glomerular disease. A study of Israeli army recruits showed that, even in asymptomatic individuals, those with isolated persistent hematuria were 18 times more likely to develop end-stage renal disease (ESRD) over a follow-up period that exceeded 20 years [",
"    <a class=\"abstract\" href=\"UTD.htm?21/34/22058/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Distinguishing between glomerular and nonglomerular causes is the first key step in the evaluation of unexplained hematuria. Isomorphic red blood cells have an appearance similar to erythrocytes in the circulation (small, anucleated cells shaped as biconcave discs) and can be seen with any cause of hematuria. In contrast, dysmorphic red blood cells (which have an altered morphology) are indicative of glomerular disease. There are no accepted criteria for defining dysmorphic red blood cells, and therefore their identification in a urine sediment is somewhat subjective. However, red blood cells that have membrane protrusions (ie, acanthocytes) are a readily definable subset of dysmorphic red blood cells (",
"    <a class=\"graphic graphic_picture graphicRef79440 graphicRef62064 \" href=\"UTD.htm?40/13/41170\">",
"     picture 8A-B",
"    </a>",
"    ). Both albuminuria and the presence of red blood cell casts in a patient with hematuria are also suggestive of glomerular hematuria. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/59/34746?source=see_link&amp;anchor=H10#H10\">",
"     \"Etiology and evaluation of hematuria in adults\", section on 'Glomerular versus nonglomerular bleeding'",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H6437027\">",
"     'Red blood cell casts'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Pyuria",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although the entire spectrum of white blood cells may be seen in the urine, neutrophils and eosinophils are the cell types of greatest practical interest to the clinician-microscopist. Neutrophils are intermediate in size compared with red blood cells and renal tubular epithelial cells and can be identified by their characteristic granular cytoplasm and multilobed nuclei (",
"    <a class=\"graphic graphic_picture graphicRef75211 \" href=\"UTD.htm?14/37/14943\">",
"     picture 9",
"    </a>",
"    ). Urinary neutrophils are most commonly associated with bacterial infection or colonization of the urinary tract but may also be present in patients with a kidney stone, interstitial nephritis, and proliferative glomerulonephritis [",
"    <a class=\"abstract\" href=\"UTD.htm?21/34/22058/abstract/24\">",
"     24",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/41/24214?source=see_link\">",
"     \"Urine sampling and culture in the diagnosis of urinary tract infection in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/36/27209?source=see_link&amp;anchor=H6#H6\">",
"     \"Clinical manifestations and diagnosis of acute interstitial nephritis\", section on 'Clinical features'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Urine eosinophils can be detected by applying Wright's or Hansel's stain to the urine sediment. The presence of eosinophiluria has classically been considered a marker of allergic interstitial nephritis. However, a positive finding may be seen with other conditions, and a negative finding does not exclude the diagnosis. Thus, testing for eosinophiluria should",
"    <strong>",
"     not",
"    </strong>",
"    be used to establish the diagnosis of allergic interstitial nephritis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/39/34418?source=see_link\">",
"     \"The significance of urinary eosinophils\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Epithelial cells",
"    </span>",
"    &nbsp;&mdash;&nbsp;Epithelial cells may appear in the urine after being shed from anywhere within the genitourinary tract. Renal tubular cells are 1.5 to 3 times larger than white cells and are further distinguished by a round, large, centrally-located nucleus (",
"    <a class=\"graphic graphic_picture graphicRef86348 \" href=\"UTD.htm?1/17/1300\">",
"     picture 10",
"    </a>",
"    ). Transitional epithelial cells originate anywhere from the renal pelvis to the proximal urethra and are slightly larger than renal tubular epithelial cells. They may have a pear-like or oval appearance (",
"    <a class=\"graphic graphic_picture graphicRef83886 \" href=\"UTD.htm?18/1/18448\">",
"     picture 11",
"    </a>",
"    ). Squamous epithelial cells are derived from the distal urethra or external genitalia. They are large and irregular in shape with a small central nucleus, and their presence represents contamination by genital secretions (",
"    <a class=\"graphic graphic_picture graphicRef83632 \" href=\"UTD.htm?34/18/35105\">",
"     picture 12",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     CASTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Casts are cylindrical structures that are formed in the tubular lumen; several factors favor cast formation: urine stasis, low pH, and greater urinary concentration [",
"    <a class=\"abstract\" href=\"UTD.htm?21/34/22058/abstract/2\">",
"     2",
"    </a>",
"    ]. Casts will assume the shape and size of the renal tubule in which they are formed. All casts have an organic matrix composed primarily of Tamm-Horsfall mucoprotein, which comprises the basic architecture for any cast. Casts are defined by the nature of the cells or other elements that are embedded in the cast matrix.",
"   </p>",
"   <p>",
"    Some casts can be found in normal individuals, while others are diagnostic of significant renal disease. The observation of cells within a cast is highly significant since their presence is diagnostic of an",
"    <strong>",
"     intrarenal",
"    </strong>",
"    origin.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6437027\">",
"    <span class=\"h2\">",
"     Red blood cell casts",
"    </span>",
"    &nbsp;&mdash;&nbsp;The finding of red blood cell casts, even if only one is seen, is diagnostic of glomerular hematuria, and, in the right clinical context, is suggestive of an underlying proliferative glomerulonephritis for which numerous etiologies exist (",
"    <a class=\"graphic graphic_picture graphicRef55778 \" href=\"UTD.htm?34/38/35424\">",
"     picture 8C",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/59/34746?source=see_link&amp;anchor=H10#H10\">",
"     \"Etiology and evaluation of hematuria in adults\", section on 'Glomerular versus nonglomerular bleeding'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6437063\">",
"    <span class=\"h2\">",
"     White blood cell casts",
"    </span>",
"    &nbsp;&mdash;&nbsp;White blood cell casts are indicative of kidney inflammation, the cause of which may be infectious (eg, pyelonephritis) or non-infectious (eg, interstitial nephritis, proliferative glomerulonephritis) (",
"    <a class=\"graphic graphic_picture graphicRef54319 graphicRef68147 \" href=\"UTD.htm?27/1/27669\">",
"     picture 13A-B",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6437165\">",
"    <span class=\"h2\">",
"     Renal tubular epithelial cell casts",
"    </span>",
"    &nbsp;&mdash;&nbsp;These may be observed in any setting where there is desquamation of the tubular epithelium, including acute tubular necrosis (ATN), acute interstitial nephritis, and proliferative glomerulonephritis (",
"    <a class=\"graphic graphic_picture graphicRef65729 \" href=\"UTD.htm?31/15/31985\">",
"     picture 18B",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6437217\">",
"    <span class=\"h2\">",
"     Granular casts",
"    </span>",
"    &nbsp;&mdash;&nbsp;Granular casts represent degenerated cellular casts or the aggregation of proteins within a cast matrix [",
"    <a class=\"abstract\" href=\"UTD.htm?21/34/22058/abstract/2\">",
"     2",
"    </a>",
"    ] (",
"    <a class=\"graphic graphic_picture graphicRef59811 \" href=\"UTD.htm?7/34/7715\">",
"     picture 14",
"    </a>",
"    ). Granular casts may be coarse or fine in nature, although the clinical significance of this distinction is unclear. Coarse, deeply-pigmented granular casts (ie, \"muddy brown\" or heme-granular casts) are considered characteristic of ATN, the leading cause of acute kidney injury (AKI) in hospitalized patients [",
"    <a class=\"abstract\" href=\"UTD.htm?21/34/22058/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Hyaline casts",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hyaline casts are only slightly more refractile than water and have a transparent, empty appearance (",
"    <a class=\"graphic graphic_picture graphicRef86339 \" href=\"UTD.htm?33/53/34643\">",
"     picture 15",
"    </a>",
"    ). Hyaline casts may be observed with small volumes of concentrated urine or with diuretic therapy and are generally nonspecific.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6437321\">",
"    <span class=\"h2\">",
"     Waxy casts",
"    </span>",
"    &nbsp;&mdash;&nbsp;Waxy casts are thought to be the last stage in the degeneration of a granular cast. They are homogeneous in appearance and are characterized by sharp indentations and darker edges that are more distinct (",
"    <a class=\"graphic graphic_picture graphicRef83885 \" href=\"UTD.htm?28/1/28688\">",
"     picture 16",
"    </a>",
"    ). Waxy casts are nonspecific and may be observed in a variety of acute and chronic kidney diseases.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6437328\">",
"    <span class=\"h2\">",
"     Broad casts",
"    </span>",
"    &nbsp;&mdash;&nbsp;As their name implies, broad casts are wider than other casts, a characteristic believed to be due to their formation in large dilated tubules with little flow (",
"    <a class=\"graphic graphic_picture graphicRef86555 \" href=\"UTD.htm?15/25/15762\">",
"     picture 17",
"    </a>",
"    ). The presence of broad casts is typically associated with advanced chronic kidney disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h1\">",
"     THE ASSESSMENT OF LIPIDURIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lipid droplets, composed primarily of cholesterol esters and, to a lesser degree, cholesterol, are commonly seen on urinalysis in patients with conditions that are associated with the nephrotic syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?21/34/22058/abstract/33,34\">",
"     33,34",
"    </a>",
"    ]. These fat droplets may be free within tubular cells (called oval fat bodies) or within casts (called fatty casts) (",
"    <a class=\"graphic graphic_picture graphicRef69603 \" href=\"UTD.htm?29/6/29792\">",
"     picture 8D",
"    </a>",
"    ). Fat droplets have a characteristic \"Maltese cross\" appearance under polarized light (",
"    <a class=\"graphic graphic_picture graphicRef79604 \" href=\"UTD.htm?31/0/31758\">",
"     picture 8E",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Fat droplets are round and may be confused with red cells. They can be differentiated from red cells under routine light microscopy by their variable size (ranging from larger to much smaller than red cells), their dark outline, and the \"Maltese cross\" appearance under polarized light.",
"   </p>",
"   <p>",
"    The origin of urinary lipid is not well understood [",
"    <a class=\"abstract\" href=\"UTD.htm?21/34/22058/abstract/34\">",
"     34",
"    </a>",
"    ]. The initial step is the filtration of lipoprotein-bound cholesterol, particularly HDL-cholesterol. Filtration of lipoproteins is minimal in normal individuals but is markedly enhanced when glomerular permeability to macromolecules is increased in the nephrotic syndrome. Some of the filtered lipoprotein is taken up by the proximal tubular cells. The cholesterol will be seen in the urine sediment as an oval fat body when the cell is desquamated",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    as free droplets or fatty casts if the lipid is extruded from the cells.",
"   </p>",
"   <p>",
"    Because of the apparent requirement for increased glomerular permeability, lipiduria is almost always diagnostic of some form of glomerular disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/31/27130?source=see_link\">",
"     \"Differential diagnosis and evaluation of glomerular disease\"",
"    </a>",
"    .) One exception is autosomal dominant polycystic kidney disease [",
"    <a class=\"abstract\" href=\"UTD.htm?21/34/22058/abstract/35,36\">",
"     35,36",
"    </a>",
"    ]. In one report, urinary oval fat bodies were observed in 21 of 35 patients with autosomal dominant polycystic kidney disease and corresponded to a urine dipstick exceeding trace proteinuria [",
"    <a class=\"abstract\" href=\"UTD.htm?21/34/22058/abstract/35\">",
"     35",
"    </a>",
"    ]. Oval fat bodies were also seen in cyst fluid from five of six patients with hemorrhagic cysts, raising the possibility that urinary oval fat bodies in patients with autosomal dominant polycystic kidney disease result from bleeding into cysts. Occasional lipid bodies (five or fewer per high power field) may be seen in other nonglomerular diseases, such as acute or chronic interstitial nephritis or even prerenal azotemia [",
"    <a class=\"abstract\" href=\"UTD.htm?21/34/22058/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h1\">",
"     CORRELATION OF URINARY FINDINGS WITH KIDNEY DISEASES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Various patterns of urinary findings may suggest specific categories of kidney disease. As with all diagnostic tests, these urinary findings must be interpreted in the context of the history, physical exam, and available laboratory data (",
"    <a class=\"graphic graphic_table graphicRef56160 \" href=\"UTD.htm?37/51/38715\">",
"     table 2",
"    </a>",
"    ). Patterns of urinary findings and the diagnoses to which they point include:",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1067607\">",
"    <span class=\"h2\">",
"     Hematuria with dysmorphic RBC, casts, and proteinuria",
"    </span>",
"    &nbsp;&mdash;&nbsp;The constellation of hematuria with dysmorphic red blood cells, red blood cell casts, proteinuria,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    lipiduria is virtually diagnostic of proliferative glomerular diseases (",
"    <a class=\"graphic graphic_picture graphicRef79440 graphicRef62064 graphicRef55778 graphicRef69603 graphicRef79604 \" href=\"UTD.htm?39/38/40553\">",
"     picture 8A-E",
"    </a>",
"    ). However, isolated hematuria with no dysmorphic features does",
"    <strong>",
"     not",
"    </strong>",
"    reliably exclude these disorders. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/31/27130?source=see_link&amp;anchor=H93801583#H93801583\">",
"     \"Differential diagnosis and evaluation of glomerular disease\", section on 'Nephritic pattern'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1067630\">",
"    <span class=\"h2\">",
"     Heavy proteinuria with absent or minimal hematuria",
"    </span>",
"    &nbsp;&mdash;&nbsp;Heavy proteinuria with oval fat bodies, lipid-laden casts, and absent or minimal hematuria is indicative of nonproliferative glomerular diseases including severe diabetic nephropathy. In addition, this pattern may be seen with membranous nephropathy, focal segmental glomerulosclerosis, minimal change disease, and amyloidosis, each of which has both primary and secondary forms. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/18/32041?source=see_link\">",
"     \"Overview of heavy proteinuria and the nephrotic syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1067637\">",
"    <span class=\"h2\">",
"     Granular or epithelial cell casts",
"    </span>",
"    &nbsp;&mdash;&nbsp;In a patient with acute kidney injury (AKI), the presence of multiple granular",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    epithelial cell casts with or without free renal tubular epithelial cells is strongly suggestive of acute tubular necrosis (ATN). However, the absence of these findings does",
"    <strong>",
"     not",
"    </strong>",
"    exclude this diagnosis (",
"    <a class=\"graphic graphic_picture graphicRef56438 graphicRef65729 \" href=\"UTD.htm?19/21/19800\">",
"     picture 18A-B",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    In patients with ischemic or toxic injury to the tubular epithelial cells, cell sloughing into the tubular lumen, due either to cell death or to defective cell-to-cell or cell-to-basement membrane adhesion, may lead to the formation of granular",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    epithelial cell casts. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/4/4170?source=see_link&amp;anchor=H4#H4\">",
"     \"Pathogenesis and etiology of postischemic (ischemic) acute tubular necrosis\", section on 'Epithelial cell injury and dysfunction'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The presence and quantity of granular casts or renal tubular epithelial cells in the urine was evaluated as a diagnostic tool in 267 patients with hospitalized AKI [",
"    <a class=\"abstract\" href=\"UTD.htm?21/34/22058/abstract/37\">",
"     37",
"    </a>",
"    ]. Prior to performing a urinalysis, trained clinicians were asked to make a clinical diagnosis of ATN, prerenal AKI, or other. Since kidney biopsies were not routinely performed, the final diagnosis of ATN versus prerenal disease was determined by whether the renal function improved within 48 hours after fluid resuscitation",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    hemodynamic manipulation. The following observations were made:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A pre-urinalysis diagnosis (based upon the history, physical examination, and other available data) of ATN had a positive predictive value of 86 percent. In such patients who also had at least one granular cast or tubular epithelial cell in the urinalysis, the positive predictive value increased to 100 percent. Of patients with a pre-urinalysis diagnosis of ATN and no granular casts or tubular epithelial cells, 44 percent had a final diagnosis of ATN. Thus, a diagnosis of ATN is still possible even if the urinalysis has no granular casts or tubular epithelial cells.",
"     </li>",
"     <li>",
"      A pre-urinalysis diagnosis of prerenal AKI had a positive predictive value of 77 percent. In such patients, the absence of granular casts or tubular epithelial cells increased the positive predictive value to 91 percent for a final diagnosis of prerenal AKI.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The presence of granular casts and tubular epithelial cells in the urine are also associated with progression of AKI in the hospital [",
"    <a class=\"abstract\" href=\"UTD.htm?21/34/22058/abstract/38\">",
"     38",
"    </a>",
"    ]. Patients whose urinalyses revealed six or more granular casts per low powered field (without tubular epithelial cells), six or more tubular epithelial cells per high powered field (without granular casts), or any number of granular casts and tubular epithelial cells present in the same specimen had a significantly greater likelihood of developing worse kidney function, initiation of dialysis, or death compared with patients who had no granular casts or tubular epithelial cells (54-67 percent versus 9 percent).",
"   </p>",
"   <p>",
"    A study of critically ill patients with AKI in Australia found that a higher \"urine microscopy score\" (also defined by the number of granular casts and renal tubular epithelial cells, albeit using a slightly different scoring system than the previous study) was associated with more severe AKI and the receipt of dialysis [",
"    <a class=\"abstract\" href=\"UTD.htm?21/34/22058/abstract/39\">",
"     39",
"    </a>",
"    ]. Septic patients had higher urine microscopy scores than non-septic patients despite similar serum creatinine concentrations and similar degrees of oliguria. This study suggests that urine sediment findings provide additional prognostic information in patients with AKI beyond the serum creatinine and urine volume.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1067644\">",
"    <span class=\"h2\">",
"     Isolated pyuria",
"    </span>",
"    &nbsp;&mdash;&nbsp;Assuming no contamination with vaginal secretions, pyuria alone is usually indicative of urinary tract infection (including tuberculosis, in which conventional bacterial cultures may be negative). Sterile pyuria may also suggest an asymptomatic kidney stone or some form of tubulointerstitial disease, such as analgesic nephropathy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1067675\">",
"    <span class=\"h2\">",
"     Normal or near-normal urinalysis",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients with AKI, a relatively normal urinalysis (few cells with little or no proteinuria and no casts other than hyaline casts) can be associated with ATN but may also indicate one of the following diseases:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Prerenal AKI",
"     </li>",
"     <li>",
"      Urinary tract obstruction",
"     </li>",
"     <li>",
"      Hypercalcemia",
"     </li>",
"     <li>",
"      Cast nephropathy in multiple myeloma",
"     </li>",
"     <li>",
"      Vascular disease that produces glomerular ischemia but not infarction (eg, hypertensive emergency, scleroderma, thrombotic microangiopathies) or that affects extra-glomerular vessels (eg, cholesterol atheroemboli, polyarteritis nodosa)",
"     </li>",
"     <li>",
"      Tumor lysis syndrome",
"     </li>",
"     <li>",
"      Acute phosphate nephropathy",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In patients with chronic kidney disease, a normal urinalysis most commonly indicates: persistent states of decreased effective circulating volume, such as in patients with heart failure; urinary tract obstruction; chronic tubulointerstitial diseases; and ischemic or hypertensive nephrosclerosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, \"The Basics\" and \"Beyond the Basics.\" The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on \"patient info\" and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?22/59/23474?source=see_link\">",
"       \"Patient information: Blood in the urine (hematuria) in adults (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?9/53/10066?source=see_link\">",
"       \"Patient information: Blood in the urine (hematuria) in adults (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?36/35/37426?source=see_link\">",
"       \"Patient information: Glomerular disease overview (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13702294\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A complete urinalysis consists of three components: gross evaluation, dipstick analysis, and microscopic examination of the urine sediment. A complete urinalysis should be performed in the following settings (see",
"      <a class=\"local\" href=\"#H2\">",
"       'When to perform a complete urinalysis'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      In a patient with evidence of kidney disease, such as someone with albuminuria or an acute or chronic reduction in the glomerular filtration rate.",
"     </li>",
"     <li>",
"      In a patient with suspected kidney disease. Kidney disease may be suspected on the basis of clinical findings (eg, edema) or because of a concurrent illness that is commonly associated with kidney disease (eg, active systemic lupus erythematosus, secondary hypertension).",
"     </li>",
"     <li>",
"      In a patient with known or suspected kidney stones. A complete urinalysis may identify crystals that clarify the etiology of the kidney stone.",
"     </li>",
"     <li>",
"      A complete urinalysis is also needed to clarify the significance of findings noted on urine dipstick analyses (eg, microscopic hematuria) from otherwise asymptomatic individuals who may have had the urine dipstick as part of a workup for another condition (eg, hypertension, diabetes mellitus).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The urine specimen must be properly collected in order to reliably interpret the findings and thus maximize diagnostic utility. The following technique should be followed whenever feasible (see",
"      <a class=\"local\" href=\"#H4220647\">",
"       'Obtaining the specimen for analysis'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      The specimen should be collected into a clean dry container.",
"     </li>",
"     <li>",
"      Patients should be asked to clean the external genitalia and provide a midstream specimen for analysis.",
"     </li>",
"     <li>",
"      In patients with indwelling urinary catheters, a recently produced urine sample should be obtained (ie, directly from the catheter tubing), if feasible, rather than a sample from the urometer or drainage bag.",
"     </li>",
"     <li>",
"      The specimen should be examined at room temperature within two hours of retrieval. If this is not feasible, the sample should be refrigerated at 2 to 8 degrees Celsius and then re-warmed to room temperature prior to assessment.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Normal urine is clear and light yellow in color. Urine turbidity and color may be altered in a number of settings. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Gross assessment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The urine dipstick provides a rapid semiquantitative assessment of urinary characteristics on a series of test pads embedded on a reagent strip. Most dipsticks permit the analysis of the following core urine parameters: heme, leukocyte esterase, nitrite, albumin, hydrogen ions, specific gravity, and glucose. (See",
"      <a class=\"local\" href=\"#H4221132\">",
"       'Urine dipstick'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Microscopic examination of the urine sediment is an essential part of the urinalysis, as it enables confirmation and clarification of urine dipstick findings and also the identification of structures that are not evaluated by the urine dipstick (eg, epithelial cells, casts, crystals). To perform the urine sediment examination, at least 10 mL of urine is centrifuged at 3000 rpm for five minutes. Most of the supernatant is then poured out, and the pellet is resuspended with gentle shaking of the tube. A pipette can then be used to place approximately 50 microL (or a small drop) of resuspended sediment on a glass slide, followed by application of a coverslip. A brightfield (or if available, phase-contrast) microscope with a binocular head, built-in light source, and polarizing filters should be used to examine the urine. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Urine sediment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The following diagnostically useful structures may be identified with microscopic examination:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Crystals, such as uric acid crystals (",
"      <a class=\"graphic graphic_picture graphicRef61827 graphicRef73642 \" href=\"UTD.htm?23/39/24177\">",
"       picture 2A-B",
"      </a>",
"      ), calcium phosphate or calcium oxalate crystals (",
"      <a class=\"graphic graphic_picture graphicRef65169 graphicRef67694 \" href=\"UTD.htm?14/28/14788\">",
"       picture 3A-B",
"      </a>",
"      ), cystine crystals (",
"      <a class=\"graphic graphic_picture graphicRef56834 \" href=\"UTD.htm?2/10/2208\">",
"       picture 4",
"      </a>",
"      ), and magnesium ammonium phosphate crystals (",
"      <a class=\"graphic graphic_picture graphicRef54594 \" href=\"UTD.htm?34/38/35439\">",
"       picture 5",
"      </a>",
"      ) (see",
"      <a class=\"local\" href=\"#H14\">",
"       'Crystalluria'",
"      </a>",
"      above).",
"     </li>",
"     <li>",
"      Bacteria or fungi (",
"      <a class=\"graphic graphic_picture graphicRef83631 \" href=\"UTD.htm?17/21/17747\">",
"       picture 6",
"      </a>",
"      ) (see",
"      <a class=\"local\" href=\"#H15\">",
"       'Microorganisms'",
"      </a>",
"      above).",
"     </li>",
"     <li>",
"      Red blood cells (",
"      <a class=\"graphic graphic_picture graphicRef80282 \" href=\"UTD.htm?43/46/44768\">",
"       picture 7",
"      </a>",
"      ), which can be benign or reflect serious underlying disease (",
"      <a class=\"graphic graphic_figure graphicRef61296 \" href=\"UTD.htm?13/34/13870\">",
"       figure 1",
"      </a>",
"      ) (see",
"      <a class=\"local\" href=\"#H17\">",
"       'Hematuria'",
"      </a>",
"      above).",
"     </li>",
"     <li>",
"      White blood cells (",
"      <a class=\"graphic graphic_picture graphicRef75211 \" href=\"UTD.htm?14/37/14943\">",
"       picture 9",
"      </a>",
"      ) (see",
"      <a class=\"local\" href=\"#H18\">",
"       'Pyuria'",
"      </a>",
"      above).",
"     </li>",
"     <li>",
"      Renal tubular epithelial cells (",
"      <a class=\"graphic graphic_picture graphicRef86348 \" href=\"UTD.htm?1/17/1300\">",
"       picture 10",
"      </a>",
"      ), transitional epithelial cells (",
"      <a class=\"graphic graphic_picture graphicRef83886 \" href=\"UTD.htm?18/1/18448\">",
"       picture 11",
"      </a>",
"      ), and squamous epithelial cells (",
"      <a class=\"graphic graphic_picture graphicRef83632 \" href=\"UTD.htm?34/18/35105\">",
"       picture 12",
"      </a>",
"      ). The latter represent contamination by genital secretions. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Epithelial cells'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Red blood cell casts, which are usually diagnostic of glomerular hematuria and in the right clinical context, are suggestive of an underlying proliferative glomerulonephritis (",
"      <a class=\"graphic graphic_picture graphicRef55778 \" href=\"UTD.htm?34/38/35424\">",
"       picture 8C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H6437027\">",
"       'Red blood cell casts'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      White blood cell casts, which are indicative of kidney inflammation, the cause of which may be infectious (eg, pyelonephritis) or non-infectious (eg, interstitial nephritis, proliferative glomerulonephritis) (",
"      <a class=\"graphic graphic_picture graphicRef54319 graphicRef68147 \" href=\"UTD.htm?27/1/27669\">",
"       picture 13A-B",
"      </a>",
"      ) (see",
"      <a class=\"local\" href=\"#H6437063\">",
"       'White blood cell casts'",
"      </a>",
"      above).",
"     </li>",
"     <li>",
"      Renal tubular epithelial cell casts, which may be observed in any setting where there is desquamation of the tubular epithelium, including acute tubular necrosis (ATN), acute interstitial nephritis, and proliferative glomerulonephritis (",
"      <a class=\"graphic graphic_picture graphicRef65729 \" href=\"UTD.htm?31/15/31985\">",
"       picture 18B",
"      </a>",
"      ) (see",
"      <a class=\"local\" href=\"#H6437165\">",
"       'Renal tubular epithelial cell casts'",
"      </a>",
"      above).",
"     </li>",
"     <li>",
"      Granular casts, which represent degenerated cellular casts or the aggregation of proteins within a cast matrix (",
"      <a class=\"graphic graphic_picture graphicRef59811 \" href=\"UTD.htm?7/34/7715\">",
"       picture 14",
"      </a>",
"      ). Coarse, deeply-pigmented granular casts (ie, \"muddy brown\" or heme-granular casts) are considered characteristic of ATN. (See",
"      <a class=\"local\" href=\"#H6437217\">",
"       'Granular casts'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Hyaline casts, which are only slightly more refractile than water and have a transparent, empty appearance (",
"      <a class=\"graphic graphic_picture graphicRef86339 \" href=\"UTD.htm?33/53/34643\">",
"       picture 15",
"      </a>",
"      ), may be observed with small volumes of concentrated urine or with diuretic therapy and are generally nonspecific. (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Hyaline casts'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Lipid droplets (",
"      <a class=\"graphic graphic_picture graphicRef69603 \" href=\"UTD.htm?29/6/29792\">",
"       picture 8D",
"      </a>",
"      and",
"      <a class=\"graphic graphic_picture graphicRef79604 \" href=\"UTD.htm?31/0/31758\">",
"       picture 8E",
"      </a>",
"      ), composed primarily of cholesterol esters and, to a lesser degree, cholesterol, are commonly seen on urinalysis in patients with conditions that are associated with the nephrotic syndrome. (See",
"      <a class=\"local\" href=\"#H26\">",
"       'The assessment of lipiduria'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Various patterns of urinary findings may suggest specific categories of kidney disease. As with all diagnostic tests, these urinary findings must be interpreted in the context of the history, physical exam, and available laboratory data (",
"      <a class=\"graphic graphic_table graphicRef56160 \" href=\"UTD.htm?37/51/38715\">",
"       table 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H30\">",
"       'Correlation of urinary findings with kidney diseases'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Rabinovitch A, Arzoumanian L, Curcio KM, et al. Urinalysis-approved guideline, 3rd ed. Clinical and Laboratory Standard Institute, 29(4), 2009 Wayne, PA. file://www.clsi.org/source/orders/free/gp16-a3.pdf (Accessed on March 07, 2012).",
"    </li>",
"    <li>",
"     Graff L. A Handbook of Routine Urinalysis, Lippincott, Williams and Wilkins, Philadelphia 1983.",
"    </li>",
"    <li>",
"     Rose BD. Pathophysiology of Renal Disease, 2nd ed, McGraw-Hill, New York City 1987. p.10.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/34/22058/abstract/4\">",
"      Pimstone NR. Renal degradation of hemoglobin. Semin Hematol 1972; 9:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/34/22058/abstract/5\">",
"      Sakata S, Yoshioka N, Atassi MZ. Human haptoglobin binds to human myoglobin. Biochim Biophys Acta 1986; 873:312.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/34/22058/abstract/6\">",
"      Adornato BT, Kagen LJ, Garver FA, Engel WK. Depletion of serum hemopexin in fulminant rhabdomyolysis. Evidence for an interaction of hemopexin with myoglobin-derived heme. Arch Neurol 1978; 35:547.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/34/22058/abstract/7\">",
"      WATSON WC, LUKE RG, INALL JA. BEETURIA: ITS INCIDENCE AND A CLUE TO ITS MECHANISM. Br Med J 1963; 2:971.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/34/22058/abstract/8\">",
"      Thompson WG. Things that go red in the urine; and others that don't. Lancet 1996; 347:5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/34/22058/abstract/9\">",
"      Tunnessen WW, Smith C, Oski FA. Beeturia. A sign of iron deficiency. Am J Dis Child 1969; 117:424.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/34/22058/abstract/10\">",
"      Crane DB, Wheeler WE, Smith MJ. Chyluria. Urology 1977; 9:429.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/34/22058/abstract/11\">",
"      Nates J, Avidan A, Gozal Y, Gertel M. Appearance of white urine during propofol anesthesia. Anesth Analg 1995; 81:210.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/34/22058/abstract/12\">",
"      Stratta P, Barbe MC. Images in clinical medicine. Green urine. N Engl J Med 2008; 358:e12.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/34/22058/abstract/13\">",
"      Bernante P, Francini F, Zangrandi F, et al. Green urine after intragastric balloon placement for the treatment of morbid obesity. Obes Surg 2003; 13:951.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/34/22058/abstract/14\">",
"      Blakey SA, Hixson-Wallace JA. Clinical significance of rare and benign side effects: propofol and green urine. Pharmacotherapy 2000; 20:1120.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/34/22058/abstract/15\">",
"      Lepenies J, Toubekis E, Frei U, Schindler R. Green urine after motorcycle accident. Nephrol Dial Transplant 2000; 15:725.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/34/22058/abstract/16\">",
"      Gillett MJ, Burnett JR. Medications and green urine. Intern Med J 2006; 36:64.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/34/22058/abstract/17\">",
"      Leclercq P, Loly C, Delanaye P, et al. Green urine. Lancet 2009; 373:1462.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/34/22058/abstract/18\">",
"      Slotki IN, MacIver JE, Mallick NP, Palmer HM. Acute intravascular hemolysis with minimal renal impairment in Clostridium perfringens infection. Clin Nephrol 1976; 6:451.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/34/22058/abstract/19\">",
"      Massoud OI, Yousef WI, Mullen KD. Hemoglobinuria with ribavirin treatment. J Clin Gastroenterol 2003; 36:367.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/34/22058/abstract/20\">",
"      Cohen RA, Brown RS. Clinical practice. Microscopic hematuria. N Engl J Med 2003; 348:2330.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/34/22058/abstract/21\">",
"      Schr&ouml;der FH. Microscopic haematuria. BMJ 1994; 309:70.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/34/22058/abstract/22\">",
"      Daum GS, Krolikowski FJ, Reuter KL, et al. Dipstick evaluation of hematuria in abdominal trauma. Am J Clin Pathol 1988; 89:538.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/34/22058/abstract/23\">",
"      Mazouz B, Almagor M. False-positive microhematuria in dipsticks urinalysis caused by the presence of semen in urine. Clin Biochem 2003; 36:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/34/22058/abstract/24\">",
"      Fogazzi GB, Verdesca S, Garigali G. Urinalysis: core curriculum 2008. Am J Kidney Dis 2008; 51:1052.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/34/22058/abstract/25\">",
"      Nicot GS, Merle LJ, Charmes JP, et al. Transient glomerular proteinuria, enzymuria, and nephrotoxic reaction induced by radiocontrast media. JAMA 1984; 252:2432.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/34/22058/abstract/26\">",
"      Cheng KH, Chu CS, Lee KT, et al. Evaluation of microalbuminuria after non-ionic radiocontrast medium exposure in patients undergoing coronary angiography. Int J Cardiol 2008; 127:126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/34/22058/abstract/27\">",
"      Tsai JJ, Yeun JY, Kumar VA, Don BR. Comparison and interpretation of urinalysis performed by a nephrologist versus a hospital-based clinical laboratory. Am J Kidney Dis 2005; 46:820.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/34/22058/abstract/28\">",
"      Wald R, Bell CM, Nisenbaum R, et al. Interobserver reliability of urine sediment interpretation. Clin J Am Soc Nephrol 2009; 4:567.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/34/22058/abstract/29\">",
"      Daudon M, Hennequin C, Boujelben G, et al. Serial crystalluria determination and the risk of recurrence in calcium stone formers. Kidney Int 2005; 67:1934.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/34/22058/abstract/30\">",
"      Daudon M, Cohen-Solal F, Barbey F, et al. Cystine crystal volume determination: a useful tool in the management of cystinuric patients. Urol Res 2003; 31:207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/34/22058/abstract/31\">",
"      Vivante A, Afek A, Frenkel-Nir Y, et al. Persistent asymptomatic isolated microscopic hematuria in Israeli adolescents and young adults and risk for end-stage renal disease. JAMA 2011; 306:729.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/34/22058/abstract/32\">",
"      Esson ML, Schrier RW. Diagnosis and treatment of acute tubular necrosis. Ann Intern Med 2002; 137:744.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/34/22058/abstract/33\">",
"      ZIMMER JG, DEWEY R, WATERHOUSE C, TERRY R. The origin and nature of anisotropic urinary lipids in the nephrotic syndrome. Ann Intern Med 1961; 54:205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/34/22058/abstract/34\">",
"      Streather CP, Varghese Z, Moorhead JF, Scoble JE. Lipiduria in renal disease. Am J Hypertens 1993; 6:353S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/34/22058/abstract/35\">",
"      Duncan KA, Cuppage FE, Grantham JJ. Urinary lipid bodies in polycystic kidney disease. Am J Kidney Dis 1985; 5:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/34/22058/abstract/36\">",
"      Braden GL, Sanchez PG, Fitzgibbons JP, et al. Urinary doubly refractile lipid bodies in nonglomerular renal diseases. Am J Kidney Dis 1988; 11:332.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/34/22058/abstract/37\">",
"      Perazella MA, Coca SG, Kanbay M, et al. Diagnostic value of urine microscopy for differential diagnosis of acute kidney injury in hospitalized patients. Clin J Am Soc Nephrol 2008; 3:1615.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/34/22058/abstract/38\">",
"      Perazella MA, Coca SG, Hall IE, et al. Urine microscopy is associated with severity and worsening of acute kidney injury in hospitalized patients. Clin J Am Soc Nephrol 2010; 5:402.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/34/22058/abstract/39\">",
"      Bagshaw SM, Haase M, Haase-Fielitz A, et al. A prospective evaluation of urine microscopy in septic and non-septic acute kidney injury. Nephrol Dial Transplant 2012; 27:582.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7196 Version 13.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-125.39.66.147-0E3ADE63EF-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_34_22058=[""].join("\n");
var outline_f21_34_22058=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H13702294\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      WHEN TO PERFORM A COMPLETE URINALYSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4220647\">",
"      OBTAINING THE SPECIMEN FOR ANALYSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      GROSS ASSESSMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24158999\">",
"      Turbidity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24158992\">",
"      Urine color",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - Red to brown urine",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H2011323053\">",
"      Hemoglobinuria and myoglobinuria",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H4221030\">",
"      Other causes of red urine",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Other urine colors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4221132\">",
"      URINE DIPSTICK",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H88671922\">",
"      Detection of heme",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4221400\">",
"      Detection of leukocyte esterase",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4221431\">",
"      Nitrite",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Protein",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H413867\">",
"      - Sulfosalicylic acid test",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Hydrogen ion concentration",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H418670915\">",
"      Specific gravity",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H413987\">",
"      - Urine osmolality",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Glucose",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      URINE SEDIMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Crystalluria",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Microorganisms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Cells",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Hematuria",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Pyuria",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Epithelial cells",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      CASTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6437027\">",
"      Red blood cell casts",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6437063\">",
"      White blood cell casts",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6437165\">",
"      Renal tubular epithelial cell casts",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6437217\">",
"      Granular casts",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Hyaline casts",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6437321\">",
"      Waxy casts",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6437328\">",
"      Broad casts",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      THE ASSESSMENT OF LIPIDURIA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      CORRELATION OF URINARY FINDINGS WITH KIDNEY DISEASES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1067607\">",
"      Hematuria with dysmorphic RBC, casts, and proteinuria",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1067630\">",
"      Heavy proteinuria with absent or minimal hematuria",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1067637\">",
"      Granular or epithelial cell casts",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1067644\">",
"      Isolated pyuria",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1067675\">",
"      Normal or near-normal urinalysis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13702294\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEPH/7196\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEPH/7196|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?22/63/23550\" title=\"algorithm 1\">",
"      Etiology of red urine",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEPH/7196|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?13/34/13870\" title=\"figure 1\">",
"      Causes of hematuria by age",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEPH/7196|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?14/47/15088\" title=\"picture 1\">",
"      Urine in AIP",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?10/50/11040\" title=\"picture 2A\">",
"      Uric acid crystals in the urine",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?20/51/21309\" title=\"picture 2B\">",
"      Uric acid crystals under polarized light",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?41/19/42302\" title=\"picture 3A\">",
"      Calcium oxalate crystals",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?10/20/10561\" title=\"picture 3B\">",
"      Ca oxalate monohydrate crystals",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?2/10/2208\" title=\"picture 4\">",
"      Cystine crystals",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?34/38/35439\" title=\"picture 5\">",
"      Struvite crystals",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?17/21/17747\" title=\"picture 6\">",
"      Urine sediment with bacteria budding yeast and hyphae",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?43/46/44768\" title=\"picture 7\">",
"      Phase contrast micrograph showing monomorphic red cells in urine",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?24/0/24591\" title=\"picture 8A\">",
"      Phase contrast micrograph showing dysmorphic red cells in urine",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?13/47/14079\" title=\"picture 8B\">",
"      Scanning electron micrograph showing dysmorphic red cells",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?34/38/35424\" title=\"picture 8C\">",
"      Photomicrograph of urine sediment with a red cell cast",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?29/6/29792\" title=\"picture 8D\">",
"      Fatty cast",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?31/0/31758\" title=\"picture 8E\">",
"      Fatty cast polarized",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?14/37/14943\" title=\"picture 9\">",
"      Photomicrograph of urine sediment with white blood cells",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?1/17/1300\" title=\"picture 10\">",
"      Urine sediment renal tubular and epithelial cell cast",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?18/1/18448\" title=\"picture 11\">",
"      Urine sediment showing a transitional epithelial cell",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?34/18/35105\" title=\"picture 12\">",
"      Urine sediment showing squamous epithelial cells",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?24/51/25393\" title=\"picture 13A\">",
"      White blood cell cast I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?33/49/34591\" title=\"picture 13B\">",
"      White blood cell cast II",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?7/34/7715\" title=\"picture 14\">",
"      Granular casts",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?33/53/34643\" title=\"picture 15\">",
"      Urine sediment showing a hyaline cast",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?28/1/28688\" title=\"picture 16\">",
"      Urine sediment showing a waxy cast",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?15/25/15762\" title=\"picture 17\">",
"      Urine sediment showing a broad cast",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?37/63/38900\" title=\"picture 18A\">",
"      Urinary sediment in acute tubular necrosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?31/15/31985\" title=\"picture 18B\">",
"      Tubular epithelial cell cast in acute tubular necrosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEPH/7196|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?20/58/21420\" title=\"table 1\">",
"      Urinary clues to inborn errors of metabolism",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?37/51/38715\" title=\"table 2\">",
"      Urinary patterns associated with different kidney diseases",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/19/42295?source=related_link\">",
"      Approach to the adult with asymptomatic bacteriuria",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/45/36570?source=related_link\">",
"      Assessment of kidney function",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/37/13914?source=related_link\">",
"      Assessment of urinary protein excretion and evaluation of isolated non-nephrotic proteinuria in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/1/14355?source=related_link\">",
"      Chapter 13B: Meaning of urine osmolality and pH",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/10/16552?source=related_link\">",
"      Chapter 6B: Antidiuretic hormone and water balance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/29/17875?source=related_link\">",
"      Chapter 9A: Water balance and regulation of plasma osmolality",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/6/22632?source=related_link\">",
"      Clinical features and diagnosis of heme pigment-induced acute kidney injury (acute renal failure)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/36/27209?source=related_link\">",
"      Clinical manifestations and diagnosis of acute interstitial nephritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/55/32632?source=related_link\">",
"      Clinical manifestations and diagnosis of rhabdomyolysis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/61/27610?source=related_link\">",
"      Clinical presentation and diagnosis of non-Hodgkin lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/47/20217?source=related_link\">",
"      Clinical presentation, diagnosis, and staging of bladder cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/62/25577?source=related_link\">",
"      Cystine stones",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/47/24312?source=related_link\">",
"      Diagnosis of polyuria and diabetes insipidus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/60/35785?source=related_link\">",
"      Diagnostic approach to the patient with acute kidney injury (acute renal failure) or chronic kidney disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/31/27130?source=related_link\">",
"      Differential diagnosis and evaluation of glomerular disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/4/23624?source=related_link\">",
"      Disorders of tyrosine metabolism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/44/18120?source=related_link\">",
"      Etiology and diagnosis of distal (type 1) and proximal (type 2) renal tubular acidosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/54/12138?source=related_link\">",
"      Etiology and diagnosis of prerenal disease and acute tubular necrosis in acute kidney injury (acute renal failure)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/59/34746?source=related_link\">",
"      Etiology and evaluation of hematuria in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/63/36857?source=related_link\">",
"      Etiology and evaluation of hypernatremia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/20/21832?source=related_link\">",
"      Evaluation of the patient with hyponatremia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/16/20745?source=related_link\">",
"      High albuminuria (microalbuminuria) and cardiovascular disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/11/21690?source=related_link\">",
"      Indications for and complications of renal biopsy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/3/4154?source=related_link\">",
"      Methanol and ethylene glycol poisoning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/33/39449?source=related_link\">",
"      Microalbuminuria in type 2 diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/53/10074?source=related_link\">",
"      Osmotic demyelination syndrome and overly rapid correction of hyponatremia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/18/32041?source=related_link\">",
"      Overview of heavy proteinuria and the nephrotic syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/32/10759?source=related_link\">",
"      Overview of renal tubular acidosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/54/40802?source=related_link\">",
"      Pathogenesis and clinical manifestations of struvite stones",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/1/22551?source=related_link\">",
"      Pathogenesis and diagnosis of myeloma cast nephropathy (myeloma kidney)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/4/4170?source=related_link\">",
"      Pathogenesis and etiology of postischemic (ischemic) acute tubular necrosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?9/53/10066?source=related_link\">",
"      Patient information: Blood in the urine (hematuria) in adults (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?22/59/23474?source=related_link\">",
"      Patient information: Blood in the urine (hematuria) in adults (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?20/41/21151?source=related_link\">",
"      Patient information: Collection of a 24-hour urine specimen (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?36/35/37426?source=related_link\">",
"      Patient information: Glomerular disease overview (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/53/33626?source=related_link\">",
"      Risk factors for calcium stones in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/39/34418?source=related_link\">",
"      The significance of urinary eosinophils",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/1/19481?source=related_link\">",
"      Tumor lysis syndrome: Definition, pathogenesis, clinical manifestations, etiology and risk factors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/48/27400?source=related_link\">",
"      Types of renal disease in multiple myeloma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/57/27541?source=related_link\">",
"      Uric acid renal diseases",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/24/44422?source=related_link\">",
"      Urinary tract infection associated with urethral catheters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/41/24214?source=related_link\">",
"      Urine sampling and culture in the diagnosis of urinary tract infection in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_34_22059="Diarrhea referral indications";
var content_f21_34_22059=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F66399&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F66399&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Indications for referral for medical evaluation in children with acute diarrhea",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Young age (eg, age &lt;6 months or weight &lt;8",
"kg)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        History of premature birth, chronic medical conditions,",
"or concurrent illness",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fever (&ge;38&deg;C",
"for infants &lt;3 months or &ge;39&deg;C",
"for children 3 to 36 months)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Visible blood in stool",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Frequent and substantial volumes of diarrhea",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Persistent vomiting",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Caregiver's report of signs consistent with dehydration",
"(eg, sunken eyes or decreased tears, dry mucous membranes, or decreased",
"urine output)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Change in mental status (eg, irritability, apathy, or",
"lethargy)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Suboptimal response to oral rehydration therapy already",
"administered",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Inability of the caregiver to administer oral",
"rehydration therapy",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from King, CK, Glass, R, Bresee, JS, Duggan, C. Managing acute gastroenteritis among children: oral rehydration, maintenance, and nutritional therapy. MMWR Recomm Rep 2003; 52:1.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_34_22059=[""].join("\n");
var outline_f21_34_22059=null;
var title_f21_34_22060="Ear pressurization techniques";
var content_f21_34_22060=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F61166&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F61166&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Middle ear pressure equalization maneuvers",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Maneuver",
"       </td>",
"       <td class=\"subtitle1\">",
"        Description",
"       </td>",
"       <td class=\"subtitle1\">",
"        Comment",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Simple techniques",
"       </td>",
"       <td>",
"        Yawn, swallow, jaw thrust, head tilt",
"       </td>",
"       <td>",
"        Useful in patients with widely patent Eustachian tubes, but usually ineffective with marginally patent Eustachian tubes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Frenzel maneuver",
"       </td>",
"       <td>",
"        Diver pinches the nostrils, closes the glottis, and makes a \"k\" or \"guh\" sound to compress air in the back of the throat",
"       </td>",
"       <td>",
"        Can be performed at any point in the respiratory cycle and can be quickly repeated.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Valsalva maneuver",
"       </td>",
"       <td>",
"        Diver pinches the nostrils, tightens cheek muscle and exhales forcefully",
"       </td>",
"       <td>",
"        Prolonged efforts can reduce systemic venous return and cause hypotension",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Toynbee maneuver",
"       </td>",
"       <td>",
"        Diver pinches the nostrils while swallowing",
"       </td>",
"       <td>",
"        Limited effectiveness during rapid descent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Beance tubaire voluntaire maneuver",
"       </td>",
"       <td>",
"        Diver contracts the muscles of the soft palate while using the muscles of the upper throat to open the Eustachian tubes",
"       </td>",
"       <td>",
"        Difficult to teach and not easily mastered",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Roydhouse maneuver",
"       </td>",
"       <td>",
"        Diver contracts the muscles of the soft palate while tensing the tongue to open the Eustachian tubes",
"       </td>",
"       <td>",
"        Difficult to teach and not easily mastered; concomitant jaw thrust may be helpful",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Edmonds technique",
"       </td>",
"       <td>",
"        Combination of pressurization from the Frenzel or Valsalva maneuver with a jaw thrust or head tilt",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lowry technique",
"       </td>",
"       <td>",
"        Diver pinches the nostrils, builds up pressure with a Frenzel or Valsalva maneuver, and simultaneously swallows",
"       </td>",
"       <td>",
"        Requires coordination and practice but is very effective",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Twitch maneuver",
"       </td>",
"       <td>",
"        Diver builds up pressure with a Frenzel or Valsalva maneuver, then suddenly twitches the head sideways",
"       </td>",
"       <td>",
"        Throat muscle tension increases effectiveness of the technique",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from Kay, E, Undersea J 2000; 4:30.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_34_22060=[""].join("\n");
var outline_f21_34_22060=null;
var title_f21_34_22061="Limb-girdle muscular dystrophies";
var content_f21_34_22061=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F78969&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F78969&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Limb-girdle muscular dystrophies",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Type",
"       </td>",
"       <td class=\"subtitle1\">",
"        Gene location",
"       </td>",
"       <td class=\"subtitle1\">",
"        Protein",
"       </td>",
"       <td class=\"subtitle1\">",
"        Inheritance",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        LGMD1A",
"       </td>",
"       <td>",
"        5q31",
"       </td>",
"       <td>",
"        Myotilin",
"       </td>",
"       <td>",
"        AD",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        LGMD1B",
"       </td>",
"       <td>",
"        1q21.2",
"       </td>",
"       <td>",
"        Lamin A/C",
"       </td>",
"       <td>",
"        AD",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        LGMD1C",
"       </td>",
"       <td>",
"        3p25",
"       </td>",
"       <td>",
"        Caveolin-3",
"       </td>",
"       <td>",
"        AD",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        LGMD1E",
"       </td>",
"       <td>",
"        7q36",
"       </td>",
"       <td>",
"        <span class=\"RECOMMENDED\">",
"         DnaJ homolog subfamily B member 6",
"        </span>",
"       </td>",
"       <td>",
"        AD",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        MFM1",
"       </td>",
"       <td>",
"        2q35",
"       </td>",
"       <td>",
"        Desmin",
"       </td>",
"       <td>",
"        AD",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        LGMD1F",
"       </td>",
"       <td>",
"        7q32.1-q32.2",
"       </td>",
"       <td>",
"        ?",
"       </td>",
"       <td>",
"        AD",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        LGMD1G",
"       </td>",
"       <td>",
"        4q21.21",
"       </td>",
"       <td>",
"        ?",
"       </td>",
"       <td>",
"        AD",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        LGMD1H",
"       </td>",
"       <td>",
"        3p25.1-p23",
"       </td>",
"       <td>",
"        ?",
"       </td>",
"       <td>",
"        AD",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        LGMD2A",
"       </td>",
"       <td>",
"        15q15.1-q21.1",
"       </td>",
"       <td>",
"        Calpain-3",
"       </td>",
"       <td>",
"        AR",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        LGMD2B",
"       </td>",
"       <td>",
"        2p13.3-p13.1",
"       </td>",
"       <td>",
"        Dysferlin",
"       </td>",
"       <td>",
"        AR",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        LGMD2C",
"       </td>",
"       <td>",
"        13q12",
"       </td>",
"       <td>",
"        Gamma-sarcoglycan",
"       </td>",
"       <td>",
"        AR",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        LGMD2D",
"       </td>",
"       <td>",
"        17q12-q21.33",
"       </td>",
"       <td>",
"        Alpha-sarcoglycan",
"       </td>",
"       <td>",
"        AR",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        LGMD2E",
"       </td>",
"       <td>",
"        4q12",
"       </td>",
"       <td>",
"        Beta-sarcoglycan",
"       </td>",
"       <td>",
"        AR",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        LGMD2F",
"       </td>",
"       <td>",
"        5q33-q34",
"       </td>",
"       <td>",
"        Delta-sarcoglycan",
"       </td>",
"       <td>",
"        AR",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        LGMD2G",
"       </td>",
"       <td>",
"        17q12",
"       </td>",
"       <td>",
"        Telethonin",
"       </td>",
"       <td>",
"        AR",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        LGMD2H",
"       </td>",
"       <td>",
"        9q32-9q34.11",
"       </td>",
"       <td>",
"        TRIM32",
"       </td>",
"       <td>",
"        AR",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        LGMD2I (MDDGC5)",
"       </td>",
"       <td>",
"        19q13.3",
"       </td>",
"       <td>",
"        FKRP",
"       </td>",
"       <td>",
"        AR",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        LGMD2J",
"       </td>",
"       <td>",
"        2q24.3",
"       </td>",
"       <td>",
"        Titin",
"       </td>",
"       <td>",
"        AR",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        LGMD2K (MDDGC1)",
"       </td>",
"       <td>",
"        9q34.1",
"       </td>",
"       <td>",
"        POMT1",
"       </td>",
"       <td>",
"        AR",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        LGMD2L",
"       </td>",
"       <td>",
"        11p14.3",
"       </td>",
"       <td>",
"        ANO5",
"       </td>",
"       <td>",
"        AR",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        LGMD2M (MDDGC4)",
"       </td>",
"       <td>",
"        9q31",
"       </td>",
"       <td>",
"        Fukutin",
"       </td>",
"       <td>",
"        AR",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        LGMD2N (MDDGC2)",
"       </td>",
"       <td>",
"        14q24.3",
"       </td>",
"       <td>",
"        POMT2",
"       </td>",
"       <td>",
"        AR",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        MDDGC3",
"       </td>",
"       <td>",
"        1p34-p33",
"       </td>",
"       <td>",
"        POMGnT1",
"       </td>",
"       <td>",
"        AR",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     AD: autosomal dominant; ANO5: anoctamin 5; AR: autosomal recessive; FKRP: fukutin related protein; LGMD: limb-girdle muscular dystrophy; MDDGC: muscular dystrophy-dystroglycanopathy type C; POMGnT1: protein O-mannose beta-1,2-N-acetylglucosaminyltransferase; POMT1: protein O-mannosyl transferase 1; POMT2: protein O-mannosyl transferase 2; TRIM32: tripartite motif containing protein.",
"    </div>",
"    <div class=\"reference\">",
"     Modified from: Darras, BT, Jones, HR, Jr. Diagnosis of pediatric neuromuscular disorders in the era of DNA analysis. Pediatr Neurol 2000; 23:289.",
"     <br>",
"      Data from:",
"      <a href=\"file://www.ncbi.nlm.nih.gov/omim\">",
"       Online Medelian Inheritance in Man",
"      </a>",
"      .",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_34_22061=[""].join("\n");
var outline_f21_34_22061=null;
var title_f21_34_22062="Manubriosternal osteoarthrosis";
var content_f21_34_22062=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F71428&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F71428&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Manubriosternal osteoarthrosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 243px; height: 342px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Oblique view of the manubriosternal joint (arrow) in a patient with anterior chest pain demonstrating irregularity and sclerosis of the manubriosternal joint.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Christopher Wise, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_34_22062=[""].join("\n");
var outline_f21_34_22062=null;
var title_f21_34_22063="Stenosis basilic vein";
var content_f21_34_22063=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F65660&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F65660&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Multiple areas of stenosis affecting the basilic vein",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 223px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    As can be seen the graft extends above the elbow. There is also stenosis at the venous anastomosis. On the left is the post treatment appearance.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Gerald Beathard, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_34_22063=[""].join("\n");
var outline_f21_34_22063=null;
